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Abstract 
 
Humans and the environment are continuously exposed to a multitude of substances via different routes of exposure. 
However, the risk assessment of chemicals for regulatory purposes does not generally take into account the “real life” 
exposure to multiple substances, but mainly relies on the assessment of individual substances. This report summarises 
the different methodologies that are used to assess the toxic effects of mixtures. It also provides an overview of current 
legislation in the European Union (EU) that deals with the safety assessment of chemicals in different matrices and the 
extent to which the current legislation addresses the toxicological risk of mixtures. Relevant Guidance Documents from the 
EU and other countries (USA, Canada) and international organisations, such as the World Health Organisation (WHO) and 
the Organisation for Economic Cooperation and Development (OECD) are also included in this review. 
 
 Executive Summary 
Humans and the environment are continuously exposed to a multitude of substances via 
different routes of exposure. However, the risk assessment of chemicals for regulatory 
purposes does not generally take into account the “real life” exposure to multiple substances, 
but mainly relies on the assessment of individual substances. This report summarises the 
different methodologies that are used to assess the toxic effects of mixtures (Chapter 1). It 
also provides an overview of current legislation in the EU that deals with the safety 
assessment of chemicals in different matrices and the extent to which the current legislation 
addresses the toxicological risk of mixtures (Chapter 2). Relevant Guidance Documents from 
the EU and other countries (USA, Canada) and international organisations, such as the World 
Health Organisation (WHO) and the Organisation for Economic Cooperation and 
Development (OECD) are also included in this review (Chapter 3). 
Some mixtures that need to be assessed are intentional and thus have a known 
composition, e.g. personal care products, food additives and pesticides. However, in many 
cases, mixtures are unintentional and (largely) of unknown composition, e.g. the combination 
of dozens to hundreds of substances in surface water, drinking water and air. Two approaches 
are used to assess mixture toxicity: testing of the whole product/mixture, and testing of the 
individual substances followed by mathematical modelling to predict the combined effect. 
Testing of the total mixture is frequently applied for environmental samples, as it has the 
advantage of assessing the toxicity of mixtures of unknown composition. However, the 
substances driving the overall response frequently remain unidentified. A more common 
approach is to consider the toxicity of the individual constituents, but this requires more 
information regarding identity, concentration and toxicity (including mode of action) of the 
substances, which is frequently lacking. To some extent, missing information regarding 
concentration and toxicity of known chemicals can be estimated using computational models. 
Several mathematical models are commonly applied to estimate the combined 
toxicological effect of known substances. Based on the mode of action, these models either 
assume that substances act independently (independent action, IA) or additively (dose or 
concentration addition, CA). IA models regard a combined effect to be the result of 
statistically independent random events, and no risk is anticipated as long as exposure 
concentrations do not exceed zero-effect levels. In contrast, CA models are based on 
pharmacological concepts like receptor binding and assume that the response of substances 
are additive if they share the same biological target. Generally, models assuming dose 
addition are the most frequently applied, because they provide reliable estimates of combined 
effects and are regarded to be more conservative than independent action models. Other 
models can also take into account antagonistic and synergistic effects, although the relevance 
of these interactions at the low concentrations generally encountered is still matter of debate. 
Several pieces of EU legislation are in place to regulate single and multiple compounds. 
These compounds and mixtures can be intentional (i.e. products) and they are generally 
relatively simple in their composition. Hence, their toxicity can usually be assessed relatively 
easily based on knowledge of their individual components, or by toxicity tests on the final 
 product mixture. The following pieces of EU legislation have been identified that apply to 
intentional mixtures: 
 Industrial chemicals and related intentional mixtures are assessed under 
REACH (Regulation No 1907/2006). Risk assessment focuses on human and 
environmental (mainly aquatic) risk. Substances and mixtures are divided into 
different hazard classes based on the Classification, Labelling and Packaging 
regulation (Regulation No 1272/2008), which has specific provisions for assessing 
mixtures.  
 Plant Protection Products (PPPs) (Regulation No 1107/2009, 283/2013 and 
284/2013) and biocides (Regulation No 528/2012) are generally mixtures composed 
of one or more active substances. Their safety is mainly assessed based on the 
individual substances and the final products. Attention is given to cumulative and 
synergistic effects.  
 Human and veterinary pharmaceuticals are generally applied as mixtures. The 
risk assessment of human pharmaceuticals (Directive 2001/83/EC) focuses on 
humans, including potential interactions with other pharmaceuticals. An 
environmental risk assessment is also required but no attention is given to cumulative 
or mixture effects. Veterinary products (Directive 2001/82/EC) are assessed with 
emphasis on animal, human and environmental risks. The ecotoxicity assessment of 
veterinary mixtures is more extensive than for human pharmaceuticals, but joint 
occurrence with other pharmaceuticals or other pollutants is not taken into account. 
 Cosmetic products (Regulation 1223/2009) usually consist of several 
substances, and their risk can be assessed on the basis of individual ingredients, 
combinations thereof or the whole product. Animal testing is not allowed. The 
anticipated exposure to the individual ingredients has to be taken into account, 
including possible interactions. Environmental risks are not addressed but are 
considered to be assessed via REACH.  
 Food and feed stuff can be regarded as complex mixtures. Additives 
(Regulation No 1333/2008) are assessed for toxicity, but the assessment of mixtures is 
mainly based on individual compounds. Cumulative toxic effects have to be taken 
into account, but how the cumulative assessment should be conducted is not specified. 
 Human risk assessment via toys (Directive 2009/48/EC) focuses on individual 
compounds that should not be used in toys, with emphasis on the sensitivity of the 
target group (i.e. children). Only individual chemicals (beside nitrosamines and 
nitrosable compounds) are taken into account. For the toxicological properties, 
reference is made to REACH and the classification and labelling legislation. 
 
In contrast to intentional compounds and mixtures, unintentional mixtures 
(contaminants, by-products and environmental pollutants) are much more challenging to 
assess, because they are of varying and often complex composition, and many of the 
substances present are unidentified and toxicity data are lacking. Legislation generally 
includes limit values for some of the known individual constituents. The following pieces of 
 (mostly environmental) legislation have been identified that address the toxicological risk of 
unintentional mixtures: 
 Regulations on contaminants in food (Regulation No 315/93/EEC and follow-
up regulations) contain limit values for individual contaminants and generally do not 
take mixture toxicity into account, with the exception of dioxins and dioxin-like 
compounds. Food contact materials are addressed separately (Regulation No 
1935/2004), considering cumulative effects (undefined) but not mixture toxicity. 
Pesticide residues in food and feed are also regulated separately (Regulation No 
396/2005), which acknowledges the need for cumulative and mixture toxicity 
assessment. This has recently been addressed by EFSA. 
 Water contaminants in general are regulated under the Water Framework 
Directive (Directive 2006/60/EC), with the related Groundwater Directive (Directive 
2006/118/EC) in place to address groundwater specifically. Both focus on limit values 
for individual chemicals and do not specifically address mixtures or aggregated 
exposure. However, reference is made to Environmental Quality Standards (EQS) 
(Directive 2013/39/EU), which do address mixture toxicity. The marine environment 
is covered separately by the Marine Strategy Framework Directive (2008/56/EC), 
which emphasises that risk assessment should also consider cumulative and mixture 
effects but without further specification.  
 The Drinking Water Directive (98/83/EC) regulates the maximum levels of 
contaminants in drinking water. It includes a list of individual compounds but mixture 
toxicity and cumulative exposure are not specifically addressed. 
 Soil quality is addressed by several regulations. A thematic strategy for soil 
protection is in place (COM(2006)231) and a Directive has been proposed 
(COM(2006)232). The focus of the proposed directive is on soil function, pollution 
and risk, but mixture toxicity is not specifically addressed. 
 The Directive on ambient air quality (Directive 2008/50/EC) contains target 
values as limits for individual compounds, but no special attention is given to mixture 
toxicity. 
 Waste production is addressed by the Waste Framework Directive (Directive 
2008/98/EC). It does not directly address the toxicological assessment of waste, but 
rather the management and refers to the legislation on classification and labelling for 
toxicity assessment. It covers general waste streams but excludes some specific 
industrial wastes and other waste streams which are covered by other (environmental) 
legislation. The Waste Framework Directive is linked to the Directive on Integrated 
Pollution Prevention and Control (IPPC) (Directive 2010/75/EU), which addresses 
(waste) emissions to the air, including waste incineration. The IPPC does not address 
mixtures with the exception of dioxins and furans.  
 To ensure the safety of workers against chemical agents at work, Directive 
98/24/EC specifies maximum levels for individual substances. It also refers explicitly 
to chemical agents in combination, covering both intentional and coincidental 
mixtures. 
  A separate directive (Directive 2011/92/EU) is in place for the environmental 
impact assessment of large scale public and private projects (e.g. motorways, airports) 
that are likely to have significant effects on the environment. This includes 
estimations of emissions of pollutants, including cumulative effects, but mixture 
toxicity is not specifically addressed.  
 
In addition to the existing pieces of EU legislation, several guidance documents and 
reviews are available that provide information on how to apply risk assessment of mixtures. 
These are mostly based on combined exposure to different substances with a similar mode of 
action. Special attention is given to exposure via different (dietary) routes and mathematically 
based physiological models are recommended to determine the potential uptake. The 
European Food Safety Authority (EFSA) has proposed a tiered approach for cumulative risk 
assessment, focusing on human exposure to pesticides. However, in principle the concepts 
developed could be applied to other groups of chemicals (e.g. PAHs and flame retardants). 
An opinion of the European Commission’s non-food scientific committees (SCCS, SCHER 
and SCENIHR) acknowledged the relevance of joint exposure, but emphasised that regarding 
human health the assessment of individual substances is sufficient for dissimilar acting 
substances. However, it was concluded that environmental effects cannot be excluded, even 
when concentrations are below the individual no effect concentrations. Major knowledge 
gaps exist however, regarding mode of action, environmental or human concentrations, and 
toxicity of individual components. Approaches that have been put forward generally apply 
the CA concept, as is recently applied in an EU regulation on biocidal products. 
Several non-EU guidance documents are also available that address mixture toxicity. 
Especially in the USA, guidance documents have been in place for decades that focus on the 
toxicity of mixtures, and several governmental bodies including the Environmental Protection 
Agency (EPA), Food and Drug Administration (FDA) and the Agency for Toxic Substances 
and Disease Registry (ATSDR) are involved in the assessment of mixtures. Several acts are 
in place requiring cumulative risk assessment, like the Comprehensive Environmental 
Response Compensation and Liability Act (CERCLA), the Food Quality Protection Act and 
the Safe Drinking Water Act. The US EPA has published several guidelines dealing with the 
risk assessment of chemicals, including mixtures. These generally do not consider 
interactions, but focus on grouping of chemicals and on the basic concept of addition. In 
2008, the National Research Council emphasised the need for mixture toxicity assessment 
and the grouping of compounds based on their adverse outcome rather than structural 
similarity. The Canadian Environmental Assessment Review Office has a reference guide on 
cumulative environmental effects, under the Canadian Environmental Assessment act. It 
considers the combined effects of human activities on the ecosystem, not only including 
chemical pollution but also for example global warming and loss of biodiversity and takes 
aggregated exposure into account. 
In addition to legislative initiatives above, the WHO, together with the FAO, has also 
been working on several projects that address the human and environmental risk assessment 
of chemicals, including (sometimes specific) mixtures. Others focus solely on 
 ecotoxicological effects, e.g. addressed in recent publications by ECETOC or OSPAR. All 
stress the relevance of mixture toxicity assessment and acknowledge the lack of information 
that is hampering the practical application of these concepts and approaches. 
In conclusion, while many pieces of EU legislation are in place to protect humans and 
the environment against adverse effects of chemicals including mixtures, in many cases it 
remains unclear how this is to be carried out and only few explicitly consider (real life) 
exposure to mixtures. In cases where mixtures are considered, the assessment is frequently 
limited to some well-known components. Several mathematical models and approaches have 
been developed to assess the toxicity of mixtures, but their routine application is hampered by 
considerable information gaps. 
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 1 
1 - Introduction 
Recent decades have witnessed an important increase in the synthesis, manufacture and 
use of chemicals worldwide, in both developed and developing countries. As a consequence, 
humans and the environment are exposed continuously to large numbers of chemicals 
simultaneously or sequentially and through multiple exposure routes often in low 
concentrations; i.e. they are exposed to combinations of chemical in time and in space, from 
different sources, and most often chronically. The term "chemical mixtures" refers to such a 
combined exposure to multiple chemicals, and this term is defined as any set of multiple 
chemicals, regardless of their source, that may or may not be identifiable and that may 
contribute to joint toxicity in a target population (Mumtaz et al., 2010).  
Chemical mixtures can be separated into three types: 
-"Intentional mixtures", which are mixtures that are intentionally manufactured as such (i.e 
regulated and manufactured products such as pesticide formulations or laundry detergent) 
-"Generated mixtures" contain additional compounds that are by-products of processes 
involved (e.g. smelting, drinking water disinfection, fuel combustion); they are usually 
originating from a single source  
-"Coincidental mixtures" are composed of unrelated chemicals from different sources, but 
having the potential to reach the same "receptor population", e.g. by their presence in or 
migration into the same medium (e.g. groundwater), or through multiple pathways (ATSDR, 
2004). 
A distinction is also made between simple and complex mixtures based on their 
composition: a simple mixture consists of a relatively small number of chemicals (e.g ten or 
fewer), and its composition is qualitatively and quantitatively known (ex: cocktail of 
pesticides, a combination of medicines or a group of allyl alcohol esters), whereas a complex 
mixture is a mixture that comprises tens, hundreds or thousands of chemicals, the 
composition of which is qualitatively and quantitatively not fully known (ex: a workplace 
atmosphere, drinking water, welding fumes but also products based on natural ingredients 
like plant extracts) (Feron and Groten, 2002).  
The US Agency for Toxic Substances and Disease Registry (ATSDR) also defines the 
term "similar mixtures" as mixtures having the same chemicals but in slightly different 
proportions or having most but not all chemicals in common and in highly similar 
proportions. Similar mixtures are thus expected to have similar fates, transports, and health 
effects (ATSDR, 2004). 
Thus, long term exposures to low doses of chemical mixtures are now the rule rather 
than the exception, which implies multiple potential interactions between chemicals, and risk 
assessment must cope with such challenges. This is especially prominent when it comes to 
endocrines disruptors (EDs) exposure, as they can be present at very low doses and originate 
from multiples sources (e.g. drinking water, diet, residential environment). Thus they lead to 
a final exposure which is much higher than the individual concentrations. Moreover, the 
mixture may display a complex mode of action compared to its constituents due to different 
 2 
interactions (i.e. mixture effects), which are usually ignored (Danish Ministry of the 
Environment, 2009). This is also true for any kind of long term exposure to bioaccumulating 
substances, which could over time result in a final high level of exposure of the individual, 
although the environmental concentrations are low.  
Nevertheless, human health risk assessment in a regulatory context is still mainly based 
on in vivo toxicity data generated from exposure to a single substance through a single 
exposure route and medium. Uncertainty factors are then applied to those data to allow for 
interspecies and inter-individual variation, but they generally do not take into account the 
possibility of combined actions or interactions between substances. However, from a public 
health point of view it is essential to take into account the combined exposure, including 
potential interactions that can influence the overall effect. Another approach consists in 
testing the mixtures itself (whole mixture testing), especially in the case of the registration of 
chemical mixtures under sectorial regulations such as the plant protection products and 
biocidal products regulations. However, for ethical and economical reasons, and in the light 
of the Directive on the protection of animals used for scientific purposes (Directive 
2010/63/EU), the EU policy now aims at reducing the use of laboratory animals and at 
promoting alternative methods: thus, in vivo testing of the whole mixture is not an option any 
more. Moreover, testing of individual mixtures is also hardly possible due to the almost 
infinite number of possible different combinations. 
It should also be highlighted that an individual substance, depending on its type and/or 
expected use, can be subject to various EU and national legislation and might need to be 
specifically authorized for a certain use. The actual risk assessment requirements are defined 
for a certain use within specific pieces of EU legislation (e.g. as an active ingredient in a 
plant protections product or pharmaceutical) and do not take into account that the end user 
could be the same and exposed to higher doses of a specific substance than foreseen in the 
individual risk assessments for different uses.  
In other words, current regulatory requirements do not generally address the exposure to 
a single substance by multiple pathways and routes of exposure, following its possible 
different uses (i.e the so-called "aggregated exposure"). Exposure to multiple components 
sharing a common mechanism of action (i.e the so-called cumulative exposure) might also 
pose a health problem even if the individual components are present at levels below their 
respective NOAELs (No Observed Adverse Effects Levels); however the risk assessment 
regimes under the different existing regulations do often not take into account such risks. 
For all these reasons, there is a need to develop a consistent, cross-sector approach to 
deal with the combined exposure to multiple chemicals.  
On 22nd December 2009, the Council expressed some concerns on the "combination 
effects of chemicals" and invited the Commission, "… to assess how and whether relevant 
existing Community legislation adequately addresses risks from exposure to multiple 
chemicals from different sources and pathways, and on this basis to consider appropriate 
modifications, guidelines and assessment methods, and report back to the Council by early 
2012 at the latest." On 31 May 2012 the Commission reported to the Council and engaged to 
launch a new process to ensure that risks associated with chemical mixtures are properly 
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understood and assessed (EC, 2012a). Under the new approach, the Commission will identify 
priority mixtures to be assessed, ensure that the different strands of EU legislation deliver 
consistent risk assessments for such priority mixtures, and tackles some of the data and 
knowledge gaps to improve understanding of the mixtures to which people and the 
environment are exposed. The new Commission approach draws heavily on the recent 
opinion of the three non-food scientific Committees (EC, 2011b) as well as on the "State of 
the Art Report on Mixture Toxicity" (Kortenkamp et al., 2009) a study contracted in 2007 by 
DG Environment and completed in 2009, which review the current scientific knowledge and 
regulatory approaches.  
In this context, the objective of this review was to update the work previously done on 
the analysis of EU regulations and risk assessment regimes and requirements regarding 
mixtures toxicity. The first part of this review summarises the different theoretical and 
mathematical approaches used in the risk assessment of mixtures, whereas the second part of 
the review focuses on the requirements across EU legislative sectors for both human health 
and the environment. Finally, the third part reviews activities in the area of development of 
guidance and risk assessment methodologies by Member State (MS) authorities, agencies and 
international organisations. 
 4 
2 - Theory and methodology underlying the risk assessment of 
chemical mixtures 
2.1 Source of exposure and environmental fate 
Regarding human health, exposure to mixtures can result from the use of specific 
(intentional) chemical mixtures (i.e. one single source of exposure to the several components 
of the mixture), in a particular context (i.e. occupational settings) or from diverse 
environmental sources of one or more chemicals (e.g. food, water, air). This is the case of the 
exposure of the public, in which exposure may occur via multiple pathways, routes, and 
media (aggregate exposure). Therefore, in order to do a realistic risk assessment, aggregated 
and cumulative exposure from all sources to multiple chemicals may need to be considered.  
When assessing the risk for occupational exposure, the chemical composition of the 
resulting mixture to which the worker is exposed, is often known and direct measurements 
and various models for estimating the exposure are available. This is not the case when 
assessing general public exposure, in which case the chemical composition of the mixture is 
often unknown and no, or very limited measured data, are available. Therefore, it is necessary 
to rely on assumptions and simplification and to use modelling to provide relevant exposure 
estimates. For a worst case estimate, it is possible to assume maximum exposure to each 
component of the mixture based on the assessment of daily exposure from all sources, 
although information to support such an assessment is rarely available (EC, 2011b).  
Environmental exposure is even more complex, as it results from intricate patterns 
depending on emissions, point releases, fate, distribution and persistence of chemicals in the 
different compartments (i.e. water, sediment, air, soil and biota). The environment is 
continuously exposed to a wide range of anthropogenic compounds (and their breakdown 
products), including industrial mixtures (e.g. plant protection products) containing several 
active substances with possibly different environmental behaviour, but also chemical 
mixtures emitted by specific human activity (such as complex effluent), and resulting 
mixtures from multiple emission sources (i.e the combination of all the emissions of human 
activities in a given territory). In the case of commercial mixtures and mixtures emitted by 
specific human activities, the composition of the mixture is likely to be known and 
characterised, at least partly and at a local scale (i.e. emission point). However, the 
composition may change with time due to differences in environmental fate of each 
substance. Moreover, regarding plant protection products for example, even if theoretically 
the risk of a mixture of active substances in one commercial formulation is considered in the 
RA process, in practice most of the time different formulations are combined before field 
application and the resulting mixtures are not the same as those assessed in the authorisation 
process. In the case of mixtures resulting from multiple emission sources, the composition of 
the mixtures is rarely known, and probably even fluctuates in time and space as it might 
concern a bigger territory (i.e. a hydrographic basin). Whereas the two first cases could be 
linked to the implementation of prospective risk assessment schemes using modelling to 
predict mixture toxicity, the third case could be addressed by retrospective risk assessment 
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approach, aiming at assessing the impact of an unknown mixture on an ecosystem when 
compared to a reference state. 
Thus, due to e.g. specific and different physico-chemical properties of the components, 
their potential for biodegradation, abiotic and biotic environmental factors, the climate, the 
geography and the time of the year, the composition of any kind of mixture in the 
environment at a given time may be completely different from those of the originally emitted 
mixture, and significant differences should be expected between the mixture which is 
released and the mixture to which organisms are exposed.   
To simplify the mixture issue, instead of considering every single substance, one 
approach consists in grouping chemicals in "blocks" of chemicals having similar structure, 
since they might have similar physico-chemical and environmental degradation properties, 
similar distribution and similar environmental fate. These blocks should also contain 
substances with a similar mode of action and a narrow range of toxicity in order to make this 
approach reliable. Once the blocks are defined, PEC values (Predicted Environmental 
Concentrations) can be calculated for each block in each environmental compartment (King 
et al., 1996).  This approach, the so-called "hydrocarbon block method", is used to perform 
risk assessments of complex petroleum substances (ECHA, 2008a). 
Moreover, the distribution in different environmental compartments can be predicted by 
modelling, and is usually based on individual substances (i.e the FOCUS models for 
pesticides). Mixture compositions may then be obtained through their combination (EC, 
2011b), as the assumption is made, at environmentally relevant concentrations, that the 
distribution of each component of a mixture is not influenced by the physico-chemical 
properties of the other components, although biodegradation of one component can be 
influenced by the presence of others. Up to now, no satisfactory model has been developed 
for modelling mixtures' biodegradation, which is probably due to the complexity of the 
biochemical mechanisms implicated in this process (substrate competition, metabolism, 
enzyme induction etc.). 
2.2 Whole-mixture analysis and component-based analysis   
The hazard of chemical mixtures can be assessed as a whole (whole-mixture analysis, or 
top-down approach), or based on the individual components of the mixture (components-
interaction analysis or bottom-up approach).  
Whole mixture effects can be assessed by testing the mixture itself, but can also be based 
on data generated with a mixture of similar composition (i.e. close in composition regarding 
components and proportions). If adverse effects are found in relevant toxicity studies, a 
quantitative assessment can then be carried out directly from these data. This approach allows 
consideration of any unidentified materials in the mixtures and any interactions among 
mixture components, but it does not identify the chemicals responsible for interactions, and 
does not provide any information on the toxicity of individual mixture components. 
Moreover, this approach is restricted to mixtures that do not significantly change in their 
composition, and is therefore not recommend using as a general approach (EC, 2011b). 
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A more detailed approach, which is generally used when the components of the mixture 
are known, is to assess the combined action of the components. In this analysis, the choice of 
the experimental design to follow is dependent on the complexity and number of components 
of the mixture, and the main consideration is whether the mixture components act by the 
same mode of action (MOA) or whether they are functionally independent (Groten et al., 
2001). Its optimal use is therefore dependent on the knowledge of the MOA of the individual 
components, or on the information regarding their association with groups of chemicals 
demonstrating similar or identical MOA (assessment groups). Such information may be based 
on chemical structures and structure-activity relationships (either qualitative or quantitative), 
molecular modelling, structural alerts or on toxicological responses or effects (EC, 2011b).  
Another component-based approach consists in grouping chemicals according to their 
toxicological effects. In this approach, hazard information is used to identify and group 
chemicals that have similar endpoints and a common toxic effect, to then assess the 
cumulative effects of the group of chemical, even if the underlying MOA are not known.   
2.3 Mathematical approaches used in the component-based approach 
Three basic types of action for combination of chemicals are defined: (i) dose or 
concentration addition, which implies a similar MOA of the substances in the mixture; (ii) 
independent action or response addition, which implies a dissimilar MOA of the substances 
in the mixtures; and  (iii) interactions in between substances in the mixture. The term 
interaction includes all forms of joint action that deviate from either dose or response 
addition. Hence, the combined effect of two or more substance is either greater (synergistic, 
potentiating, supra-additive) or less (antagonistic, inhibitive, sub-additive, infra-additive) than 
that predicted on the basis of dose addition or response addition. The two first concepts are 
based on the assumption that substances do not influence each other's toxicity by interacting 
at the biological target site, and they have been suggested as default approaches in regulatory 
risk assessment of chemical mixtures (EC, 2011b), although chemical mixtures are rarely 
composed of either only similarly or of only dissimilarly acting substance. Those three 
approaches for hazard assessment and risk characterisation of multiple chemicals are mostly 
applied to component-based approaches and further described below. 
2.3.1  Dose or concentration addition 
Synonyms: simple similar action, similar joint action, relative dose-addition, or 
concentration addition.  
This model assumes that the effects can be estimated directly from the sum of the dose 
or concentrations of similarly acting substances in the mixture, scaled for their potencies. 
This model is based on the pharmacological concepts of ligand binding site theory, affinity, 
potency, and receptor occupancy: receptor occupancy is proportional to the concentration of 
the ligand and its affinity for the receptor. Thus, the magnitude of the biological response to 
the chemical mixture can be predicted by summing the doses of the components after 
adjusting for the differences in potencies (USEPA, 2007a; EFSA, 2008b). In practice, doses 
or concentrations of the single substances are added after being multiplied by a scaling factor 
accounting for differences in the potency of the individual substances.  
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According to the literature, this model provides reliable estimates of combined effects 
and is appropriate for risk assessment of a mixture of chemicals if the substances share either 
a strictly identical molecular mechanism of action or belong to the group of baseline toxicants 
(acting by nonpolar narcosis) (Feron and Groten, 2002; Kortenkamp et al., 2009). However, 
for other authors, the evaluation of dose-additivity or non additivity is a matter entirely for 
observation using measured dose-response curves, with no required consideration of 
mechanism of action (NRC, 2008). Those authors also highlight several observations of 
particular interest about the definition of dose addition: 
- The dose additivity of a particular mixture does not imply the dose additivity of other 
mixtures of the same components. Mixtures of the same components may be non-
dose additive for different component doses, indeed, may be synergistic at some 
combinations of component doses, and antagonistic at others.  
- Conclusions about dose addition, synergism, or antagonism may not be the same for 
different levels of effect even for similar mixture ratios. 
Methods for dose/concentration addition approaches most frequently used in human 
health are the hazard index (HI), the reference point index (RfPI, or PODI for Point of 
departure index), or the toxic equivalency factor (TEF). They are presented in Table 1. The 
toxic unit (TU) model is often used in environmental toxicology (EC, 2011b).  
2.3.2  Independent action (response addition) 
Synonyms: independent action, effect addition, simple independent (or dissimilar) action 
and independent joint action.  
Response addition occurs when the toxicological effects of the individual substances in a 
mixture are a consequence of separate mechanism or MOA, and possibly, but not necessarily, 
when the nature and sites of toxic effects differ between the chemicals in a mixture (USEPA, 
2007a; EFSA, 2008b). This model assumes that a combination effect can be calculated from 
the responses of the individual components using the statistical concept of independent 
random events; response addition refers to the sum of probabilistic risks or incidence, 
whereas effects addition means the sum of biological responses. Excepted for non-threshold 
effect, no health risk is anticipated as long as the various exposure concentrations do not 
exceed respective zero-effect levels. 
The toxicity of a mixture is expressed in terms of probability of an individual to be 
affected. For the ecological assessment, the reference value is the Predicted No Effect 
Concentration (PNEC), set at the population or community level, which therefore does not 
exclude effects on individuals. The population/community response is the aggregation of the 
individual effects, which depends on the biology of each species and their ecological role. 
Therefore a mixture of substances with independent action at levels below the ecological 
thresholds set at the population/community level, but above the threshold for producing 
effects on individuals, may have effects at the population/community level due to the 
"aggregated" outcome of the effect on each individual. This is not currently considered in the 
derivation of the PNECs and environmental quality standards (EQSs) and new scientific 
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developments are required for a scientifically sound assessment of this "aggregated" outcome 
(EC, 2011b).   
2.3.3  Interaction: synergism and antagonism 
Biological interactions might occur at multiple levels, and interference can occur at 
either the toxicokinetic level (i.e. occur during the processes of uptake, distribution, 
metabolism and excretion, for example chemicals modifying the absorption or active 
transport of other) or the toxicodynamic level (i.e. interactions between the biological 
responses resulting from exposure to the chemical and effects of chemicals on the receptors, 
cellular target or organ). For example, compounds that influence the amount of 
biotransformation enzymes can have large effects on the toxicity of other chemicals, as well 
as competition between substrates for the same pumps or for the biotransformation enzymes 
themselves. Interactions are translated by an effect differing from additivity based on the 
dose-response relationship of the individual components, and are categorised as less than 
additive (antagonistic, inhibitive, masking) or greater than additive (synergistic, potentiating); 
they may vary according to the relative dose levels, the route(s), timing and duration of 
exposure, and the biological target. Thus, for a realistic and accurate risk assessment, the 
interactions' consideration and their integration into the toxicity assessment of a mixture is 
important. 
Antagonism happens when the combined effect of the mixture is less than explained by 
the total additive effect of the individual components. Masking occurs when components 
produce opposite or functionally competing effects on the same organ system, and diminish 
the effects of each other, or one overrides the effect of the other (ATSDR, 2004; USEPA, 
2007a; EFSA, 2008b). The result being a decreased toxicity, antagonism is not an issue for 
risk assessment and the use of additive model could constitute a worst-case.  
Synergism occurs when the effects of the mixture is greater than that estimated for 
additivity on the basis of the toxicities of the components. Potentiation occurs when a 
component that does not have a toxic effect on an organ system increases the effect of a 
second chemical on that organ system. 
A toxicologically significant synergistic effect can happen in the following cases (EC, 
2011b):  
- if one or more components significantly enhance the uptake or significantly inhibit the 
excretion/clearance of other components 
- if one or more components exert their action via the formation of toxic metabolites and 
induce the drug metabolising enzymes involved in the formation of these metabolites 
- if two or more components act on different enzymes in an important metabolic pathway 
- if two or more components act on different elements of cellular protection mechanisms or 
cellular repair mechanisms. 
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Recently, guidelines and guidance have incorporated chemical interaction concepts and 
have suggested methods to evaluate the possible influence of such interactions on the overall 
joint toxicity of chemical mixtures (ATSDR, 2004; USEPA, 2004; WHO, 2009; EC, 2011b).
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Table 1: Mathematical approaches for assessing chemical mixture effects (Boobis et al., 2008; EC, 2011b) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
UF: Uncertainty factor, HI: Hazard Index; HQ: Hazard coefficient, RV: reference Value, RP: Reference Point; CSAFs: Chemical-Specific Adjustments Factors; Dmix: mixture dose;  aDi/Di: adjusted 
dose/dose for the substance i; TSi: toxicity of the substance i; TID: toxicity of the IC; HBGV Health Based Guidance Value; WoE Weight of Evidence; 
 Hazard Index Hazard Index Interaction Reference Point Index 
  
P
ri
n
ci
p
le
 Sum of the hazard coefficient (HQ : ratio between 
exposure and respective reference value, RV) for 
each compound in the mixture 
Incorporate available interaction data by converting 
them into a numerical score (based on expert 
judgement or WoE evaluation) 
Sum of the exposures to each compound expressed as 
a fraction of its respective reference point (RP) for 
the common toxic effect (e.g. the dose that causes a 
10% effect, BMD10; or the NOAEL, etc…) 
F
o
rm
u
la
  
HI = ∑HQ 
= (Exp1/RV1) + (Exp2/RV2) + (Exp3/RV3)… 
HIint = HI . UF
WoE 
- WoE value<0 for antagonistic interactions and >0 
for synergism 
- UF: default value=10 
 
RPI= Exp1/RP1 +Exp2/RP2+Exp3/RP3… 
In
te
rp
r
-e
ta
ti
o
n
 - HI < 1: combined risk acceptable 
- HI > 1: potential health concern to be considered. 
 
- HI < 1: combined risk acceptable  
- HI > 1: potential health concern to be considered. 
 
If RPI*UF < 1: combined risk acceptable  
(UF: chosen group uncertainty factor, usually a 
default value of 100)  
 
  
 A
d
v
a
n
ta
g
e 
- Is directly related to a RV, a long-used and well-
understood index of acceptable risk 
- Can be quickly applied  
- Can accommodate the application of CSAFs early 
in the process 
 
Takes into account the nature of interaction 
(synergism/antagonism), the quality of the data, the 
plausibility of the interaction under exposure 
condition, the relevance for human health  
Sums the exposures to the different components in 
relation to their relative potencies 
- A single group UF can be applied as the last step in 
the process 
- CSAFs can be applied if needed. 
  
D
is
a
d
v
a
n
ta
g
e - RVs obtained by application of an UF that might 
incorporate policy and scientific judgements: → does 
not represent a true measure of the relative 
toxicological potency of the compounds. 
- Requires HBGV to be available for all members of 
the assessment group, which is often not the case 
-Provide only a numerical score of the potential risk  
-HI and HIint are strongly affected by a subjective 
evaluation 
-The intrinsic uncertainties affecting RVs are 
combined and amplified in HIint derivation 
Interpretation of the results relies on the value of the 
UF, for which the criteria are undefined  
  
  
  
  
  
  
  
  
  
  
  
N
o
ta
 
- An adjusted HI (aHI) can be calculated when the 
UF used to derive the RV is partly unrelated to the 
common toxic effect (Boobis et al., 2008). 
- Preferred approach when extensive mechanistic 
information is not available 
-A refinement of the hazard method, the Target-organ 
toxicity dose (TTD) method, was developed in order 
to accommodate the assessment of mixtures whose 
components do not all have the same critical effect, 
and to take into account the reality that most 
components of waste-site-related mixtures affect 
other organs at doses higher than those that cause the 
critical effects (Mumtaz et al., 1997) 
An additional factor (M, ratio between the observed 
effective dose (ED) and the ED predicted from dose 
addition approach) can also be introduced, to include 
a quantitative evaluation of the interaction 
Reciprocal of the RPI: combined margin of exposure 
MOET =1/[(1/MOE1)+(1/MOE2)+(1/MOE3)…]  
with MOE=RP /Exp  
 
When MOET>100 (or other value considered 
appropriate by the risk manager) the combined risk 
from exposure to the compound is considered 
acceptable. 
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Table 1: Mathematical approaches for assessing chemical mixture effects (Boobis et al., 2008; EC, 2011b) (continued) 
 
Relative Potency Factor (RPF) or Toxic 
Equivalency Factor (TEF) or Potency 
Equivalency Factor (PEF) 
Toxic Unit Model (TUs) Maximum cumulative ratio (MCR) 
  
P
ri
n
ci
p
le
 Sum of effects expressed as total equivalent exposure 
by potency-normalizing individual doses. One 
substance is defined as the index compound (IC) and 
the potency of all chemical are normalized to the 
single potency scale of the IC. 
Ratio between the concentration of a component in a 
mixture and its toxicological acute or chronic (e.g. 
LC50 or NOEC) endpoint. The toxic unit of a mixture 
(TUm) is the sum of TUs of individual chemical.  
Ratio between the toxicity of the mixture and the toxicity of the most toxic 
chemical in the mixture. Hence, MCR does not predict risk but provides a 
tool for investigating data on cumulative exposures to human and ecological 
receptors and identify instances where cumulative risk assessments are most 
needed. 
F
o
rm
u
la
  
Dmix = ∑aDi = ∑ Di* RPFi 
With RPFi=TSi/TID 
 
TUm=∑TUs 
 
MCR= TUm/Highest individual TU 
1<MCR<n 
                                n=number of chemical in the mixture 
In
te
rp
re
ta
ti
o
n
 -Health effect of the mixture assessed by reporting 
the Dmix on the dose-response curve of the IC. The 
Dmix can be readily compared to the HBGV 
-Used to quantify the toxicity of a mixture on the 
basis of its composition. An acute lethal TUm=10 
means that a dilution 10% of the mixture would 
produce 50% of lethality. 
MCR ≈ 1: one chemical completely dominates the toxicity; MCR ≈ “n”: each 
chemical is present in “equitoxic” concentrations. MCR indicates the amount 
of an individual’s CR missed by not doing a CRA: MCR=4 → a chemical-by-
chemical approach would underestimate the toxicity of a mixture by a factor of 
4. MCR is the measure of the fraction of toxicity that comes from the most 
toxic component: MCR=2 →1 chemical is providing 50% of the mixture’s 
toxicity, MCR=1.1 →1 chemical is providing 90% of the mixture’s toxicity 
A
d
v
a
n
-t
a
g
e 
Method transparent, easy to understand, because it 
separates potency correction from exposure 
consideration. 
- Refers to a toxicological endpoint 
- If the shape of the curve is known, TUm can be used 
to estimate the expected effect 
- Allow to decide either or not a cumulative assessment is necessary for a 
mixture 
- Can be integrated into tiered approaches to assess mixtures 
D
is
a
d
-
v
a
n
ta
g
e Determination of the risk posed by the combined 
exposure places great emphasis on the quality of the 
toxicology database of the IC 
Does not refer to the ecosystem, but only to a specific 
organism assumed to be representative of a group of 
organisms ecologically or taxonomically relevant for 
the ecosystem. 
- Data analysed so far are limited, more work is to be done to validate the 
model 
- How to predict MCR values for chemicals not yet on the market? 
  
  
  
  
  
  
  
  
  
  
  
N
o
ta
 
- Toxic Equivalency factor (TEF) is a special case of 
this method, initially developed for dioxins and other 
aryl hydrocarbon receptor (AhR) agonist. 
- The Potency Equivalency Factor is a more general 
method that has been used for compounds such as 
polycyclic aromatic hydrocarbons and certain 
pesticides. 
Frequently used in ecotoxicology. Conceptually, TUm 
is comparable to HI when applied to environmental 
concentrations, but referring to tox. endpoints and not 
to RV. The RV in ecotox is the PNEC, so 
∑PEC/PNEC ratio could be comparable to HI; 
however PEC/PNEC for components in a mixture 
may not be homogeneous as PNEC are derived by 
applying an AF to tox. endpoints obtained for the 
most sensitive organisms, which may be different for 
each chemical in the mixture. Nevertheless, this 
approach is known to be slightly more conservative 
than the ∑TUs, and could be used as a first-tier when 
applying CA. 
Low MCR values imply additive and independence models will give similar 
estimates of tox. (when one chemical is the driver of a mixtures tox. both 
models give similar answers) 
High MCR values imply that the two model’s answers will be different i.e it is 
more important to establish “assessment groups” where dose additivity occurs. 
It has been empirically demonstrated that MCR is inversely correlated with the 
toxic potency of the mixture: very dangerous mixture are driven by very few 
chemical  
Can be applied to biomonitoring data with the following equation (exposure 
based):   MCR= Total TEQ/ Maximum TEQ 
                       = ∑(Conc. * TEF)/Max (Conc. * TEF) 
TEQ: Toxicity equivalents, TEF: Toxicity equivalent factors 
UF: Uncertainty factor, ED: effective dose, RV: reference value, PEC: predicted environmental concentration, PNEC: predicted no effect concentration, MEC: measured no effect concentration, LC50 : 
Lethal Concentration 50, NOEC: No observed effect concentration, AF: Adjustment factor, CA: Concentration addition; CR: Cumulative risk. Tox: Toxicity; ecotox: ecotoxicity; WoE: Weight of 
Evidence 
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      3 - Regulatory requirements across EU legislative sectors (human 
health and environment) 
 
A review of EU risk assessment requirements regarding chemical mixtures has been 
conducted, to assess if and how the different EU directives and regulations take into account 
risks arising from mixture toxicity.  
3.1   Regulatory requirement linked to intentional mixtures  
In the case of intentional mixtures, the composition of the mixtures is well known and the 
assessment is based on the properties of the constituents supplemented, where appropriate, by 
tests carried out on the entire products. This applies to plant protection products, biocides, 
pharmaceuticals, food additives and cosmetics for example. 
3.1.1   Plant protection products (Regulations 1107/2009, 283/2013, 284/2013) 
This regulation defines plant protection products as any products "consisting of or 
containing active substances, safeners or synergists, and intended for one of the following 
uses" (Article 2): 
(a) protecting plants or plant products against harmful organisms (or preventing their action);  
(b) influencing the life processes of plants, such as their growth (other than as a nutrient);  
(c) preserving plant products, in so far as such substances or products are not subject to 
special Community provisions on preservatives;  
(d) destroying undesired plants or parts of plants, except algae unless the products are applied 
on soil or water to protect plants;  
(e) checking or preventing undesired growth of plants, except algae unless the products are 
applied on soil or water to protect plants. 
Regulation (EC) No 1107/2009 lays down rules on the evaluation, authorization, placing 
on the market and control of plant protection products (PPP) in the EU. It aims at ensuring a 
"high level of protection of both human and animal health and the environment at the same 
time to safeguard the competitiveness of Community agriculture". This regulation concerns 
both the substances and the preparations made with those active substances (i.e " mixtures or 
solutions composed of two or more substances intended for use as a plant protection product 
or as an adjuvant", Article 3 §3). However, the requirements for individual substances and 
formulated products are not the same: usually a first RA for active substances is performed at 
EU level based on a wide range of data regarding human health and environmental effects. At 
this stage only the active substance is tested, although the formulation might also be tested for 
some organism groups for ERA. Authorised active substances can then be used in 
formulations for which authorisations are granted at Member State level. Usually the 
authorisation of formulations is largely based on data provided for the active substance where 
possible to avoid unnecessary testing. Formulations are generally only assessed for acute 
toxicity to humans (by oral and dermal route, by inhalation, skin irritation, eye irritation and 
skin sensitization), as well as for organisms in the environment that may come into direct 
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contact with the product. This might be of concern as often formulations are designed to be 
more toxic than the active ingredient itself, through the use of synergist and surfactant that 
increase the bioavailability/toxicity of the formulation. These regulatory requirements are 
described in Regulations EC 283/13 (EC, 2013a) and 284/13 (EC, 2013b) for active 
substances and formulations respectively. The usual approach for formulation RA is the 
direct testing of the PPP itself (whole-mixtures approach), but this regulation also promotes 
the "development of non-animal test methods in order to produce safety data relevant to 
humans and to replace animal studies currently in use" for the risk assessment of 
preparations.  
Regarding human health, Regulation (EU) No 283/2013 on active substance 
requirements states that sufficient information should be given on the active substance and on 
the other component(s) of the PPP, as well as on one or more plant protection products 
containing the active substance, to permit both "a risk assessment of consumer exposure" and 
"an estimation of the exposure to operators, workers, residents and bystanders"  including, 
"where relevant, the cumulative exposure to more than one active substance" (Introduction to 
the Annex, Point 1.11). The need to mention the possible presence of pesticide residues 
arising "from sources other than current plant protection uses of active substances (for 
example use of active substances resulting in common metabolites, use as biocide or 
veterinary drug)" is also put forward, as the necessity to take into account their aggregate 
exposure and the cumulative exposure to more than one active substance, where relevant 
(Annex, Part A, Point 6.9).  
Regulation (EC) No1107/2009 is closely linked to the Regulation (EC) 396/2005 on 
maximum residue levels (MRLs) of pesticides in or on food and feed (see § 2.2.9), as the 
setting of adequate MRLs might be a condition for granting authorisation for PPP to be used 
on plants or plant products to be used as feed or food (Art 29 §1i). Moreover, this regulation 
introduces a clear requirement for the consideration of potential mixture effects of plant 
protection products and their residues on human health through different sources of exposure, 
as PPP and their residues“…shall not have (…) harmful effect on human health, (…), directly 
or through drinking water (taking into account substances resulting from water treatment), 
food, feed or air (…), taking into account known cumulative and synergistic effects where the 
scientific methods accepted by the Authority to assess such effects are available” (Article 4, 
§3b and §2a) for the PPP and their residues respectively. 
However, it is not clear if this requirement is also valid for the assessment of hazards and 
risks for the environment, as the only requirement stated by this regulation is that PPP and 
their residues “… shall not have any unacceptable effect on the environment…” (Article 4, 
§2b, and §3e), and as the amendment recommended by the European Parliament’s Committee 
on the Environment, Public Health and Food Safety to take into account cumulative and 
synergistic effects and all relevant exposure routes to organisms in the environment has not 
been accepted during the legislative procedure (Kortenkamp et al., 2009). Nevertheless, 
Article 29 of this same regulation states that "interaction between the active substance, 
safeners, synergists and co-formulants shall be taken into account in the evaluation of plant 
protection products", which directly mentions both the interaction between component and 
 14 
the evaluation of the PPP (i.e. as a mixture) without restricting it to the human health 
assessment. Moreover, the introduction of Annex of Regulation (EU) No 284/2013 (point 
1.3) states that "Any information on potentially unacceptable effects of the plant protection 
product on the environment, on plants and plant products shall be included as well as known 
and expected cumulative and synergistic effects", which clearly implies the need to take into 
account the expected cumulative and synergistic effects on the environment.  
Following these new regulations and to address the corresponding requirements, 
guidance documents for environmental risk assessment have been updated. To achieve an 
adequate consideration of mixture toxicity in the environmental risk assessment of PPP for 
birds and mammals, for which toxicity data with formulated products or mixtures of active 
substances are not always available, especially for birds, a 4-step approach for combined 
effects of simultaneous exposure to several active substances has been proposed (EFSA, 
2009a). This approach does not refer to an assessment of formulation toxicity as such, but of 
the expected effects from exposure to a mixture of active substances (and possibly also toxic 
co-formulants) in the environment resulting from the use of the formulation (See Chapter 
3.1.2). In an EFSA scientific opinion on the science behind the risk assessment of PPPs on 
bees (EFSA, 2012d), a chapter focuses on the evidence on cumulative and synergistic effects 
of pesticide mixtures in bees, and recommendations are made for risk assessment purposes. 
The developed risk assessment scheme also proposes to investigate for each compound 
whether there are any indications of cumulative effects. More recently, the EFSA guidance 
on the tiered risk assessment of plant protection products for aquatic organisms in edge-of-
field surface waters (EFSA, 2013d) recommends to determine if there is any synergistic 
effect in order to complete an adequate risk assessment (See Chapter 3.1.2). 
3.1.2   Biocides (Regulation 528/2012) 
This regulation applies to biocidal products defined as "any substance or mixture, in the 
form in which it is supplied to the user, consisting of, containing or generating one or more 
active substances with the intention of destroying, deterring, rendering harmless, preventing 
the action of, or otherwise exerting a controlling effect on, any harmful organism by any 
means other than mere physical or mechanical action" ((EC, 2012b), Article 3 §1a). The 
same definition for the words "substances" and "mixtures" is used as in the REACH 
regulation. This regulation seeks to simplify the procedures concerning the authorisation of 
biocidal products without reducing the high level of protection for the environment and 
human and animal health. Biocidal products must have "no immediate or delayed 
unacceptable effects" on "the health of humans including that of vulnerable groups, or 
animals, directly or through drinking water, food, feed, air, or through other indirect 
effects"; and "no unacceptable effects itself, or as a result of its residues, on the environment" 
(Article 19 §1). To achieve these protection goals, extensive toxicity testing and risk 
assessments are carried out for both the individual active substances and the formulated 
biocidal products, taken into account "cumulative and synergistic" effects (Article 19 §2).  
Annex II and III of the regulation set out the data requirements for active substances and 
formulated biocidal product respectively; besides toxicological / ecotoxicological data and 
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assessment, Annex III also requires that "for biocidal products that are intended to be 
authorised for use with other biocidal products, the risks to human health, animal health and 
the environment arising from the use of these product combinations shall be assessed "(Point 
8.5.4). Annex VI of this Regulation establishes the common principles for the evaluation of 
biocidal products, and includes again the explicit requirement to take into account cumulative 
and synergistic effects (Annex VI point 3) and the necessity to assess the overall toxicity and 
ecotoxicity of a biocidal product that may contain various substances of concern (Point 53: 
“In each of the areas where risk assessments have been carried out, i.e. effects on man, 
animals, and the environment, the competent authorities shall combine the results for the 
active substance together with the results for any substance of concern to produce an overall 
assessment for the biocidal product itself. This should take account of any likely synergistic 
effects of the active substance(s) and substances of concern in the biocidal product” and point 
54: “For biocidal products containing more than one active substance any adverse effects 
shall also be combined to produce an overall effect for the biocidal product itself.”), a 
substance of concern being defined as "any substance, other than the active substance, which 
as an inherent capacity to cause an adverse effect, immediately or in the more distant future, 
on humans (…), animals or the environment and is present or is produced in a biocidal 
product in sufficient concentration to presents risks of such an effect" (Article 3 f). 
Moreover, during the evaluation process, when the evaluating competent authority 
considers "that there are concerns for human health, animal health or the environment as a 
result of the cumulative effects from the use of biocidal products containing the same or 
different active substances", it shall "document its concerns in accordance with the 
requirements of the relevant parts of Section II.3 of Annex XV to Regulation (EC) No 
1907/2006 and include this as part of its conclusions" (Article 8 §3).   
As for plant protection products, hazard and risk assessments of formulated biocidal 
products are preferably based on toxicity tests with the final product: biocidal products are 
generally assessed for acute toxicity, skin and eye irritation, and skin sensitization, although 
other endpoints and other toxicological aspects may be assessed based on the individual 
substances present in the formulations. This acute toxicity is usually assessed by a whole 
mixture approach. The complete future guidance structure under the BPR will be 
implemented in full at a later stage, and some very specific topics such as cumulative and 
synergistic effects should be addressed
1
. This regulation is also link to other regulation 
concerning residues in food and feed as Article 19 states that "where appropriate, maximum 
residue limits for food and feed have been established with respect to active substances 
contained in a biocidal product" in accordance with such regulation
2
.  
                                                        
1 ECHA, Guidance on biocides legislation. Future Guidance Structure Volume V. http://echa.europa.eu/web/guest/guidance-
documents/guidance-on-biocides-legislation/future-guidance-structure 
2 Reg. (EEC) No 315/93 laying down Community procedures for contaminants in food, Reg. (EC) No 1935/2004 on 
materials and articles intended to come into contact with food, Reg. (EC) No 396/2005 on maximum residue levels of 
pesticides in or on food and feed of plant and animal origin, Reg. (EC) No 470/2009 laying down Community procedures for 
the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin or Directive 
2002/32/EC on undesirable substances in animal feed. 
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3.1.3   Pharmaceuticals: Human medicines (Directive 2001/83/EC) and Veterinary 
medicines (Directive 2001/82/EC) 
Both directives share some basic features. In both cases, the risk assessment follows a 
risk-benefit balance approach, in which the applicant is required to demonstrate that the 
potential risks are outweighed by the therapeutic efficacy of the product (Dir. 2001/83/EC 
Recital 7 and Dir. 2001/82/EC Recital 11). If the risk-benefit balance is not considered to be 
favourable, the marketing authorisation will be refused or an existing authorisation may be 
suspended, withdrawn or modified. Human and veterinary medicinal products may be single 
substances, but are more typically combinations of substances. However, the toxicological 
assessment and the environmental assessment of those two types of medicines slightly differ.  
Human medicines 
Two types of risks are considered when dealing with medical products and human 
health: risks to the patients’ health and risks to public health. Toxicity studies required for 
their authorization are either performed for the active substance or the combination of active 
substances present in the product or for the finished product (Annex I, Part 1, Section 4.2.3). 
Particular attention is paid to wanted and unwanted interactions of substances combined 
within a medicinal product, interactions of a medicinal product with other medicinal products 
administered concomitantly as well as interactions with alcohol, tobacco, and foodstuffs: 
non-clinical and clinical studies on pharmacokinetic and pharmacodynamic interactions are 
part of the standard dossier requirements (Annex I, Part 1, section 4.2.1, 4.2.2, 4.2.3, 5.2.3 
and 5.2.4). Thus, the toxicity of the whole product is taken into account and potential 
interactions are deeply assessed. 
An environmental risk assessment is also required, since the application must be 
accompanied by an "evaluation of the potential environmental risks posed by the medicinal 
product", and, "on a case-by-case basis, specific arrangements to limit it shall be envisaged" 
(Article 8, §3(ca)). This risk assessment overview should evaluate "possible risks to the 
environment due to use and/or disposal of the medicinal product" (Annex I, Part I, section 
1.6). A guidance document has been released in 2006 (EMEA, 2006) but it does not 
specifically address any aspect of mixture toxicity concerning environmental risk 
assessments. 
Veterinary products 
Three types of risks are considered when dealing with veterinary medicinal products: 1) 
risks to the animal, 2) risks to human health, and 3) risks of undesirable effects on the 
environment. Toxicity and ecotoxicity studies and assessments required for the authorization 
of veterinary medicinal products are performed for the product, its active substances and 
relevant metabolites (Kortenkamp et al., 2009). They aim at assessing the potential toxicity of 
the product and any dangerous or undesirable effects to the target animal, potential harmful 
effects to humans of residues of the product or substance in foodstuffs, potential risks to 
directly exposed humans (e.g. during administration), and potential risk to the environment 
resulting from the use of the product (Annex I, Title I, Part 3, Chapter I). Thus, the toxicity 
and ecotoxicity of the entire product is taken into account. 
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Attention is also paid to interactions with other medicinal products or feed additives with 
respect to effects in the target animals, but this point is less deeply assessed than for 
medicinal products intended for human use (Kortenkamp et al., 2009).  
In contrast, for ecotoxicity assessments, the information requirements are more specific 
and detailed in comparison to medicinal products for human use (Annex I, Title I, Part 3, 
Chapter I, section 6). A two phase risk assessment is required: the first phase (which is 
mandatory) focuses on the potential extent of the exposure by the active substances or their 
metabolites; in the second phase, further specific investigation of the fate and effects of the 
products on particular ecosystems is performed, when deemed necessary. However, the 
environmental toxicity of the mixture, potentially resulting from the joint occurrence of 
different residues of veterinary products or from the joint occurrence of pharmaceuticals and 
other pollutants, is not taken into account in the environmental assessment. 
3.1.4   Cosmetics (Regulation 1223/2009) 
Regulation 1223/2009 defines the term "mixture" as having "the same meaning as the 
term "preparation" previously used in the community legislation" (Recital 21), and as being a 
"solution composed of two or more substances". Thus cosmetic products are typically a 
mixture of substances. In order to ensure the safety of the cosmetic product for human health, 
a safety assessment must be performed (Art. 3) which should take into account the intended 
use of the cosmetic product and the anticipated systemic exposure to individual ingredients in 
a final formulation (Article 10 a). Moreover, this directive clearly promotes the use of 
alternative methods by prohibiting the placing on the market of cosmetic products for which 
"ingredients, combinations of ingredients or the final formulation have been the subject of 
animal testing using a method other than an alternative method" after such alternative 
method has been validated in the EU (Art. 18.1). According to recital 41 and to limit animal 
testing, "the safety of finished cosmetic products can already be ensured on the basis of 
knowledge of the safety of the ingredients that they contain", thus safety assessment or testing 
should be performed either on ingredients, combinations of ingredients, or the finished 
cosmetic product. An appropriate weight-of-evidence (WOE) approach should also be used 
for reviewing data from all existing sources (Art 10b), although the regulation does not 
precise what is an appropriate WOE. This regulation also prohibits or restricts the use of 
certain chemicals of concern, listed respectively in Annex II and III, and lays down the 
condition of use of certain colorants and preservatives (Annex IV and V). More generally, the 
use of Carcinogenic, Mutagenic and Reprotoxic (CMR) products 1A, 1B and 2 (Recital 32) is 
prohibited, except for CMR 2 substances that have been found safe for use in cosmetic 
products by the Scientific Committee for Consumer Safety (SCCS) and that are regulated in 
the previously mentioned Annexes of the Regulation, and for CMR 1A or 1B substances "in 
the exceptional case that these substances comply with food safety requirements, and that no 
suitable alternative substances exist", and that they have "been found safe by the SCCS".   
The requirements for the toxicological safety assessment are laid down in Annex I Part 
8. This includes cosmetic product safety information, with a toxicological profile of the 
substances (Part A) in which "all significant toxicological routes of absorption shall be 
considered" and in which "particular consideration shall be given to any possible impacts on 
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the toxicological profile due to interaction of substances". Additionally, the safety assessment 
of the cosmetic product itself (Part B) must also be assessed, including possible interactions 
of the substances contained in the cosmetic product.  
According to Recital 33, the safety assessment of substances, particularly those 
classified as CMR 1A or 1B substances previously mentioned, should consider the overall 
exposure to such substances stemming from all sources, which implies the development of a 
harmonised approach to the use of such overall exposure estimates. Thus, the SCCS has 
published and regularly revises the “Notes of Guidance for Testing of Cosmetic Ingredients 
and Their Safety Evaluation by the SCCS”, a document designed to provide guidance and to 
improve harmonized compliance with the EU cosmetics legislation, and is currently 
developing guidance to a harmonized approach to the development and use of overall 
exposure estimates in assessing the safe use of CMR substances (SCCS, 2012). 
Beside human health, the environmental concerns that substances used in cosmetic 
products may raise are not addressed in this regulation but should be considered through the 
application of Regulation (EC) No 1907/2006 (REACH), which enables the assessment of 
environmental safety in a cross-sectorial manner (Recital 5 of the Cosmetics Regulation). 
3.1.5   Classification, labelling and packaging of substances and mixtures 
(Regulation 1272/2008) 
The Classification, Labelling and Packaging (CLP) regulation entered into force on the 
20 January 2009 and replaces the former Directive 67/548/EEC (dangerous substances) and 
also Directive 1999/45/EC (dangerous preparations), in a stepwise manner until finally 
repealed from 1 June 2015. This Regulation is intended to ensure "a high level of protection 
of human health and the environment as well as the free movement of substances, mixtures 
and articles" (Art. 1 §1) and aims at determining "which properties of substances and 
mixtures should lead to a classification as hazardous, in order for the hazards of substances 
and mixtures to be properly identified and communicated", including physical hazards, 
hazards to human health and the environment as well as to the ozone layer. This regulation 
covers all chemicals and mixtures placed on the European market, with the exception of 
radioactive substances and mixtures, non-isolated intermediates, substances and mixtures for 
scientific research, waste products, cosmetics, medicinal and veterinary products, and food 
and feeding stuff (Art.1, §2.5). The terms and definitions used in the CLP Regulation are 
consistent with those set out in REACH: i.e. a mixture is defined as a deliberate combination 
of two or more individual substances for producing a marketed final chemical product. 
Moreover, this regulation has a strong impact within the EU, due to downstream legislation, 
(such as worker protection or SEVESO), which would deal with substances or mixtures on 
the basis of their classification under CLP.  
This regulation also confirms the EU’s intention to contribute to the global 
harmonisation of criteria for classification and labelling, at UN level, through implementation 
of the internationally agreed GHS (UN Globally Harmonised System of Classification and 
Labelling of Chemicals) criteria into EU law.  
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Each substance and/or mixture is classified into hazard classes, depending on the nature 
of the hazard, and into a hazard category, indicating the severity of the hazard. The different 
human health hazard classes and environmental hazard classes are detailed in Tables 2 and 3 
respectively, along with their corresponding classification principles.  
For the hazard classification of a mixture, all relevant, reliable and scientifically valid 
available information on the mixture and on its components should be identified in order to 
determine "whether the mixture entails a physical, health or environmental hazard" (Art. 6). 
According to recital 20, the supplier "should not be obliged" to produce any new 
(experimental) data. Thus, when experimental data on the mixtures are available, 
classification and labelling should be obtained by using those data (whole-mixture testing). 
When there is no experimental data available, the classification of the mixture should be 
based on the information on the mixture components or on the "bridging principles", using 
information on a similar mixture (Recital 23, Annex I). Moreover, if the mixture contains 
carcinogenic, germ cell mutagenic or reproductive toxic substances or if biodegradation and 
bioaccumulation properties are evaluated (in the "hazardous to the aquatic environment" 
class), the classification of the mixture should be mainly based on the information on the 
mixture components (Recital 22). The supplier should also adjust accordingly the 
classification of a substance or mixture if any new information becomes available, and a new 
hazard evaluation is necessary when the composition of a mixture is changed outside 
specified limits (Art. 15). However, the classification of a mixture should not be affected 
where the evaluation of the information indicates that the substances in the mixture react very 
slowly with other substances in the mixture to form different substances at low concentration 
(Art. 14). 
The classification of a mixture is based on the application of generic or specific 
concentration limits (SCLs) for human health hazards, M-factors (see below) for 
environmental hazards and cut-off limits. Generic concentration limits are limits assigned to a 
substance indicating a threshold at or above which the presence of that substance in the 
mixture leads to the classification of the mixture as hazardous. For human health and 
environmental hazards, they are given in Parts 3 and 4 of Annex I, respectively
3
. Specific 
concentration limits must be set by the applicant where adequate and reliable scientific 
information shows that the hazard of a substance is evident when the substance is present at a 
level below the generic concentration limits. In exceptional circumstances, specific 
concentration limits may also be set by the applicant where adequate, reliable and conclusive 
scientific information indicate that the hazard of a substance classified as hazardous is not 
evident at a level above the generic concentration (Art. 10 §1). When set in accordance with 
those rules, specific concentration limits shall take precedence over the generic concentration 
limits for classification in the relevant sections of Parts 3 and 4 of Annex I (Art. 10 § 3). 
For the hazard class "hazardous to the aquatic environment", SCLs are not applicable. 
Instead, the M-factors (Multiplying factors) concept is used. This concept has been 
                                                        
3
 Annex I: Classification and labelling requirements for hazardous substances and mixtures, Part 3: Health hazards, Part 4: 
Environmental hazards.  
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established to give an increased weight to very toxic substances when classifying mixtures. 
M-factors are only applied to the concentration of a substance classified as hazardous to the 
aquatic environment (acute category 1, with acute toxicities below 1 mg/l, or chronic 
category 1, with chronic toxicity below 0.1 mg/l if non-rapidly degradable and 0.01 mg/l if 
rapidly degradable), and are used to derive by the summation method the classification of a 
mixture in which the substance is present. They are substance-specific and should be 
established for acute and long-term hazards separately by manufacturers, importers and 
downstream users.  
Cut-off values are the concentrations above which any substance classified as hazardous 
(either as a component, an identified impurity or an additive) in a mixture, should be taken 
into account for the purposes of classification (Art.11). They are ranging from 0.1 to 1% 
depending on the hazard class (Annex 1 §1.1.2), unless there is a presumption that lower 
concentrations are still relevant.  
The classification of a mixture must also take into account all available information on 
synergistic and antagonistic interaction among the components of the mixture (Art. 12 §1c). 
Although not mentioned in the legal text, these terms seem to be defined in relation to the 
expectation of concentration-additive behaviour of the compounds (Kortenkamp et al., 2009).  
For environmental hazards, the classification of a substance or mixture focuses 
exclusively on the hazard towards aquatic organisms; however GHS experts have requested 
the OECD to explore the needs for a classification with respect to hazards for the terrestrial 
environment. It should also be noted that in contrast to the original GHS system, which 
distinguishes three hazard classes for acute toxicity, the European system only considers one 
acute toxicity category (Table 3). Moreover, even the classification for chronic toxicity into 
the chronic categories (1-4) is also based mainly on acute toxicity data (EC50 values). This is 
based on an acute to chronic extrapolation, although this approach is not directly followed for 
mixtures, as their chemical composition is assumed to undergo significant changes over 
prolonged exposure times (Kortenkamp et al., 2009).  
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Table 2: Hazard class and category for human health hazard classification under the CLP regulation 
Hazard class  Category Classification principles 
Acute toxicity Cat 1 Cat 2 Cat 3 Cat 4 - Priority is given to the use of data on the mixture, if available.  
- If no data,  use of bridging principle from similar mixtures if available 
- If no similar mixture, calculation (CA) if data available for all ingredients for 
estimating the toxicity, considering ingredients present at a concentration of ≥1% 
(unless there are indications that the compounds are relevant for classification even 
at lower concentrations, i.e substance classified as acute toxic, category 1-3, for 
which a fraction of 0.1% is to be considered for the mixture classification)  
-If no data data available for all ingredients, use other data available (extrapolation, 
evidence, QSARs…) to estimate conversion values for classification and convey 
hazards of the known ingredients  
Acute oral tox 
 (mg/kg bw) 
ATE ≤ 5 5≤ ATE ≤50 50 ≤ ATE ≤ 300 300 ≤ ATE ≤ 2000 
Acute dermal tox 
 (mg/kg bw) 
ATE ≤ 50 50≤ ATE ≤200 200 ≤ ATE ≤ 1000 1000 ≤ ATE ≤ 2000 
Acute inhalation 
tox: Gases (ppmV) 
Vapours (mg/l) 
Dust and mists 
(mg/l) 
 
ATE ≤ 100 
ATE ≤ 0.5 
ATE ≤ 0.05 
 
100 ≤ ATE ≤ 500 
0.5 ≤ ATE ≤ 2.0 
0.05 ≤ ATE ≤ 0.5 
 
500 ≤ ATE ≤ 2500 
2.0 ≤ ATE ≤ 10.0 
0.5 ≤ ATE ≤ 1.0 
 
2500 ≤ ATE ≤ 20000 
10.0 ≤ ATE ≤ 20.0 
1.0 ≤ ATE ≤ 5.0 
Skin corrosion 
and irritation 
Cat 1: Corrosive (3 subcategories) Cat 2: Irritant  (One single category) The mixture will be classified using the criteria for substances. 
-Priority is given to data on the full mixture; moreover the use of existing 
alternative tests and of a tiered weight of evidence strategy is encouraged in order 
to avoid unnecessary animal testing (Annex I 3.2.3.1.2).  
-If no data on the full mixture are available, use of bridging principles are applied, 
including the use of a summation method for estimating the overall potency of the 
mixture with cut-off values (Tables 3.2.3 and 3.3.3 of Annex I). The “theory of 
additivity” is mentioned (Annex I, 3.2.3.3.2 and 3.3.3.3.2), but no specific 
guidelines on their application is given.  
Ingredients are considered relevant if present at a concentration of ≥1%  unless 
there is a presumption that an ingredient present at a concentration of less than 1% 
can still be relevant for classifying the mixture (Table 1.1 and Annex I, 3.2.3.3.1 
and 3.3.3.1) If strong acids and bases are present, the pH should be used as a 
classification criterion (Table 3.2.4 Annex 1) 
Corrosive in > 1 of 3 animals: 
1A: If response is noted following up to 3 min 
exposure and up to 1h observation 
1B: If response is noted between 3 min and 1h 
of exposure and observation up to 14 d  
1C: If response is noted between 1h and 4h of 
exposure and observation up to 14 d 
- At least 2 of 3 animals have a mean score between 2.3 
and 4 for erythema/eschar or for oedema, or 
- Inflammation that persists to the end of the observation 
periods (14 d) in a least 2 animals, or 
- If there is a pronounced variability of response among 
animal, with very definite positives effects in a single 
animal but less than the criteria above.  
Serious damage 
to the eye and 
eye irritation 
Cat 1: Irreversible effect on the eye Cat 2: Irritating to eyes 
If the application produces:  
-at least in one animals effect on the cornea, 
iris or conjunctiva that are not expected to 
reverse  or have not fully reversed within 21 
days and/or 
-at least in 2 of 3 animals a positive response 
of corneal opacity ≥3 and/or iritis >1.5 (mean 
scores following grading at 24, 48 and 72h) 
If the application produces: 
-at least in 2 of 3 animals a positive response of corneal 
opacity ≥1 and/or iritis >1 and/or conjunctival redness 
≥2 and/or conjunctival oedema ≥2 (mean scores 
following grading at 24, 48 and 72h after application, 
and which fully reversed within 21 d) 
Respiratory or 
skin sensitisation 
Respiratory sensitizer Cat 1                           Skin sensitizer Cat 1 -When reliable experimental data or good quality evidence from human experience 
are available for the mixture, these can be used to classify the mixture by weight-
of-evidence. If not, use bridging principles on similar tested mixtures or individual 
ingredients 
-Use of generic concentration limits: should be categorised into this class if at least 
one of the components is classified into the hazard class “respiratory or skin 
sensitisation” and is present at >0.2% (gas) or >1% (solid/liquid) (Table 3.4.3 
Annex I) 
-if there is evidence in humans that the substance can lead to specific respiratory hypersensitivity / 
sensitisation by skin contact in a substantial number of persons respectively and/or 
- if there is positive result from an appropriate animal test 
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Hazard class  Category Classification principles 
Genotoxicity 
 Cat 1 Cat 2  
Germ cell 
mutagenicity 
Substance to be regarded as if they induce 
heritable mutations in the germ cells of humans. 
1A: based on positive evidence from human 
epidemiological studies. 
1B: based on positive result(s) from in vivo 
heritable germ cell mutagenicity tests in 
mammals; or from in vivo somatic cell 
mutagenicity tests in mammals and some 
evidence that the substance has potential to cause 
mutations to germ cells; or positive results from 
tests showing mutagenic effects in the germ cells 
of humans, without demonstration of 
transmission to progeny. 
Substances which cause concern for 
humans owing to the possibility that 
they may induce heritable mutations in 
the germ cells of humans 
 
 
- Priority is given to the relative content of components in the mixture that are themselves 
classified (summation method with cut-off criteria, Tables 3.5.2 of Annex I). An ingredient 
classified germ cell mutagens 1A or 1B and present at more than 0.1% trigger the 
classification of the mixture as Germ cell mutagen 1A or 1B, an ingredient classified Germ 
cell mutagens 2 and present at more than 0.1% trigger the classification of the mixture  as 
Germ cell mutagen 2. 
- Data on the mixture itself are only considered on a case-by-case basis (sections 3.5.3.2.1, of 
Annex I) when "demonstrating effects that have not been established from the evaluation 
based on the individual ingredients".  
- The bridging principles according to section 1.1.3 are also considered, if applicable. CA is 
not applied for any classification purposes. 
 
Carcinogenicity Known or presumed human carcinogens on the 
basis of epidemiological and/or animal data.  
1A: known to have carcinogenic potential for 
humans, classification is largely based on human 
evidence, or 
1B: presumed to have carcinogenic potential for 
humans, classification is largely based on animal 
evidence. 
Suspected human carcinogens 
Classification on the basis of evidence 
obtained from human and/or animal 
studies, but which is not sufficiently 
convincing to place the substance in 
Category 1A or 1B. 
- Priority is given to the relative content of components in the mixture that are themselves 
classified (summation method with cut-off criteria, Tables 3.6.2 of Annex I). An ingredient 
classified Carcinogen cat.1A or 1B and present at more than 0.1% trigger the classification of 
the mixture as Carcinogen 1A or 1B, an ingredient classified Carcinogen 2 and present at 
more than 0.1% trigger the classification of the mixture Carcinogen 2. 
- Data on the mixture itself are only considered on a case-by-case basis (sections 3.6.3.2.1 of 
Annex I) when "demonstrating effects that have not been established from the evaluation 
based on the individual ingredients".  
- The bridging principles according to section 1.1.3 are also considered, if applicable. CA is 
not applied for any classification purposes. 
Reproductive 
toxicity 
Known or presumed human reproductive 
toxicant (i.e clear evidence of an adverse effect 
on sexual function and fertility or on 
development). In addition, effects on lactation 
are allocated to a separate hazard category. 
1A: Known human reproductive toxicant; 
classification is largely based on evidence from 
humans. 
1B: Presumed human reproductive toxicant; 
classification is largely based on data from 
animal studies.  
Suspected human reproductive toxicant 
Classification based on some evidence 
from humans or experimental animals, 
possibly supplemented with other 
information, of an adverse effect on 
sexual function and fertility, or on 
development, and where the evidence is 
not sufficiently convincing to place the 
substance in Category 1.  
 
- Priority is given to the relative content of components in the mixture that are themselves 
classified (summation method with cut-off criteria, Tables 3.7.2 of Annex I). An ingredient 
classified Reproductive Toxicant cat.1A, 1B, 2 or "additional effect on or via lactation" and 
present at more than 0.3% trigger the classification of the mixture as Reproductive Toxicant 
cat.1A, 1B, 2 or "additional effect on or via lactation"  respectively. 
- Data on the mixture itself are only considered on a case-by-case basis (sections 3.7.3.2.1, of 
Annex I) when "demonstrating effects that have not been established from the evaluation 
based on the individual ingredients".  
- The bridging principles according to section 1.1.3 are also considered, if applicable. CA is 
not applied for any classification purposes. 
 
 
 
Table 2: Hazard class and category for human health hazard classification under the CLP regulation (continued) 
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Hazard class  Category Classification principles 
Specific target organ toxicity 
Specific target organ 
toxicity – single dose 
Cat 1 Cat 2 Cat 3  
-  Primary classification criterion is the data on the mixture itself, 
although specific care is advised by the guideline to ensure that 
“the dose, duration, observation or analysis does not render the 
results inconclusive” (sections 3.8.3.2.1 and 3.9.3.2.1 of Annex 
I). 
- The application of bridging principles is put forward in sections 
3.8.3.3 and 3.9.3.3 of 
Annex I.  
- If no reliable data are available on the mixture itself and the 
bridging principles cannot be used, the mixture is classified for its 
specific organ toxicity using the cut-off values given in Tables 
3.8.3 and 3.9.4 of Annex I: an ingredient classified as Cat 1 
Specific target organ toxicant and present at more than 10% 
triggers the classification of the mixture as Cat 1 Specific target 
organ toxicant 1A; if present between 1 to 10%, it triggers the 
classification Cat 2. An ingredient classified as Cat 2 Specific 
target organ toxicant and present at more than 10% triggers the 
classification of the mixture as Cat 2 specific target organ 
toxicant. 
- When extrapolating toxicity of a mixture that contains Specific 
target organ toxicity – single exposure Category 3 ingredient(s), a 
generic concentration limit of 20 % is appropriate; however, this 
concentration limit may be higher or lower depending on the 
Category 3 ingredient(s) and that some effects such as respiratory 
tract irritation may not occur below a certain concentration while 
other effects such as narcotic effects may occur below this 20 % 
value, therefore expert judgement is required (section 3.8.3.4.5). 
- CA is not applied for any classification purposes. 
- Care shall be exercised when toxicants affecting more than one 
organ system are combined that the potentiation or synergistic 
interactions are considered, because certain substances can cause 
target organ toxicity at < 1 % concentration when other 
ingredients in the mixture are known to potentiate its toxic effect 
(sections 3.8.3.4.4 and 3.9.3.4.4) 
Substances that have produced significant 
toxicity in humans or that, on the basis of 
evidence from studies in experimental 
animals, can be presumed to have the 
potential to produce significant toxicity in 
humans following single exposure 
Classification on the basis of: 
(a) reliable and good quality evidence 
from human cases or epidemiological 
studies; or 
(b) observations from appropriate studies 
in experimental animals in which 
significant and/or severe toxic effects of 
relevance to human health were produced 
at generally low exposure concentrations.  
Substances that can be presumed 
to have the potential to be harmful 
to human health following single 
exposure 
Classification on the basis of 
observations from appropriate 
studies in experimental animals in 
which significant toxic effects, of 
relevance to human health, were 
produced at generally moderate 
exposure concentrations.  
 
Transient target organ effects 
This category only includes 
narcotic effects and respiratory 
tract irritation. These are target 
organ effects for which a 
substance does not meet the 
criteria to be classified in 
Categories 1 or 2.  
These are effects which 
adversely alter human function 
for a short duration after 
exposure and from which 
humans may recover in a 
reasonable period without 
leaving significant alteration of 
structure or function.  
Specific target organ 
toxicity – repeated 
dose 
Cat 1 Cat 2 
Substances that have produced significant toxicity in 
humans or that, on the basis of evidence from studies in 
experimental animals, can be presumed to have the 
potential to produce significant toxicity in humans 
following repeated exposure. 
Classification on the basis of: 
- Reliable and good quality evidence from human cases 
or epidemiological studies; or 
- Observations from appropriate studies in experimental 
animals in which significant and/or severe toxic effects, 
of relevance to human health, were produced at 
generally low exposure concentrations.  
Substances that can be presumed to have the potential 
to be harmful to human health following repeated 
exposure. 
Classification on the basis of observations from 
appropriate studies in experimental animals in which 
significant toxic effects, of relevance to human health, 
were produced at generally moderate exposure 
concentrations.  
 
Aspiration hazards Cat 1: Substances known to cause human aspiration toxicity hazards or to be regarded as if they 
cause human aspiration toxicity hazard 
Classification based on (a) based on reliable and good quality human evidence, or 
(b) if it is a hydrocarbon and has a kinematic viscosity of 20,5 mm2/s or less, measured at 40ºC. 
The classification of a mixture into the hazard class “aspiration 
hazard” follows the same outline: use of data on the whole 
mixture of interest, bridging principles, and cut-off values for 
individual compounds (section 3.10.3. of Annex I). 
Table 2: Hazard class and category for human health hazard classification under the CLP regulation (continued) 
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Hazard class  Category Classification principles 
Acute aquatic 
toxicity 
Cat 1  
Classification on the basis of acute aquatic toxicity data only (EC50 or LC50).  
- A substance or a mixture (on the bases of a whole-testing approach)  is classified as acute category I if its EC50 
is ≤ 1mg/L (Table 4.1.0) 
-Summation methods: if the mixture contains ≥ 25% of compounds classified into acute toxicity category I, the 
mixture is also classified into Cat 1. 
-Priority is given to the data on the whole mixture (if available) 
-If no information available, the classification can be based on 
bridging principle. 
-If this is not possible, the “summation method” is applied; highly 
toxic compounds are given increased weight for the summation by 
the application of M-factors (Table 4.1.3, Annex I).  
-If the mixture contains not yet classified compounds for which 
adequate toxicity data are available, CA is used for the assignment 
of an acute category to that portion of the mixture (§ 4.1.3.5.2 of 
Annex I), which is then used in applying the summation method 
for the whole mixture. 
If relevant compounds are present in the mixture that are not 
classified for their acute toxicity and for which no toxicity data are 
present the classification of the mixture shall be based on the 
assessable rest of the mixture (§4.1.3.6.1 of Annex I). 
Chronic aquatic 
toxicity 
Cat 1 Cat 2  Cat 3 Cat 4  
Classification of a substance into the chronic categories combines 
two types of information, i.e. acute aquatic toxicity data and 
environmental fate data (degradability and bioaccumulation data). 
Data on the chronic toxicity data (NOEC values) of the whole 
mixture and/or the classification information on the individual 
compounds are used for the classification of the mixture into 
chronic aquatic toxicity category 1-4 (§4.1.3.5.5.4 of Annex I). 
 
If EC50 ≤ 1mg/L 
and the substance 
is not rapidly 
biodegradable  
and/or the 
experimental 
determined BCF ≥ 
500 (or log Kow≥4) 
Summation 
methods:  
If  ∑(comp. 
Chronic Cat 1 * 
M) ≥ 25 % 
M= multiplying 
factor, dependant 
on the LC50 of the 
component 
If is 1 mg/L ≤ EC50 ≤ 
10mg/L and the 
substance is not rapidly 
biodegradable and/or 
the experimental 
determined BCF ≥ 500 
(or log Kow ≥ 4), unless 
the chronic toxicity 
>1mg/L. 
Summation methods:  
If ∑[(M*10* comp. 
Chronic Cat 1) + 
Chronic Cat 2] ≥ 25 % 
 
If is 10 mg/L ≤ EC50 
≤ 100 mg/L and the 
substance is not 
rapidly biodegradable  
and/or the 
experimental 
determined BCF ≥ 
500 (or log Kow≥4), 
unless the chronic 
toxicity > 1mg/L 
Summation 
methods: If 
∑[(100*M* comp. 
Chronic Cat 1) + 
(10*M* Chronic Cat 
2] ≥ 25 % 
‘Safety net’ classification for use when 
the data available do not allow 
classification under the formal criteria 
but there are nevertheless some 
grounds for concern 
 
∑[ Chronic Cat 1+ Chronic Cat 2+ 
Chronic Cat 3+ Chronic Cat 4] ≥ 25 % 
ATE: acute toxicity estimate (LD/EC50), ppmV: parts per million per volume, CA: Concentration Addition, Exp: exposure; Obs: Observation, min: minutes, d: days 
Table 3: Hazard class and category for environmental hazard classification under the CLP regulation 
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Thus, in most cases the CLP regulation relies on the concentration addition method to 
classify mixtures into acute toxicity to human health classes or environmental hazard classes, 
and does not mention the concept of independent action. This seems to be a defendable 
approach as there is empirical evidence that the differences between the mixture toxicity 
according to CA and IA is usually small, and because CA is usually slightly more 
conservative (Kortenkamp et al., 2009). The summation method (i.e the classification in 
dependence of the relative amount of already classified compounds) also plays an important 
role in this regulation. This is an easy-to-use method which allows a rapid classification of 
any mixture;  however, according to Kortenkamp et al (2009) it includes a substantial risk for 
underestimating the toxicity of the mixture. For example, a mixture would be classified for 
“acute toxicity (environment)” category 1 by the summation method if it contains 25% at 
least of compounds classified Acute Aquatic Toxicity cat.1. Thus, if it contains only 24% of 
these compounds, the mixture would not be classified (with assumed multiplying factors of 
1). However, if the acute toxicity classification for all the classified compounds is based on 
an acute EC50 of 0.11 mg/L, CA would predict an overall toxicity of the mixture of 0.46 mg/L 
which implies the classification of the mixture. Indeed, the CA methods would allow no more 
than 11% of "acutely toxic to the environment" classified compounds with an EC50 of 0.11 
mg/L (for which the M factor is still 1) in the mixture before classifying it, whereas the 
summation methods allow 24% of these compounds in the mixtures before reaching the 
classification threshold, i.e. a 2.5 times higher concentration. It could even be worse if the 
remaining 76% of the mixture are made of compounds with an EC50 slightly superior to 1 
mg/L (i.e not classified but showing a low acute aquatic toxicity); in this case CA would 
calculate a mixture toxicity of 0.34 mg/L. 
Thus, this regulation provides guidance on the hazard classification of commercial 
chemical mixtures for human health and the aquatic environment according to four different 
classification methods:  
1) Use of test data on the whole mixture and classification of the mixture as if it were a 
single substance  
2) Use of the “bridging principles” and classification of a mixture on the basis of a 
similar mixture that is already classified 
3) Use of the summation methods when the amounts of individual classified substances 
in the mixture of interest are known  
4) Use of concentration addition if there are toxicity data available for the mixture 
components, even though the individual components are not classified 
As such, even though the regulation expresses the need to take into account the possible 
interaction effects between ingredients of a mixture, none of the above-mentioned calculation 
methods does so, and those interaction effects are only taken into account if the classification 
is based on test data on whole mixture. 
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3.1.6   REACH (Regulation 1907/2006)  
REACH aims at ensuring the chemical safety assessment (CSA) of all commercial 
chemicals that are not specifically covered by other sectorial regulations, through their 
hazard, exposure and risk assessment. It aims to ensure "a high level of protection of human 
health and the environment" and "the free movement of substances, on their own, in mixtures 
and in articles" (EC, 2006b). 
The term "chemical mixture" under REACH is used synonymously with "preparation" 
(ECHA, 2008c), that is, a deliberate combination of two or more individual substances. Thus, 
they are "intentional mixtures" of non-reacting chemicals for producing final chemical 
products. REACH registration requirements apply to each of the individual chemicals in the 
preparation, but not to the preparation itself.  
However, Multi-Constituent Substances (or MCS) which are substances resulting from a 
chemical reaction in which several constituents are present at >10%, and UVCB (substances 
of Unknown or Variable composition, Complex reaction products or Biological materials) 
which are mixtures that cannot be completely identified by their chemical composition, are 
included in the legal "substance" definition. Thus these are generally treated as a single 
substances under REACH, "provided that the hazardous properties do not differ significantly 
and warrant the same classification", and the testing of hazard and fate properties is made on 
the mixture itself. Moreover, an individual chemical (or mono-constituent substance) can 
contain up to 20% arbitrary by-products without the need for specific consideration. 
The Chemical Safety Assessment under REACH implies the following steps: 
1) Determining the intrinsic hazard toxicity (ECHA, 2008b) of the substance or the 
mixture, through the hazard classification and the characterisation of the dose/concentration 
response. This step implies either the estimating of Derived No-effect-Levels (DNEL) for 
human health or Predicted No Effect Concentration (PNEC) for environmental assessment, as 
well as to assess the persistence, bioaccumulation and toxicity (PBT) properties of the 
substance/mixture.     
2) Determining the exposure assessment, by building exposure scenarios and estimating 
exposure levels  
3) Characterizing the risk  
Regarding exposure, it has to be stressed that under REACH, a registrant is not obliged 
to take into account an exposure to the same substance from activities from other producers 
or importers (ECHA, 2008c), although there might be multiple sources of exposure to the 
same substance in real life (i.e. aggregate exposure). Moreover, there is no specific hazard 
assessment required for chemical mixtures, preparations, MCS or UVCBs, unless they have 
PBT/vPvB properties. These mixtures are defined as PBT or vPvB
4
 substances if they contain 
more than 80% of a substance with PBT/vPvB properties (R 11.1.1.2 (ECHA, 2008a), but 
management measures have to be considered as soon as a substance contains or degrades to 
                                                        
4
 PBT: Persistent, Bioaccumulative, toxicity; vPvB: very persistant, very bioaccumulative; vPvB are characterized by a 
particular high persistency and a high tendency to bio-accumulate, but not necessarily proven toxicity 
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PBT or vPvB substances above the threshold of 0.1%. A detailed guidance for their 
assessment is given in the chapter R11 (R 11.1.4.2 , (ECHA, 2008a), and is summarized in 
Figure 1.   
The first step is a chemical characterisation of the mixture. Since it might be difficult to 
identify all components down to the 0.1% threshold amount, it is advised to define 
"representative structures" used in the following steps for describing the properties of whole 
blocks of the mixtures. Then, the available information for the PBT assessment for each 
constituent/block of the mixtures is compiled and assessed (Kortenkamp et al., 2009). A case-
by-case approach for substances containing many constituents is necessary, and only general 
guidance can be given. The REACH guidance gives an example based on the Hydrocarbon 
Block approach in Appendix R11-3 (ECHA, 2008a). 
Besides the testing of the substance/mixture itself, the REACH guidance also foresees 
the use of other methodological approaches for predicting the overall risk based on 
information on the individual components (EC, 2011b).  
Thus, REACH is a typical substance-oriented regulation, providing mainly for individual 
chemical substances but also for commercial chemical mixtures resulting from chemical 
reactions or that are natural products such as UVCBs and MCSs, which are included in the 
legal definition of "substances" under REACH.  
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Figure 1: PBT assessment of MCS (Multi-Constituent Substances) and UVCBs (substances of 
Unknown or Variable composition, Complex reaction products or Biological materials) under 
REACH (according to ECHA, 2008a, § 1.4.2 and appendix R11-3, modified) 
Source: European Chemicals Agency 
1- Chemical Characterisation of the substance: 
Identification of the main constituent (10-80% of the substance) and 
significant impurities (0.1-10% of the substance) 
2- Gathering and assessing available information 
- Relating to the constituent defined in a MCS or to the fraction/blocks for UVCBs 
- Regarding the use of the substances and emission patterns  
- Relating to aquatic and mammalian toxicology, as well as the data that relate to persistence and potential to 
bioaccumulate 
    
 
Where necessary, generation of new 
information 
- by QSAR estimation and read across 
- by the testing of strategically selected 
individual constituent if needed 
MCS: Listing of the relevant 
constituents, and their approximates 
percentage  
 
UVCBs:    - Specify all known constituents present at concentrations ≥10%, 
with typical concentrations/concentrations range. 
- Assess unidentifiable constituents/fraction using the following 
strategies: 
1: Assess the available data used to characterized /describe UVCB (ex: 
boiling point for petroleum substances can be used to generate a list of 
structures potentially present in the UVCB; distribution of polar and non-
polar functional group for surfactants; molecular weights or chain lengths 
for halogenated  UVCB) 
2: Identify the structures that are to be used as representative of the 
unknown fraction, or representative for groups of closely related 
molecules 
3: Demonstrate that the fraction for any representative structure is present 
at less than 0.1% (i.e. it is not necessary to generate representative 
structures) 
3 - Assessment of Persistence  
-if UVCB consist of homologous structures and meet the ready 
biodegradation test criterion (>60% in 28d), it can be 
concluded that the underlying constituents are not expected to 
be persistent 
-If non homologous structures: judgement on a case-by-case 
basis  
4 - Assessment of Bioaccumulation Potential: use the same 
"mapping" or "blocking" approach as previously, by use of test 
data or valid QSARs prediction: 
- First tier: estimates for the individual components based on 
Kow, QSARs or multi-components measuring techniques (SPME, 
HPLC) 
-Second tier if necessary: testing of representative structures 
5 - Assessment of Toxicity 
Toxicity is defined via a concentration response and is 
dependent on the bioavailability of the individual constituents 
in an MCS or an UVCB test substance. 
For petroleum derived UVCBs substances, the lethal loading test 
procedure can be used (OECD, 2000). 
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3.1.7   Food law  
Regulation (EC) No 178/2002 is the general European food law which lays down 
general principles and requirements in this field, as well as procedures in matters of food 
safety. This regulation also established the European Food Safety Authority (EFSA), which 
became responsible for carrying out corresponding safety evaluations.  
Food additives – Regulation (EC) No 1333/2008  
The legislation on food additives aims at, amongst others, "ensuring a high level of 
protection of human health and a high level of consumer protection, (…) taking into account, 
where appropriate, the protection of the environment" (Article 1). Accordingly, Article 6 
specifies that food additives must meet three general conditions: consumer safety, 
technological need, and no misleading of the consumer, as well as, where relevant, "other 
legitimate factors, including environmental factors”. Three additional regulations establish 
complementary rules for food enzymes (Regulation (EC) No 1332/2008), food flavourings 
(Regulation (EC) No 1334/2008) and a common authorisation procedure for food additives, 
food enzymes and food flavourings (Regulation (EC) No 1331/2008). Regulation 1331/2008 
requires that, in accordance with the framework for risk assessment in matters of food safety 
established by Regulation (EC) No 178/2002, the authorisation to place substances on the 
market must be preceded by an independent scientific assessment of the risks that they pose 
to human health, which must be carried out under the responsibility of the Authority (i.e. 
EFSA) and must be followed by a risk management decision taken by the Commission 
(Recital 12). 
According to Regulation 1333/2008 a food additive should not, “on the basis of the 
scientific evidence available, pose a safety concern to the health of the consumer” (Article 6, 
§1a). Established procedures for the safety assessment of food additives are based on 
Acceptable Daily Intake values (ADI), and permitted use levels are considered to be safe 
when the intake of additives does not exceed the corresponding ADI values. When necessary, 
maximum use levels are fixed in Annexes II and III of the regulation.  
However, although the previous regulation on food additives provided a basis for 
mixture toxicity assessments, stating that the evaluation of a food additive "should also take 
into account, for example, any cumulative, synergistic or potentiating effect of its use" 
(Directive 89/107/EEC, Annex II, §3), the current Regulation 1333/2008 does not mention 
any of the terms cumulative, synergistic or potentiating and does not allude to the need for 
mixture toxicity assessments. Besides, established procedures for the safety assessment of 
food additives on the basis of ADI values for single substances do not specifically consider 
joint actions or interactions between additives and food consumption (Groten et al., 2000). 
Nevertheless, food safety requirements defined in Regulation (EC) No 178/2002 apply, and 
state that: “In determining whether any food is injurious to health, regard shall be had (…) to 
the probable cumulative toxic effects” (Article 14, §4). However, this Regulation does not 
define the term “cumulative toxic effects”, which could mean, in a narrow sense, a toxic effect 
resulting from repeated exposure to a single toxicant from the same, similar or different 
sources via the same or via different routes of exposure; or in a wide sense a toxic effect 
resulting from simultaneous or sequential exposure to different toxicants and thus be used as 
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a synonym for mixture toxicity (Kortenkamp et al., 2009). In the context of the general food 
law, the term has often been used in the narrow sense of repeated doses, and without any 
further indications or specifications the term “cumulative toxic effects” cannot be interpreted 
as a legal requirement for mixture toxicity assessments (Kortenkamp et al., 2009). Moreover, 
Recital 7 and Article 11 §1b i) states that maximum levels of a food additive should take into 
account the intake of the food additive from other sources, stating that “any acceptable daily 
intake, or equivalent assessment, established for the food additive and the probable daily 
intake of it from all sources” should be taken into account when establishing the maximum 
level of use. This formulation avoids the term cumulative and the possible confusion that may 
arise from it, and is in line with the narrow sense that could be given to this term. Thus, 
Regulation (EC) 1333/2008 neither excludes the need for mixture toxicity assessments nor 
does it explicitly define such a need (Kortenkamp et al., 2009).  
Feed additives (Regulation (EC) No 1831/2003) and feed additive assessment 
(Directive 2001/79/EC and Regulation (EC) No 429/2008) 
The purpose of Regulation (EC) No 1831/2003 is “to establish a Community procedure 
for authorising the placing on the market and use of feed additives and to lay down rules for 
the supervision and labelling of feed additives and premixtures” (Article1§ 1). To be placed 
on the market and used, feed additives must undergo a harmonised scientific safety 
assessment by EFSA (Recitals 4 and 14) and they must be authorised by the Community 
(Articles 3 and 9). Moreover, the procedures and rules established by this Regulation are 
intended to “… provide the basis for the assurance of a high level of protection of human 
health, animal health and welfare, environment and users’ and consumers’ interests in 
relation to feed additives, whilst ensuring the effective functioning of the internal market” 
(Article 1, § 1), which explicitly includes the environment in the protection goals. 
Accordingly, feed additives should be authorised only if they do “not have an adverse effect 
on animal health, human health or the environment”, do "not harm the consumer by 
impairing the distinctive features of animal products or mislead the consumer with regard to 
the distinctive features of animal products”, is “not presented in a manner which may mislead 
the user”, and it "favourably affect the characteristics of feed" to which it is added and "the 
characteristic of animal products" (Article 5). 
If EFSA's opinion is in favour of authorising the feed additive, it shall provide a proposal 
for the establishment of corresponding Maximum Residues Limits (MRLs) in the relevant 
foodstuffs (Article 8, §4 e). The methods and procedures to be used for these assessments are 
not specified in the Regulation, but it is EFSAs’ general task to provide “the best possible 
scientific opinions” and to develop “uniform risk assessment methodologies in the field 
falling within its mission” (Regulation (EC) No 178/2002, Article 23 a and b). 
The feed additives regulation also covers mixtures of additives sold to the end-user 
(Recital 9; Article 1; Article 2), whereby “the marketing and use of those mixtures should 
comply with the conditions laid down in the authorisation of each single additive” (Recital 9), 
However this regulation does not address the topic of mixture toxicity, and does not include 
provisions for taking into account hazards and risks arising from mixture toxicity 
(Kortenkamp et al., 2009). As mentioned previously, the general requirement to consider 
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"probable cumulative toxic effects" in food safety assessments (Regulation (EC) No 
178/2002) may apply, but cannot be interpreted as a mandatory requirement for mixture 
toxicity assessments. Moreover, this regulation does not prescribe how scientific risk 
assessments should be performed. 
Commission Regulation (EC) No 429/2008 establishes the detailed rules for "the 
preparation and the presentation of applications and the assessment and the authorisation of 
feed additives", and provides the requirements and the studies to be submitted to demonstrate 
the feed additive efficacy and "its safety for humans, animals and the environment" (Recital 
2). It lists the physico-chemical, toxicological, and ecotoxicological data and studies that may 
be required to support safety assessments in relation to target species, workplace exposure, 
consumers ingesting residues of feed additives or their metabolites, and the environment. 
This regulation also provides guidance for the derivation of proposals for standard safety 
criteria from toxicological and ecotoxicological test results, in particular NOAEL, ADI, 
MRL, and PEC/PNEC values (Annex II).  
This regulation explicitly addresses hazards and risks that may arise from mixture 
toxicity, as it requires that "Where an additive has multiple components, each one may be 
separately assessed for consumer safety and then consideration given to the cumulative effect 
(where it can be shown that there are no interactions between the components). Alternatively, 
the complete mixture shall be assessed" (Annex II, section General Aspects, subsection 
Safety assessment). However, no further guidance on the practical performance of cumulative 
effect assessments is included in the document. 
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3.2    Regulatory requirements linked to generated or coincidental mixtures with 
unknown/varying composition  
Discharge to the environment during the production, transport, use or disposal of goods 
often implies a mixture of chemical substances. Depending of the cases, the composition can 
either be known, in which cases the assessments can be based on the knowledge of the 
constituents, or unknown. The release of such mixtures is of concern for legislation such as 
the Water Framework Directive or waste-related regulation. Other mixtures originating from 
various sources are unintentional and coincidental. Such a situation could be related either to: 
a) water/soil/air-related regulation; b) the exposure of workers in the workplace, for which a 
risk assessment is required for all hazardous chemicals, including in combination; or c) the 
exposure of humans to multiple chemicals from food and drinking water. The assessment of 
multiple substances from multiple sources is the main issue raised by the European 
Commission when dealing with the assessment of chemicals mixture (EC, 2012a).  
3.2.1   Environmental impact assessment (Directive 2011/92/EU) 
This Directive "on the assessment of the effects of certain public and private projects on 
the environment" states that competent national authorities in EU Member States must carry 
out an environmental impact assessment before giving consent to “projects likely to have 
significant effects on the environment” (Article 2). The directive covers a broad range of 
project categories, from agricultural and industrial installations to infrastructure projects, 
including certain facilities which are or may be a source of emission of chemical pollutants 
during construction or operation. The Environmental Impact Assessment (EIA) shall 
“identify, describe and assess (…) the direct and indirect effects” on “human beings, fauna 
and flora, soil, water, air, climate and the landscape, material assets and the cultural 
heritage”, as well as “the interaction between the factors” (Article 3). 
Regarding chemicals, the information required from the developer of a project shall, 
include (i) an estimate, by type and quantity, of expected residues and emissions (water, air 
and soil pollution, …), and (ii) a description of the likely significant effects (…) on the 
environment resulting from (…) the emission of pollutants (…) and the elimination of wastes, 
(iii) a description of forecasting methods used to assess the effects (…) and a description of 
measures envisaged to prevent, reduce and where possible offset any significant adverse 
effects (…) (Annex IV, § 1, 4, 5 and 6). Based on this information, the EIA of the competent 
authority shall identify, describe and assess the effects in an appropriate manner (Article 3), 
but the directive does not prescribe any specific procedures, methods, or criteria and the 
specification and methodology of the effects assessment is left to the choice of the competent 
national authorities and in accordance with national legislation. As a support to Member 
States, the European Commission has published guideline documents for the implementation 
of the EIA
5
, but these guidelines also address procedural aspects on a very general level and 
do not detail any rules for assessing the effects of pollutants (Kortenkamp et al., 2009). 
                                                        
5 Available at: http://ec.europa.eu/environment/eia/eia-guidelines/g-screening-full-text.pdf; 
http://ec.europa.eu/environment/eia/eia-guidelines/g-scoping-full-text.pdf; http://ec.europa.eu/environment/eia/eia-
guidelines/g-review-full-text.pdf 
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Regarding mixture assessment, Annex IV states that the description of the likely 
significant effects required shall cover the direct effects and any indirect, secondary, 
cumulative, short, medium and long-term, permanent and temporary, positive and negative 
effects of the project (Footnote 1 to §4), and considerations should be given to the cumulation 
with other projects in deciding about the need for an EIA for a specific project (Annex III, § 
1), therefore, likely significant effects from mixtures of pollutions, if relevant for specific 
projects, should be covered. However, whether and how such mixture effects might be 
identified, described and assessed is left to the competent national authorities and 
corresponding national legislation. As mentioned above, a guidance document on the 
Assessment of Indirect and Cumulative Impacts as well as Impact Interactions has been 
published (EC, 1999), but this guideline only sets out rules and options on a general 
procedural level of EIA enforcement and is of no practical relevance for mixture toxicity 
assessments (Kortenkamp et al., 2009). Thus, this leads to the question of whether 
assessments of mixture toxicity actually play any role in the practice of environmental impact 
assessments at the Member States level, and if so, how this is done. This has been partly 
addressed in Part 3 of the Kortenkamp report (2009), dealing with approaches and practical 
experience in assessing the mixture toxicity of complex environmental samples and wastes 
samples in the EU. 
3.2.2   Integrated pollution prevention and control (Directive 2010/75/EU)  
The Integrated pollution prevention and control (IPPC) Directive, 2010/75/EU, which 
repeals Directive 2008/1/EC from 7
th
 January 2014, aims at preventing or reducing 
"emissions in the air, water and land (…) in order to achieve a high level of protection of the 
environment taken as a whole" (Article 1). In order to do so, this directive defines the 
activities with a high potential for pollution that require a permit (Article 4, Annex I), and 
adopts an integrated approach: emissions into air, water or soil, water management, energy 
efficiency and accident prevention are controlled in a single permit, with the aim to avoid the 
shifting of pollution between various environmental media, which otherwise might be 
encouraged by a fragmented approach (Recitals 3). 
Application of the "best available techniques" (BAT; i.e. using established techniques 
which are the most effective in achieving a high level of environmental protection as a 
whole) (Article 3a) and setting of "Emission limit values" (ELV) - usually based on the BAT 
principle without any direct considerations of toxicity - are the key principles for pollution 
reduction under this directive. Every permit shall include such ELVs for polluting substances 
(…) likely to be emitted from the installation concerned in significant quantities (Article 14, 
§1a) but toxicological hazard and/or risk assessments do not play a direct role in this 
approach. Approaches used in mixture toxicology play however an indirect role, as they may 
be used in the setting of ELVs, such as the Toxic Equivalence Factor (TEF) in the setting of 
ELVs for dioxins and furans. Another interesting aspect of the IPPC in the context of mixture 
toxicity comes from the interrelation with the European Pollutant Emission Register (EPER) 
and the European Pollutant and Transfer Register (E-PRTR), based on the IPPC directive, 
which document information on pollutant emissions from IPPC establishments. These 
databases may provide valuable information for modelling approaches to the assessment of 
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cumulative exposure to multiple pollutants, one of the current bottlenecks in assessing 
potentially resulting cumulative risks (Kortenkamp et al., 2009).  
3.2.3   Waste and waste streams (Directive 2008/98/EC) 
A general framework for waste management is given in the Waste Framework Directive 
(Directive 2008/98/EC), which repealed the older individual directives on waste 
(2006/12/EC), hazardous waste (91/689/EEC) and waste oils (75/439/EEC). It "lays down 
measures to protect the environment and human health by preventing or reducing the adverse 
impacts of waste" (Article 1), and it generally states that waste should be managed "without 
harming the environment and, in particular (a) without risk to water, air, plants and 
animals" (Article 13). Several types of waste are excluded absolutely from the Directive: 
gaseous effluents emitted into the atmosphere, decommissioned explosives, agricultural or 
forestry material used in farming, forestry or production of biomass, and radioactive waste 
(addressed in 2011/70/EURATOM). Others are only excluded to the extent that they are 
covered by other legislation, like waste waters (addressed in the Water Framework Directive 
and related directives), animal by-products and carcasses (covered by Directive 1774/2002), 
waste from specialized industries, e.g. extractive industries like mining (Directive 
2006/21/EC).  
A list of the different types of waste is defined in Decision 2000/532/EC, which 
established a classification system for waste including a distinction between hazardous waste 
and non-hazardous wastes. It is closely linked to the list of the main characteristics which 
render waste hazardous contained in Annex III to the Waste Framework Directive. The Waste 
Framework Directive does not address the toxicological assessment of waste, but rather refers 
via Annex III to the Directive on classification and labelling for classification of the 
toxicological properties. For disposal operations to seas and oceans, reference is made to 
international conventions, in particular the Convention on the Prevention of Marine Pollution 
by dumping Waste and Other Matter (London, 1972 and the Protocol thereto as amended in 
2006) (Recital 21). Waste emissions to the air, including waste incineration, are covered by 
the Directive on Integrated pollution prevention and control (IPPC) (2010/75/EU) (see § 
3.2.2), which addresses mixture toxicity for dioxins and furans specifically based on the TEF 
concept.  
3.2.4   Water Framework Directive (2000/60/EC) and Groundwater Directive 
(2006/118/EC) 
The Water Framework Directive aims to establish the basic principles of sustainable 
water policy in the European Union, and to assess, maintain or improve the chemical status of 
European waters. In order to do so, this directive aims at progressively reducing the 
emissions of hazardous substances to water; with the ultimate aim of eliminating priority 
hazardous substances (Recital 27 and Article 16.1) or reducing concentrations to near natural 
background concentrations. In this context, this directive both identifies priority hazardous 
substances presenting a significant risk to or via the aquatic environments on the basis of a 
scientific assessment of the risk carried out under Regulation No 793/93, the PPP regulation 
or the biocidal products regulation (Article 16.2 and 16.3), and sets common environmental 
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quality standards (EQS) and emission limit values for chemicals or certain groups or families 
of pollutants (Recital 42 and Article 16.7). The identified priority substances are listed in 
Annex X of this regulation, and Annex V describes a procedure for the setting of chemical 
quality standards in surface water (Point 1.2.6), established from the application of safety 
factors on ecotoxicity data. The first list of priority pollutants was described in 2455/2001/EC 
and the initial EQS, as well as a (revised) set of priority pollutants, are described in Directive 
2008/105/EC. Recently, the EQS together with the list of priority pollutants have been 
amended (Directive 2013/39/EU), adding new compounds to the list of priority pollutants. 
Although the focus remains on a selected set of compounds, it does add an additional "watch 
list" of compounds under consideration (Article 8b). This watch list currently includes several 
pharmaceuticals, a group of compounds regarded as relevant for mixture toxicity but not 
currently covered by other regulations (nor assessed under REACH), which is why the 
Commission aims to develop by the end of 2015 a strategic approach to pollution of water 
by pharmaceutical substances (Article 8c). Moreover, a more complete guidance document 
was published in 2011, presenting the methodology for the establishment of environment 
quality standards (EQS) for a new list of priority substances and for river-basin-specific 
pollutants, based not only on the water column but also on sediment or biota matrices (EC, 
2011a). This technical guidance document describes a methodology consistent “with the 
guidance for effects assessments performed for chemical risk assessment under REACH”, that 
should account for “all direct and indirect exposure routes in aquatic systems i.e. exposure in 
the waterbody via water and sediment or via bioaccumulation, as well as possible exposure 
via drinking water uptake”. 
 Although the Water Framework Directive considers families or groups of chemicals, it 
does not mention chemical mixtures or mixture effects but aims to focus on a limited number 
of substances, including temporarily in a watch list. Nevertheless, the EQS guidance 
document recognises that in some circumstances, such as the release of known and largely 
constant composition mixtures (biocides, pesticides) or other mixtures with a partly 
unknown, reasonably constant composition, that both change after entry into environment, an 
EQS for mixtures of substances may be preferable to deriving EQSs for the individual 
constituent substances (§ 2.7). Section 7 of the guidance document briefly outlines how to 
estimate EQS for mixtures, using the toxic unit (TU) approach for well-defined mixtures, and 
the hydrocarbon blocks and the use of non-testing methods such as PETROTOX
6
 for the 
derivation of EQS for petrochemical mixtures of unknown or variable composition (See also 
Part 3 of this report). 
 To ensure a proper strategy against groundwater pollution, as specified in Article 17 
of the Water Framework Directive, the Groundwater Directive has been developed. In Annex 
I, this Directive sets a provisional limit of 0.1 µg/l for active substances in pesticides (plant 
protection products and biocidal products as defined in Directive 91/414/EEC and 98/8/EC 
respectively) as well as a sum limit of 0.5 µg/l in total. Additional thresholds can be set 
however that "take into account human toxicology and ecotoxicology knowledge" (Article 3) 
                                                        
6
 PETROTOX (CONCAWE) is a tool using QSAR modelling to assess aquatic toxicity hazard of complex petroleum and 
related substances. https://www.concawe.eu/Content/Default.asp?PageID=778 
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and reference is made to the priority substances mentioned in the WFD. Annex II sets 
guidelines for the establishment of threshold values and includes a minimum list of pollutants 
for which threshold values have to be considered. As Annexes I and II have to be reviewed 
every six years after implementation, they have been reviewed in 2013, and the following 
changes to the groundwater directive have been approved and are expected to be published in 
2014: a “watch list” will be set up, similar to the watch list for surface water pollutants, to 
collect more information on pollutants, including emerging contaminants, and identify which 
need to be addressed in future. Moreover, because of their contribution to eutrophication, 
nitrite and total phosphorous are being added to Annex II of the directive, which lists the 
substance member states should consider setting national threshold values for. Finally, the 
directive’s guidelines for reporting the chemical status of groundwater have been rewritten 
and more guidance provided on determining threshold values
7
. 
3.2.5   Marine Strategy Framework Directive (Directive 2008/56/EC) 
The Directive on a marine environmental policy is in place to ensure the implementation 
of "a thematic strategy for the protection and conservation of the marine environment" 
(Article 4) which "addresses all human activities that have an impact in the marine 
environment" (Article 5). It builds on other Directives that are already in place, including 
Directive 92/43/EEC (Conservation of natural habitats and of wild fauna and flora), Directive 
79/409/EEC (Conservation of wild birds) and the Water Framework Directive (2000/60/EC) 
and aims to "contribute to coherence between different policies and foster the integration of 
environmental concerns into other policies, such as the Common Fisheries Policy, the 
Common Agricultural Policy and other relevant Community Policies" (Article 9).  Although 
it focuses on a wide range of pressures, special attention is given to the impact of pollutants, 
while not restricting itself to a limited list of pollutants but treating the list as indicative 
(Articles 8.1.b.i, 9.1 and 10.1) and taking into account potential cumulative and synergistic 
effects (Article 8.1.b.ii). The indicative list of compounds is reviewed and updated every six 
years (Article 17.2.b) or sooner in the light of scientific and technical progress (Article 24.1). 
The directive is quite straightforward in that the compounds present may not pose any risk to 
the marine environment, but it was recognized that the scientific understanding to support this 
Directive was still lacking. Therefore, it was decided that before implementing the Directive, 
more research was needed for assessing good environmental status in a coherent and holistic 
manner to support the ecosystem-based approach (Commission Decision 2010/477/EU, 
Article 3). It was still emphasized however, that it is important to consider cumulative and 
synergistic effects, not only by compounds listed in the Water Framework Directive 
(Directive 2000/60/EC) and others, but also compounds that may entail significant risks to 
the marine environment from past and present pollution (Descriptor 8.iii). 
3.2.6   Drinking Water Directive (Directive 98/83/EC) 
This directive aims at ensuring a good quality of water intended for human consumption, 
by setting individual parametric values for substances that are of health concern at a level 
                                                        
7 Draft directive at: http://www.endseurope.com/docs/140217a.doc 
 
 37 
strict enough to ensure "the protection of human health from the adverse effect of any 
contamination of water" (Article 1). The parametric values, listed in Annex I of the Directive, 
should be based "on the scientific knowledge available" and on a risk assessment method, and 
should take into account microbiological risk, chemical risks and public-health considerations 
(Recital 13 and 14). They should also have been "selected to ensure that water intended for 
human consumption can be consumed safely on a life-long basis, and thus represent a high 
level of health protection" (Recital 13). 
Member States are in charge of ensuring that water intended for human consumption 
respects the minimum requirements of the Directive (Article 4) and of setting values for those 
parameters which shall not be less stringent than those set out in Annex I. They shall also, 
where required by human health protection, set values for additional parameters not included 
in this Annex. It is also the duty of the Member States to ensure the efficiency of the 
disinfection treatment applied and that regular monitoring of the quality of drinking water is 
carried out (Article 7). Where disinfection is carried out, any contamination from disinfection 
by-products must be kept as low as possible without compromising the disinfection (Article 
7). 
In case of non-compliance with the required parametric values, the Member State 
concerned shall ensure that the necessary remedial action is taken as soon as possible to 
restore the water quality (Article 8), and should assess the extent to which the relevant 
parametric value has been exceeded as well as the potential risk to human health (Article 8 
and Recital 27).  
Thus, this regulation requires the monitoring of individual parameters in drinking water 
but does not address chemical risk assessment or any mixture issue, although disinfection 
products or by-products might be of concern for human health (Nieuwenhuijsen et al., 2009; 
Jeong et al., 2012).   
3.2.7   Soil Thematic Strategy and Proposal for Soil Framework Directive  
Given the importance of soil and the need to prevent further soil degradation, the Sixth 
Environment Action Programme called for the development of a Thematic Strategy on Soil 
Protection, which was adopted on September 2006 (COM(2006)231). Soil is subject to a 
series of degradation processes or threats. These include erosion, decline in organic matter, 
local and diffuse contamination, sealing, compaction, decline in biodiversity, salinisation, 
floods and landslides. Along with the Soil Thematic Strategy, a Soil Framework Directive 
(SFD)
8
 was also proposed (COM(2006)232), although this has not yet been adopted. Within 
the proposal, many different threats to soil are covered. Among these threats is also the risk 
of soil contamination and related actions for remediation. The SFD "should contribute to the 
prevention and reduction of the introduction of dangerous substances into soil to avoid soil 
contamination and to preserve soil functions". However, the problem of soil contaminations 
is mostly already tackled at national level. SFD Article 9 on Prevention of soil contamination 
                                                        
8
 Proposal for a Directive of the European Parliament and of the Council establishing a framework for the protection of soil 
and amending Directive 2004/35/EC (COM(2006) 232 final) 
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states "For the purposes of preserving the soil functions referred to in Article 1(1), Member 
States shall take appropriate and proportionate measures to limit the intentional or 
unintentional introduction of dangerous substances on or in the soil, […] in order to avoid 
accumulation that would hamper soil functions or give rise to significant risks to human 
health or the environment." An inventory of contaminated sites should be developed (Article 
11 (2) "the competent authorities shall have identified the location of at least the sites where 
the potentially soil-polluting activities referred to in Annex II are taking place or have taken 
place in the past.") No specific mention on how to deal with mixtures could be found, even if 
mixtures will have potentially the same relevance for soil as for water. Annex II of the 
proposal lists some potentially soil polluting activities, with most of them being clearly linked 
to contamination with multiple chemicals (e.g. ports, military sites, mining installations, 
landfills and waste water treatment installations). For soil status reports, "a chemical analysis 
determining the concentration levels of the dangerous substances in the soil, limited to those 
substances that are linked to the potentially polluting activity on the site" has to be included. 
3.2.8   Ambient air quality and cleaner air for Europe (Directive 2008/50/EC)  
Several of the above mentioned pieces of legislation are also linked to air quality, 
however, there is a specific directive on ambient air quality and cleaner air for Europe 
(Directive 2008/50/EC). Article 1 §1 of the Directive states: "This Directive lays down 
measures aimed at the following 1. defining and establishing objectives for ambient air 
quality designed to avoid, prevent or reduce harmful effects on human health and the 
environment as a whole". This Directive focuses mainly on sulphur dioxide, nitrogen dioxide 
and oxides of nitrogen, particulate matter (PM10 and PM2.5), lead, benzene and carbon 
monoxide. In Annex I of the Directive, target values are set as limits for the above mentioned 
pollutants individually, but exposure to multiple chemicals is not specifically addressed. It 
does mention however the concern regarding polyaromatic hydrocarbons (PAHs), and in 
Commission Decision 2011/850/EU, PAHs are mentioned specifically. Although the PAHs in 
this directive are addressed individually, this group of compounds are generally recognized as 
being relevant for mixture toxicity and have been addressed accordingly by e.g. the US EPA
9
. 
The pollutants covered by Directive 2008/50/EC should have been reviewed in 2013, taking 
into account progress in obtaining scientific information regarding the presence and effects of 
air pollutants. 
3.2.9    Protection of the health of workers from chemical agents at work (Directive 
98/24/EC)  
This Directive lays down minimum requirements for the protection of workers “from 
risks to their safety and health arising, or likely to arise, from the effects of chemical agents 
that are present at the workplace or as a result of any work activity involving chemical 
agents” (Article 1). The employer has the responsibility to assess any risk to the safety and 
health of workers arising from the presence of hazardous chemical agents at the work place 
(Recital 14 and Article 4), taken into consideration the level, type and duration of exposure, 
                                                        
9 http://cfpub.epa.gov/ncea/iris_drafts/recordisplay.cfm?deid=194584 
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and to set out the necessary preventive and protective measures. The given definition of 
“hazardous chemical agents” includes both individual chemical agents and chemical 
preparations "with the meaning of directive 88/379/EEC"
10
 (Article 2b), i.e, what is now 
called a “chemical mixture” in the REACH regulatory context (intentional mixture). 
Moreover, Article 4 (§4) requires that "In the case of activities involving exposure to several 
hazardous chemical agents, the risk shall be assessed on the basis of the risk presented by all 
such chemical agents in combination". Thus, the risk assessment should take in consideration 
both exposures to intentional mixtures and exposures to coincidental mixtures in the 
workplace. Moreover, it is also the employer's duty to eliminate or reduce to a minimum the 
risk associated with hazardous chemical agents (Article 5 §2) by the design and organization 
of work, the provision of suitable equipment for work with chemical agents, and by reducing 
to a minimum "the number of workers exposed or likely to be exposed, (…) the duration and 
intensity of exposure, (…) the quantity of chemical agents present at the workplace to the 
minimum required for the type of work concerned".  
According to this directive, practical guidelines for the determination and assessment of 
risks shall be developed and updated according to technical and scientific progress (Article 4 
and 12§2). To address this requirement, and to facilitate compliance in the EU Member 
States, a (non-binding) guideline document has been published in 2006 on the protection of 
the health and safety of workers from the risks related to chemical agents at work (EC, 
2006a). This document provides practical tools on how to measure and evaluate air 
concentrations, on the risk assessment methodologies, on the general principles of protection 
and prevention and on the surveillance of the health of workers exposed to lead. It also 
contains information on labelling and safety data sheets of chemical products, occupational 
limit values, biological limit values and information on the hierarchy of prevention measures. 
A simplified risk assessment methodology is given in Annex 2 and a quantitative evaluation 
of exposure to chemicals is given in Annex 4. This Annex 4 requires the setting of 
"Homogeneous exposure group" (HEG) defined as the association of a job and a chemical 
agent, or several chemical agents that produce the same effect, in a given environment. Thus, 
among workers who do the same job, there will be as many HEGs as there are chemical 
agents with independent effects to which they are exposed. Daily exposure (DE) is then 
calculated for each HEG, as well as short term exposure (SE, defined as the mean 
concentration in any 15-minute period in the working day). DE and SE can be then compared 
to the corresponding Limit value (LV-DE or LV-SE). Thus, this methodology takes into 
account the simultaneous exposure to different chemicals having the same effects by 
summing their concentrations.   
                                                        
10 Council Directive 88/379/EEC of 7 June 1988 on the approximation of the laws, regulations and administrative provisions 
of the Member States relating to the classification, packaging and labelling of dangerous preparations, repealed by Directive 
1999/45/EC of the European Parliament and of the Council of 31 May 1999 concerning the approximation of the laws, 
regulations and administrative provisions of the Member States relating to the classification, packaging and labelling of 
dangerous preparations. 
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3.2.10   Food contact materials (Regulation 1935/2004) 
The purpose of this Regulation is “to ensure functioning of the internal market” for food 
contact materials “whilst providing the basis for securing a high level of protection of human 
health and the interest of consumers” (Article 1, §1). It complements the general principles 
and requirements of food law in Regulation (EC) No 178/2002, defines general requirements 
for food contact materials (Article 3) as well as specific requirements for “active” and 
“intelligent” food contact materials (Article 4), and sets the frame for specific measures for 
specific groups of materials or articles (Article 5)
11
. 
The Regulation is focussed on the protection of human health and environmental risks 
are not considered. As a general requirement, food contact materials and articles “shall be 
manufactured (…) so that, under normal or foreseeable conditions of use, they do not 
transfer their constituents to food in quantities which could: (a) endanger human health; or 
(b) bring about an unacceptable change in the composition of the food; or (c) bring about a 
deterioration in the organoleptic characteristics thereof” (Article 3, §1), but this regulation 
does not explicitly or implicitly address the topic of mixture toxicity. The general 
requirement to consider probable cumulative toxic effects in food safety assessments as laid 
down in Regulation (EC) No 178/2002 (see above) may apply, but this cannot be interpreted 
as a mandatory requirement for mixture toxicity assessments. Moreover, this regulation does 
not prescribe how corresponding scientific risk assessments should be performed. 
3.2.11   Contaminants in food (Regulation 315/93/EEC) and feed (Directive 
2002/32/EC) 
While the above-mentioned regulations on food and feed additives refer to compounds 
and mixtures that are intentionally added to the product, various regulations relate to the 
presence of unwanted compounds and/or mixtures in food (Regulation 315/93/EEC) and feed 
(Directive 2002/32/EC). The provisions regarding the presence and levels of undesirable 
compounds have been revised many times, generally for specific types of pollutants (e.g. 
Regulation 744/2012 and 1275/2013). Regulation 2002/32/EC is one of the few regulations 
that cover some specific toxic mixtures, in this case the combined effects of dioxins and 
dioxin-like compounds like furanes and dioxin-like PCBs. The combined effects are based on 
the toxicological concept of Toxic Equivalency Factors (TEF) (Van den Berg et al., 1998), a 
mode of action (in this case Ah-receptor binding) based approach to assess the combined 
effects of a mixture of similarly acting (dioxin-like) compounds. It relies on equivalency 
factors for individual components that serve as an order of magnitude estimate of the toxicity 
of individual compounds relative to 2,3,7,8-TCDD. These values have been calculated for 
several species and are reviewed regularly. Similarly, TEF values are also used to monitor 
combined dioxin-like effects in industrial emissions (Directives 2008/1/EC and 2010/75/EU). 
                                                        
11
 It is complemented by a list of specific supplementary acts, defining specific rules for specific food contact materials such 
as regenerated cellulose film, ceramics, plastic materials, vinyl chloride, plasticisers in States relating to ceramic articles 
intended to come into contact with foodstuffs gaskets in lids, epoxy derivatives, and nitrosamines from rubber and migration 
testing. Respectively Directive 2007/42/EC, Directive 84/500/EEC, Directive 2002/72/EC, Directives 78/142/EEC, 
80/766/EEC, and 81/432/EEC, Regulation (EC) No 372/2007, Regulation (EC) No 1895/2005, Directive 93/11/EEC, 
Directives 82/711/EEC, and 85/572/EEC 
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3.2.12   Maximum residue levels of pesticides (Regulation 396/2005) 
This regulation aims at ensuring that pesticide residues are not present in food and feed 
products “at levels presenting an unacceptable risk to humans and, where relevant, to 
animals” (Recital 5). It focuses only on human risk assessment and environmental risk 
assessment is out of scope. The Regulation establishes the maximum quantities of pesticide 
residues permitted (maximum residue levels, or MRLs) in products of animal or vegetable 
origin intended for human or animal consumption. These MRLs include MRLs that are 
specific to particular foodstuffs intended for human or animal consumption and, for products 
and/or pesticides for which no specific MRLs are set, a default value of 0.01 mg/kg applies 
(Article 18, paragraph 1(b)). Risk assessment is the responsibility of EFSA (Recital 6, 
Articles 10 and 24), which provides Reasoned Opinions on each intended new MRL, 
amendment or removal.  
Established procedures for setting MRLs on the basis of ADI values and food 
consumption patterns are focused on single substance assessments, although the Regulation 
explicitly addresses the need for carrying out "further work to develop a methodology to take 
into account cumulative and synergistic effects" and states that MRLs should be set in “view 
of human exposure to combinations of active substances and their cumulative and possible 
aggregate and synergistic effects on human health” (Recital 6 ). 
As a consequence, support measures related to harmonized pesticide MRLs shall include 
“studies and other measures necessary for the preparation and development of legislation 
and of technical guidelines on pesticide residues, aimed, in particular, at developing and 
using methods of assessing aggregate, cumulative and synergistic effects” (Article 36, § 1 
(c)), and Commission decisions concerning the MRLs shall take account of “the possible 
presence of pesticide residues arising from sources other than current plant protection uses 
of active substances, and their known cumulative and synergistic effects, when the methods to 
assess such effects are available“ (Article 14, § 2 (b)). 
To address these requirements, the EFSA Panel on Plant Protection Products and their 
Residues (PPR) published a report of a colloquium held on 2006 on the Cumulative Risk 
Assessment of Pesticides to Human Health: the Way forward (EFSA, 2007), as well as an 
opinion paper on methods for cumulative risk assessment of pesticides (EFSA, 2008b) (see 
chapter 3). The latter report reviews existing methodologies for mixture toxicity assessment 
and combines these in a tiered approach. It also suggests applying this for cumulative 
assessment groups (CAG) of pesticides with a common mode of action. As a next step, EFSA 
applied the proposed strategy to the group of triazole fungicides (EFSA, 2009c). Although 
EFSA concluded that the proposed approach was appropriate, its report also highlights the 
following needs before being able to apply this approach on a routine basis: (i) an 
international consensus on which groups of pesticides could be looked at together through a 
cumulative risk assessment approach; (ii) further work on the application of new cumulative 
risk assessment methodologies in order to address uncertainties; and (iii) development of 
guidance for appropriate exposure assessments. To answer these needs, EFSA has recently 
published a guidance document on the use of probabilistic methodology for modelling dietary 
exposure to pesticide residues (EFSA, 2012c) and a scientific opinion on the identification of 
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pesticides to be included in cumulative assessment groups on the basis of their toxicological 
profile (EFSA, 2013c) (See Chapter 3).  
3.2.13   Toys (Directive 2009/48/EC) 
The safety of toys is addressed by Directive 2009/48/EC, which covers many aspects of 
safety of toys including chemical safety. It is in place to ensure a high level of protection of 
children against risks caused by chemical substances in toys. It is also stressed that the 
provisions from REACH should be adapted to the particular needs of children, who are a 
vulnerable group of consumers (Recital 21). Regarding the toxicological properties of the 
chemicals, the Directive refers to REACH (Regulation 1907/2006) and the Regulation on 
Classification & Labelling (1272/2008) (§ 3.1.6 and 3.1.5 respectively). Particularly 
substances that are classified as carcinogenic, mutagenic or toxic for reproduction (CMR 
compounds), allergenic substances and certain metals are of concern. A list is provided of 
allergenic fragrances that are not allowed or should be clearly labelled to be present when 
concentrations exceed 100 mg/kg. Specific limit values are given for certain substances in 
directive 88/378/EEC, which should be updated as scientific knowledge increases. It is 
encouraged to replace dangerous substances by less dangerous equivalents where technically 
and economically possible. Several compounds that are particularly toxic should not be used 
intentionally (arsenic, cadmium, chromium VI, lead, mercury and organic tin) and limit 
values should be set at levels half of those considered safe (Recital 22). Specific limit values 
can be adopted for toys intended for use by children under 36 months, and in other toys 
intended to be put in the mouth (Recital 24 and Article 46) (though none have been defined) 
and there is a legal obligation to assess the likelihood of the presence in the toy of prohibited 
or restricted substances (Recital 35). In some situations, CMR compounds can be used if the 
individual concentrations are below what is specified in Appendix B2, or when the 
substances are inaccessible to children when used as intended or in a foreseeable way and use 
is not prohibited for consumer articles under the REACH regulation or is compliant with the 
regulation on food contact materials. Migration limits are specified for several elements, 
although these do not apply for toys or components which clearly exclude any hazard due to 
their mass, size, volume etc.  
Mixtures are mentioned specifically in Directive 2009/48/EC, and are defined as a 
solution composed of two or more substances (definition adopted from Directive 
67/548/EEC). For the classification of substances and mixtures, a clear distinction is made 
between substances and mixtures. For substances, reference is made to the classification 
under Regulation 1272/2008, while for mixtures Directive 1999/45/EC and Directive 
67/548/ECC applies until 31 May 2015, from which point Regulation 1272/2008 will apply. 
Nitrosamines and nitrosable substances are treated as a group and are not allowed if the total 
migration of the substances is equal to or higher than 0.05 mg/kg for nitrosamines and 1 
mg/kg for nitrosable substances.  
Directive 2009/48/EC solely addresses human health concerns, environmental concerns 
are addressed by horizontal environmental legislation and the legislation on waste. 
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3.3   Conclusions 
Table 4 and Table 5 summarise the different EU requirements across sectors regarding 
chemical monitoring/risk assessment and mixture risk assessment, respectively for intentional 
mixture and generated or coincidental mixture. Chemical mixtures are predominantly 
assessed and regulated in relation to intentional mixtures under EU legislation. Some 
complex mixtures discharged/emitted to the environment from a single source are also 
subject to controls, but there are very few requirements for, and examples of, control and risk 
assessment being carried out in relation to several substances originating from different 
sources and through different pathways. Moreover, whereas a product can be subject to 
several sectorial regulations, each sectorial regulation requires a risk assessment for its own 
type of use only, without taking into account the possible additional exposure to other type of 
use under other sectorial regulation. As such, current EU legislation does not provide a 
mechanism for a systematic, comprehensive and integrated assessment of cumulative effects 
of different chemicals taking into account different routes of exposure and different product 
types (EC, 2012a).  
Therefore, although there is a very extensive corpus of legislation aiming at ensuring that 
humans, animals and the environment are exposed to individual chemicals within safe limits, 
there is a need to examine whether or not an exposure to a mixture of chemicals substances, 
originating from different sources and through different pathways, in which each of the 
substances is present at a concentration below its threshold of concern, could have negative 
effects on human health or the environment. 
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Table 4: Summary table. Chemical and mixture assessment requirement in the European regulation. Intentional mixtures. 
 
  
Chemical 
monitoring 
and analysis 
Encouraging 
alternative 
methods to 
animal 
testing 
Chemical risk assessment Mixture assessment 
Prospective 
RA 
Retrospective 
RA 
  
Human 
health 
Environmental 
health 
Human 
health 
Environmental 
health 
Plant protection products Reg 1107/2009 
No 
(Environment)/ 
Yes (Residues) 
Yes  Yes Yes 
Yes – WM approach (for 
formulation) 
Yes No PPP- AI Requirement Reg 283/2013 
PPP- Formulation 
Requirement 
Reg 284/2013 
Biocides Reg 528/2012 
No 
(Environment)/ 
Yes (Residues) 
Yes  Yes Yes 
Yes – WM approach, plus 
risk assessment if the 
biocidal product is intended 
to be used in combination 
with other biocidal product. 
Yes No  
Human medicines 
Dir 
2001/83/EC 
No Not specified Yes Yes Yes No Yes No 
Veterinary medicines 
Dir 
2001/82/EC 
No 
(Environment)/ 
Yes (Residues 
in foodstuff) 
Not specified Yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Yes Yes No Yes No
Cosmetics Reg 1223/2009 No Yes Yes 
Through 
REACH 
Yes No Yes No 
CLP Reg 1272/2008 No Yes Yes Yes Yes Yes Yes No 
REACH Reg 1907/2006 No Yes Yes Yes Yes Yes Yes No 
Food additive Reg 1333/2008 Yes (Intake) No Yes No No No Yes No 
Feed additive and feed 
additive assessment 
Reg1331/2008; 
Reg 429/2008 
Yes (Residue) No Yes Yes 
 
Additive with multiple 
components: consideration is 
given for the cumulative 
effects or WM assessment. 
No consideration for mixture 
assessment from different 
sources 
 
Yes No 
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Table 5: Summary table. Chemical and mixture assessment requirement in the European regulation. Generated or coincidental mixtures. 
  
Chemical 
monitoring and 
analysis 
Encouraging 
alternative 
methods to 
animal testing 
Chemical risk assessment Mixture risk assessment 
Prospective 
RA 
Retrospective 
RA   Human health 
Environmental 
health 
Human 
health 
Environmental 
health 
Environmental Impact 
Assessment (EIA) 
Dir 2011/92/EC No No testing Yes Yes Should be addressed Yes  No 
Integrated pollution 
prevention and control 
(IPPC) 
Dir 2010/75/EC Yes No testing No No No No No No 
Waste and waste streams Dir 2008/98/EC 
No, but refers to 
other 
legislation, e.g 
REACH, IPPC 
No Refers to CLP Refers to CLP No No No 
Water Framework 
Directive 
(WFD) 
Dir 98/83/EC Yes No testing Yes Yes 
Mentioned in Guidance, but 
not addressed in detail 
No Yes 
Groundwater Directive 
Dir 
2006/118/EC 
Yes, with 
reference to 
WFD 
No 
No RA, but 
contained additional 
threshold value for 
pesticides and 
nitrates 
No No No No No 
EQS Directive Dir 2013/39/EU Yes Yes No 
No RA, but QS 
are derived from 
ERA studies  
No Yes No No 
Marine Strategy Dir 2008/56/EC 
Yes, with 
reference to 
WFD 
No testing No Yes No No No No 
Drinking water Dir 98/83/EC Yes No testing 
No RA, but 
parametric values 
should be based on 
a RA method  
No No No No No 
Soil thematic strategy – 
Soil framework directive 
COM(2006)231/C
OM(2006) 232 
final,2006/0086 
(COD)) 
Yes No  Yes Yes No No No Yes 
Ambient Air quality and 
cleaner air for Europe 
Dir 2008/50/EC Yes No testing Yes Partly No No No Yes 
Food Contact material Reg 1935/2004 Yes Not specified Yes No No No Yes No 
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Chemical 
monitoring and 
analysis 
Encouraging 
alternative 
methods to 
animal testing 
Chemical risk assessment Mixture risk assessment 
Prospective 
RA 
Retrospective 
RA 
Human health 
Environmental 
health 
Human 
health 
Environment
al health 
Food contaminant 
Reg 
315/93/EEC 
Yes (Food) Not specified Yes No No No Yes No 
Feed contaminant Dir 
2002/32/EC 
Yes (Feed) Not specified Yes Yes No No Yes No 
Maximum Residue Levels 
(MRLs) 
Reg 396/2005 Yes Not specified Yes No Yes No Yes No 
Protection of the health of 
workers 
Dir 98/24/EC Yes Not specified Yes No  Yes No Yes No 
Toys 
Dir 
2009/48/EC 
Yes No testing 
No RA but 
threshold value 
and refers to CLP 
No 
Refers to 
CLP 
No No No 
Table 5: Summary table. Chemical and mixture assessment requirement in the European regulation. Generated or coincidental mixtures (continued) 
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4 - Existing guidance documents on mixture toxicity assessment 
The first part of this chapter reviews the recommended approaches to handling mixtures 
and combined exposures in risk assessment in a regulatory context in EU Member States, 
based on guidance documents and guidelines. The second part describes approaches to 
mixture toxicity assessment used in other parts of the world or by international agencies or 
organizations (such as the World Health Organization, the OECD, or the European Centre for 
Ecotoxicology and Toxicology of Chemicals). 
 
4.1   Mixture toxicity in European Guidance Documents 
4.1.1   Toxicological guidance and mixture toxicity assessment 
REACH 
A document was published in 2010 as a result of a joint CEFIC/VCI project to develop 
tools and guidance on exposure assessment for industry (CEFIC, 2010). It deals with mixture 
exposure assessment and communication in the supply chains, and describes the tasks and 
obligations of the different actors who handle mixtures (i.e. manufacturer and downstream 
user such as formulators or end user). Nearly all REACH obligations are related to substances 
as such or as part of a mixture – but not to mixtures themselves. Although the chemical safety 
assessment of a substance should cover its whole life cycle and consider the different 
exposure routes, operational conditions and risk management measures, most of the time the 
registrant does not know the recipes of the mixtures in which his substance will be used by 
downstream formulators. In general, the registrant assumes that the use of a substance in a 
mixture can be seen primarily as a dilution of the substance by other substances, considered 
to be inert. If substances with the same hazards and/or effects profile are formulated together, 
the possible synergistic or antagonistic effects have to be considered; if the manufacturer of 
the substance does not know about this, it is the task of the formulator to take his specific 
knowledge on the mixture into account. However, this document highlights that REACH sets 
no formal obligation to perform a cumulative risk assessment of mixtures with exposure 
estimation and quantitative risk characterisation, and that there is no formal obligation for any 
actor in the supply chain to develop an exposure scenario for a mixture. In addition, 
authorities have several possibilities but no obligations to take into account possible effects of 
aggregated and cumulative exposure to the multitude of substances under their review. 
Finally evaluation of specific properties of mixtures relies heavily on the expert knowledge of 
the formulator, which should take into account existing knowledge regarding the function and 
possible interaction between substances when assessing a mixture. If mixtures have specific 
properties with relevance for the exposure situation it is likely that they require an advanced 
evaluation, and information should be given by the formulator to his supplier in order to 
ensure that these properties are covered by the registration.  
More recently, a report describing and discussing approaches for the environmental risk 
assessment (aquatic compartment) of mixtures under REACH was published (Bunke et al., 
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2014). It presents the results of a research and development project of the German Federal 
Environmental Agency (project short title: “4M: Mixtures under REACH”), which took into 
account findings regarding the assessment of mixtures under other pieces of legislation. It 
focuses on technical mixtures and discharge mixtures and considers both cumulative and 
aggregated exposures. The report also briefly discusses interfaces to other regulations (e.g. 
Water Framework Directive) and consideration of substances not regulated under REACH 
(e.g. biocides). 
In this project, a tiered component based approach for the risk assessment of technical 
mixtures is proposed, allowing the environmental assessment of technical mixtures in the 
aquatic compartment with increasing degrees of precision. Figure 2 shows the structure of the 
proposed tiered approach for the risk assessment of technical mixtures, which consists of 
three components: a tiered exposure assessment (left column), a tiered hazard assessment 
(right column) and a tiered risk assessment (central part). As usual, the resulting risk is 
calculated as the quotient of the estimates from the exposure assessment and the hazard 
assessment. 
 
 
Figure 2: Schematic presentation of a tiered approach for assessment of technical mixtures 
under REACH (Bunke et al., 2014). Source: German Federal Environmental Agency (UBA). 
 
Note that numbering of tiers is flexible and not necessarily identical to tiers as used in similar schemes. This 
figure only demonstrates the principle factors and hierarchies schematically. For a final guidance, numbering 
and assigned definitions may have to be adapted. 
At tier 1, concentration addition is applied in its simplest form. For each substance in the 
mixture, risk characterisation ratios are calculated using PECs and PNECS, and the ratios of 
the substances are summed up (the result of which is commonly called the “Hazard Index", 
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HI, for the technical mixture). If HI<1, no risk for environmental effects from the exposure to 
the mixture is expected. This approach is relatively simple but it may overestimate the risk as 
predicted environmental concentrations often overestimate the real exposure situation. In 
addition, the PNEC as a single value must be protective for all three trophic levels - algae, 
daphnia and fish. Species-specific toxicity data (e.g. chronic toxicity values for fish) are not 
evaluated specifically at this tier. 
At tier 2, the assessment is refined by replacing PNECs by the “chronic reference values 
specific for trophic level” (CRVTL), based on species-specific ecotoxicity data. For each 
trophic level, such a reference value is calculated for each substance, and Risk 
Characterization Ratio for the substances are calculated using these reference values and the 
respective exposure levels. The substance “RCRs” for each trophic level (RCRTL) are added 
up to calculate a hazard index for the mixture for each trophic level (HITL). Finally, the 
highest of these hazard indexes is chosen to characterise the risk posed by the mixture. This 
index, called the “trophic level hazard index” (THI), is comparable to Hazard Index HI at tier 
1, but does not add up effect data from different species to estimate mixture effects, and will 
usually be lower than the risk quotient calculated at tier 1. This step avoids overestimation of 
mixture ecotoxicity at least to some degree due to the separate assessment of each trophic 
level. 
At tier 3 and tier 4, more sophisticated elements are introduced on the hazard side, such 
as differentiation between specific and unspecific (narcotic) toxicity and knowledge on the 
mode of action. For tiers 1 – 3 of the hazard assessment, concentration addition is assumed as 
the basic principle for emerging mixture effects. In the fourth tier, independent action (IA) 
and more detailed information may be used for mixture risk quantification. It is not feasible 
to complete a hazard assessment at tier 3 and 4 with the set of data usually generated (and 
published) under REACH, and they require expert knowledge. This tiered approach has been 
tested on real technical mixtures from a tannery.  
As possible supplementary elements, mixture assessment factors (MAFs) and whole 
mixture testing can be considered. MAFs are sometimes proposed if a tiered approach is not 
feasible, and used as an additional assessment factor to calculate a PNEC for all those single 
substances known to be present within the mixture. Whole mixture approaches/whole effluent 
approaches are proposed to assess effects of mixtures with (partly) unknown substances, or 
for mixtures of known composition to assess whether and which kind of mixture effects 
occur. Because of the almost infinite number of resulting potential mixtures, this approach 
would not be feasible as a routine regulatory procedure to assess mixture toxicity, but may be 
helpful to: a) validate CA, IA or synergism/antagonism assumptions for specific mixtures 
with known substances; and b) compare such assessments based on known substances with 
the additional influence by unknown further substances within a mixture; and c) assess 
constant emission scenarios, where substances are present in stable compositions in 
environmental media. 
This document also identifies and acknowledges current limitations for risk assessment 
of technical mixtures under REACH, i.e. the generic and very crude substance exposure 
levels (PECs) generated by REACH risk assessment tools, the disparity in the availability of 
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suitable data across the supply chain limiting the possibilities of different actors to assess 
mixture risks, and the missing link between the responsibilities of the single REACH actors 
and the real environmental risk of the actual local coincidental mixture in the receiving water 
volume. 
As priority setting is essential for deciding in which cases an additional risk assessment 
of technical mixtures should be performed, this document also describes two different 
concepts for priority setting: a) nomination of “Mixture Assessment Triggering Substances” 
(or MATS, defines as a substance which causes concern, because it already occurs in relevant 
concentrations in the environment in relation to its ecotoxicity) and b) the identification of 
“priority mixtures” having specific properties (from composition or critical uses/exposures) 
which increase the likelihood of mixture effects. Thus, the concept of MATS aims to identify 
substances which occur already in relevant concentrations in the environment (the proposal 
foresees that in most cases such substances will be nominated and selected by a regulatory 
decision from authorities), whereas the starting point for the identification of “priority 
mixtures” is the composition of the mixtures and their uses. The authors also propose that 
priority substances from the Water Framework Directive could be used as long as no official 
MATS are nominated.  
This report also describes several options to assess technical mixtures under REACH, 
which refer not only to registrants, but also to formulators and end-users; e.g. a formulator 
could use a tiered approach as an indicator for safe use of a specific technical mixture, 
whereas an end-user could assess the aggregated exposure if he uses the same substance in 
different technical mixtures. Also options to act for the national competent authorities are 
presented – related to substance evaluation, restriction and authorisation. A first and 
preliminary, qualitative assessment of the feasibility of the options was conducted, and their 
implementability without changes of the legal text was assessed.  
Finally, the following five activities were recommended by the authors: 
- Assessment of aggregated exposures by end-users 
- Communication and use of existing knowledge on mixture effects in the supply chain 
- Development of prioritisation criteria for mixtures 
- Application and further development of the tiered approach by formulators 
- Mixture assessment as an element of the tasks of authorities 
The two first activities could be implemented in the short term, as they require fairly low 
efforts and have benefits regarding an improved risk management (aggregated exposures) and 
knowledge dissemination and awareness raising. All other options identified as possibly 
feasible should be subject to further assessment, testing and discussion before 
implementation. 
External experts have been invited to discuss major findings of the project at a 
workshop, and the results and conclusions of those discussions are presented in the final 
report. Possible next steps for validating and refining the proposed mixture risk assessment 
strategy and for implementation are described, and the need for more coordination with other 
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pieces of legislation in order to develop a common strategy not only for REACH, but 
including also other regulations. 
Cumulative risk assessment and MRLs 
Regulation (EC) No. 396/2005 on maximum residue levels of pesticides in or on food 
and feed of plant and animal origin emphasises the importance of developing a methodology 
to take into account cumulative and possible synergistic effects of pesticides to human health.  
In this context EFSA organised a Colloquium in 2007 to allow for an open scientific 
debate on methods available for conducting a CRA (i.e. referring to the assessment of the risk 
from exposure to more than one pesticide) for pesticides with a common MOA, and to 
explore the scientific basis for grouping pesticides, not sharing a common MOA, in a hazard 
assessment (EFSA, 2007). Participants discussed the choice of data and methodology for 
combined exposure assessment, and possibilities for joining efforts internationally to further 
develop harmonised approaches.  
They agreed that a number of methodological options exist with respect to food 
consumption, residue and effect data; and that it was important to start the CRA process in a 
step-wise approach in order to develop a pragmatic strategy within the EU. The first priority 
would be substances sharing a common MOA for which evidence indicates that they act with 
dose addition and for which data were already available in the US. They also recommended 
that sources of exposure other than the dietary route should be included in the longer term, 
and that EFSA should not restrict CRA issue to pesticides because CRA is a general issue 
which goes beyond exposure to pesticides alone. 
Based on the output of this colloquium, the PPR Panel published an opinion on specific 
actions needed for the near future (EFSA, 2008b), in which they evaluated existing 
methodologies for assessing risks of exposure to two or more pesticides in combination, 
particularly in the context of setting MRLs (Reg. (EC) No. 396/2005). 
Although the Panel's opinion is that all sources (e.g., PPP, veterinary drugs, human 
medicines), pathways (e.g., food, drinking water, residential, occupational) and routes of 
exposure should be considered, they highlighted that appropriate data on levels of exposure to 
pesticides from pathways and sources other than PPP residues in food are not generally 
available. Therefore the PPR Panel restricted its consideration of CRA to exposures from PPP 
residues in food. Having considered the potential relevance of the different forms of 
combined toxicity (i.e. dose addition, independent action or interaction) to RA for pesticide 
residues in food, and having noted that there is no empirical evidence for interactions 
occurring at the expected levels of exposure, they also restricted this opinion to the possible 
impact of dose addition when consumers are exposed to combinations of pesticide residues 
that share (or might share) the same MOA. 
The PPR Panel identified criteria for selecting groups of compounds for consideration in 
a CRA, such as frequency of detection in monitoring programmes, high use, evidence of 
“high” intake from biomonitoring data, or high exposures relative to reference values. In 
addition they noted that the assessment of specific pesticide combinations might be carried 
out if there were strong evidence that certain compounds may interact below their respective 
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NOAELs, and that the presence of relevant non-food sources of exposure might require an 
assessment of the margin of exposure for the food part. 
The PPR Panel also proposed criteria for the grouping of pesticides into a cumulative 
assessment group (CAG), such as chemical structure or mechanism of pesticidal action, 
common toxic effect, or ultimately toxic MOA. Amongst the various methods described for 
CRA, the Panel concluded that the most useful were, in increasing levels of complexity and 
refinement, the hazard index, the reference point index, the relative potency factor method 
and physiologically-based toxicokinetic (PBTK) modelling. 
Acute and chronic exposure scenarios for RA were considered, both in the context of 
MRL-setting and in relation to actual exposures based on monitoring data; and they discussed 
which data source should be used in each exposure scenario. Proposals were made on how to 
deal with residues below the Limit of Detection (LOD), Limit of Quantification (LOQ), or 
Limit of Reporting (LOR). An overview of the food consumption data available at the 
European level and how to use them in cumulative exposure assessment was also provided. 
They presented general issues on uncertainties as well as those specific to CRA, related to 
residue data, consumption and toxicity evaluation, and reported a qualitative estimate of their 
relevance. 
The PPR Panel also performed a critical overview of CRA already done, and noted that 
some compounds initially included in a CAG on the basis of toxicological considerations 
were further excluded from the CRA on the basis of exposure considerations.  
Finally, they proposed a tiered approach for both hazard assessment and exposure 
assessment in order to make the most efficient use of available resources. This tiered 
approach is presented in Figure 3. 
In this Opinion, they also highlighted the necessity to establish a continuing dialogue 
between toxicologists, exposure assessors, and risk managers, in order to identify the relevant 
issues, to best use available resources, and to consider collection of data more representative 
of actual exposure to pesticides forming CAG. Moreover, the raw survey data from 
monitoring programmes of pesticide residues and from national food consumption databases 
should be accessible for RA purposes and they suggested to perform a harmonized 
consumption survey at the European level along the lines of the four European GEMS/Food 
cluster diets. Moreover, they recommended adopting a case-by-case approach to assess 
combined effects in case of biological plausibility for an interaction between pesticides at 
low, non-effective doses.  
As a next step, the PPR Panel worked on a concrete example and the proposed 
methodology was applied to a selected group of triazole fungicides. They applied the tiered 
approach in different exposure scenarios of relevance for risk management, for both acute 
and chronic cumulative effects: these were actual acute exposure, actual chronic exposure, 
acute exposure relevant for MRL-setting and chronic exposure relevant for MRL-setting. 
Risk characterisation was then performed for each of the four scenarios by calculating HI, 
adjusted HI (with several tiers of refinement on the exposure side), and applying the RPF 
method to either NOAELs or BMDs as the reference point. The results were reported in a 
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separate opinion (EFSA, 2009c), in which they described progressive steps of refinement in 
CRA:  
                    (i) establishment of a CAG through the analysis of the specific toxicological 
effects common to triazole pesticides and their underlying biochemical mechanisms 
                    (ii) refinement of the hazard characterisation, making use in successive tiers 
of regulatory reference values, reference values based on the common specific toxicological 
effects and benchmark dose modelling, 
                    (iii) refinement of the cumulative exposure assessment making use of 
deterministic and probabilistic methodologies in successive tiers. 
It was recognised that, while risk assessment for single compounds is typically based on 
the most sensitive adverse effect, this will not necessarily hold true for risk assessment of 
multiple compounds which ideally should be based on an endpoint selected on the basis of a 
common MOA.  
Based on this exercise, the PPR Panel proposed a simplification of the overall tiered 
approach. The CAG should be as refined as the data would allow at an early stage, and 
exposure assessments should ideally be restricted to one deterministic and one probabilistic 
tier. 
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Figure 3: Proposed cumulative risk assessment process, using a tiered approach both on exposure and hazard assessment (EFSA, 2008b, modified) 
Source: European Food and Safety Authority
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Overall, it was concluded that this tiered approach was an appropriate way to address 
cumulative dietary risk assessment, but that the following issues must be addressed before it 
could be applied on a routine basis: the establishment of CAGs at the European level, the 
definition and agreement on desired levels of protection, and the improvement of the 
robustness of methodologies of cumulative exposure assessment and development of 
guidance on their appropriate use. 
To start addressing these issues, EFSA asked the PPR Panel to provide guidance on 
probabilistic dietary exposure assessment, and to develop a methodology to identify 
pesticides to be included in CAGs on the basis of their toxicological profile. 
In this context, the PPR Paned published in 2012 guidance on probabilistic dietary 
exposure assessment of single and multiple active substances. This guidance aims at 
complementing and supplementing the standard deterministic methodologies currently used 
in the EU (EFSA, 2012c). These deterministic methods, although having the advantage of 
being simple and fast to use, only allow estimation of the exposure of one single virtual 
consumer, whereas probabilistic methods allow estimation of the distribution of intakes
12
 
among multiple individuals in a specified population, taking into consideration the variability 
in food consumption (both between and within individuals) and in occurrence of residues in 
food commodities. Therefore, probabilistic methodologies are necessary for higher tier 
assessment where deterministic approaches are insufficient to reach a risk management 
decision. 
In the same document, the PPR Panel provided specific guidance for performing 
probabilistic modelling of both acute and chronic exposures assessment of single active 
substances in the contexts of authorisation, MRL setting, enforcement actions, and periodic 
reviews of monitoring data on actual exposures. The recommended approach makes a 
distinction between basic and refined probabilistic assessment, and provides specific 
guidance for basic probabilistic assessments but not for refined assessments, for which 
specialised expertise is required to select appropriate methods.  
A separate section deals with additional approaches required for modelling exposure to 
multiple substances (cumulative assessment), and addresses two aspects of cumulative 
assessment that have been identified as impacting the methodology for probabilistic 
modelling: the methodology for cumulation of toxicity, necessary because cumulative risk is 
assessed by combining the exposures of different compounds expressed as functions of their 
toxicities; and the need to quantify co-occurrence of residues in food. 
The methodology for cumulation of toxicity refers to the methods described in previous 
guidance i.e. in order of increasing complexity, the Hazard Index (HI), the adjusted Hazard 
Index (aHI), the Reference Points Index (RfPI), the Relative Potency Factors (RPF), and the 
physiologically based toxicokinetic and toxicodynamic modelling (PBTK and PBTD) 
approaches (EFSA, 2008b, 2009c). The assumptions and uncertainties of each of these 
methods are highlighted. PBTK and PBTD either separately or in combination can be 
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 Refers to the amount of chemical taken up by the dietary route, i.e., dietary exposure. 
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considered as options for refined assessment, and can be used to explore possible types of 
combined action other than dose addition. 
Regarding co-exposure of residue assessment, it is necessary to take account of any 
correlations that may exist between the concentrations of different members of the CAG in 
the same food sample; therefore, it is necessary to have data where the different CAG 
members are measured in the same samples. In case of complete residue datasets, in which 
the same substances are measured in every sample, the PPR Panel recommends to apply 
RPFs to combine all the substances into a single measure of cumulative potency for each 
sample, and to generate the cumulative acute assessment in the same way as for a single 
substance assessment. When the substances analysed differ between samples so that the 
matrix of samples by substances is incomplete and contains a mixture of positives, non-
detects and missing values, the Panel recommends a procedure for basic probabilistic 
assessment of acute exposure, which captures the correlations present in the available data 
and replaces missing values in a way that should over-estimate the degree of positive 
correlation. This avoids the need to estimate the level of correlation, but this also over-
estimates exposure and risk.  
The guidance also includes a checklist of key issues to be considered when writing or 
peer-reviewing reports on probabilistic exposure assessments, a list of desirable 
characteristics of software for probabilistic exposure modelling, and case studies illustrating 
some of the recommended approaches. Finally, the PPR Panel also provide some 
recommendations on further work that will be required to make the methods available to end-
users in a more practical form, including software and more specific user instructions.  
In 2013, the PPR Panel published another opinion dealing with the identification of pesticides 
to be included in cumulative assessment groups (CAGs) on the basis of their toxicological 
profile (EFSA, 2013c). As there are often few or no data available on MOA and as many 
compounds affect the same target and/or cell population, they suggest an approach for 
grouping of pesticides based on phenomenological effects, which can be applied even when 
the underlying biochemical events are not understood. The approach also takes cumulative 
effects into account in the decision on applications concerning MRLs of pesticides in or on 
food and feed. However, as interactions (synergisms or antagonisms) are not expected to 
occur at the low exposure levels of residues that are observed, the PPR Panel considers that 
mainly dose additive effects of substances are normally relevant to CAGs that may be used in 
the context of MRL setting. Moreover, when insufficient or no information is available, it is 
assumed that chemicals with the same effects may have a similar MOA, even though they 
exhibit a wide range of chemical structural features. This is based on empirical evidence that 
chemically unrelated substances may have a common effect in target organs/systems, which 
can be well approximated by dose addition (Kortenkamp et al., 2009). The methodology that 
has been developed for grouping addresses both acute and chronic dietary effects, and 
comprises four main steps, shown in  
Figure 4. 
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Figure 4: Stepwise methodology for the grouping of pesticides in CAGs based on their 
toxicological profile 
 
This approach implies the analysis and the interpretation of complex and voluminous 
data sets, and therefore requires scientific expert judgement. In particular, expert judgement 
is required to identify and characterise substances that can trigger different outcomes of the 
same toxicity pathway or that may cause toxic effects at multiples sites by a single mode of 
action. Moreover, the PPR Panel recognized that grouping based on toxic effects rather than 
on MOA leads to more uncertainties in predicting possible combination effects; nevertheless, 
when limiting CAGs to known common MOA (i.e. excluding pesticides for which 
information on MOA is not available), the degree of uncertainty in CRA would also increase. 
Thus, a higher level of protection can be afforded by using an effect-based approach, 
although this introduces some uncertainties around combination effects, until information on 
precise MOA becomes available. Moreover, further refinement of grouping might be 
achieved when data on the precise toxicological MOA are available. 
The methodology has been applied to establish CAGs for pesticides having adverse 
effects on the thyroid and nervous system: for the thyroid system, active substances were 
allocated to CAGs for effects either on C-cells/the calcitonin system or on follicular cells/the 
T3/T4 system; and active substances exhibiting neurotoxic properties were allocated to CAGs 
for both acute and chronic effects on motor, sensory and autonomic divisions of the nervous 
system and neurochemical endpoints. The allocation of pesticide active substances into CAGs 
was based on a standardised and thorough review of the dataset of oral toxicity studies 
reported in draft assessment reports (DARs). 
The PPR Panel noted that the resulting groups encompass many pesticides and that 
individual pesticides could appear in several groups; however, although some CAGs contain 
a large number of pesticides, little indication of cumulative risk may be inferred from the size 
of CAGs per se; and even within large CAGs, cumulative effects are likely to be driven 
mainly by a few active substances within the group.  
1- Identification of the specific adverse effects by: 
  i) exclusion of local effects 
  ii) exclusion of non-adverse effects 
 iii) exclusion of effects not relevant to humans 
 iv) evaluation of the unambiguous nature of the effects                                                                      
 v) identification of non-specific effects 
2- Characterisation of the specific effects 
3- Data collection 
4- Grouping of pesticides into CAGs 
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According to EFSA, this methodology should be considered specific for pesticides, and 
cannot be generalized to other types of chemicals in food, however CAGs derived from this 
methodology could in principle be used to support CRA resulting from non-dietary exposure 
(i.e operator, worker, bystander and resident exposure). The Panel recommended the 
implementation of this methodology for all major organ/systems. 
ECHA Guidance on biocidal products 
In support of Regulation No 528/2012 concerning the making available on the market 
and use of biocidal products, ECHA published a guidance document for human health risk 
assessment (ECHA, 2013). This ECHA document provides guidance on risk assessment from 
combined exposure to multiple biocidal substances within a single biocidal product on the 
basis of the tiering principles of refinement as described within the WHO/IPCS Framework 
on Combined Exposures (cf. §4.2.3)
13
.  
This approach, as shown in Figure 5, includes 3 tiers: 
- Tier 1 is the assessment of each substance within the mixture, to verify risk 
acceptability substance by substance, following all exposure scenarios which are relevant to 
the product use. The decision-making criterion for acceptability of risk is that the estimated 
level of exposure to each substance must be lower than its Acceptable Exposure Level 
(AEL), or another European validated value (e.g. DNEL for the purpose of REACH 
implementation). The hazard quotient (HQ), defined by the ratio of internal exposure and 
AEL, can also be used: if HQ<1: the risk from the individual components is considered 
acceptable and the effects of the biocidal product/mixture must be assessed (Tier 2); whereas 
if HQ>1: the risk from the individual components is not considered acceptable and before 
proceeding to Tier 2 refinement of hazard and/or exposure assessment needs to be performed 
first so that the HQ is lower than 1.  
It is noteworthy that this methodology can be applied only in order to assess systemic 
risks, and is not relevant for local effects of mixtures, in which cases CLP rules would apply.  
- Tier 2 involves assessing the combined exposure to the substances of the 
mixture/biocidal product by concentration (dose) addition by default, if no synergistic effects 
have been reported, and relies on worst-case scenarios. Hazard Quotients (HQ) for each 
substance will be used to calculate the Hazard Index (HI) for the mixture/biocidal product. 
The risk related to use of the mixture will be considered acceptable if HI ≤ 1, whereas it will 
be considered unacceptable if HI > 1 which would trigger risk refinement, considering risk 
management measure (RMM) or performing Tier 3. When RMM are considered, taking into 
account that the conditions related to the different uses should remain realistic, Hazard index 
is re-calculated using the new estimate of internal exposure of each substance.  
If synergistic effects have been identified or are suspected, the risk related to use of the 
mixture will be considered acceptable if the value of HI is less or equal to a reference HI 
(HIref), derived on a case by case basis on the available data. If data is too limited a worst case 
                                                        
13 Guidance for Human Health Risk Assessment, Volume III Part B, Section 4.4.1 
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pragmatic factor of 10
14
 could be used. Consequently, the value of this reference HIref would 
be below to 1. As a result, the decision-making criterion is in this case:   
-If HI ≤ HIref the risk related to use of the mixture will be considered acceptable;  
-If HI > HIref the risk related to use of the mixture will be considered unacceptable 
- Tier 3 is more complex than Tier 2 but is considered to be more realistic. Therefore, if 
a risk is considered acceptable in Tier 2, Tier 3 will not be necessary. Tier 3 is divided in 3 
steps of refinement, Tiers 3 A, B and C.  
Tier 3A deals with combined exposure assessment by grouping the substances with 
common target organ/MOA (with the non-refined AEL of each substance): for each group of 
substances with similar target organ/MOAs, HQto are summarized for each substance and an 
"approximate" HIto is calculated. The decision-making criterion is the same as previously, i.e.  
all adjusted HIto values must be ≤ 1 to consider the risk as acceptable. If one or more HIto > 1, 
risk is considered unacceptable and Tier 3B could be envisaged.  
Tier 3B assesses combined exposure assessment with specific AEL by target 
organ/MOA: in each group for which risk is not acceptable, specific AELs for each identified 
target organ/MOA and each substance (AELa.s.-to) are determined. Based on the exposure 
estimates calculated in Tier 1, HQa.s.-to by target organ will be then calculated for each 
substance and for each common target organ/MOA, and an "adjusted" HI for each common 
target organ/mode of action (HIto) will be calculated. As above, all adjusted HIto values must 
be less than 1 in order for the risk to be considered acceptable (or less than the reference HI 
defined in the second tier if synergistic effects were identified). If one or more adjusted HIto > 
1, risk is considered not acceptable.  
In this case, it might be possible to refine the risk assessment, by considering either 
hazard assessment if data are available and allow to perform refinement (for example skin 
absorption data for the mixture if default values were used in Tier 1, or exposure assessment 
data under actual conditions of use). The principles of higher tier refinement as described for 
active substances in this guidance document should also be investigated for applicability in 
refinement of risk assessment also for mixture assessment.  
Tier 3C uses the knowledge of the mechanism of action to refine the HIto, although it 
will be very rare in practice to have this information in the dossier.  
If there is no target organ or MOA in common, the concentration (dose) addition is not 
confirmed and the effects are considered dissimilar. Consequently, independent action is the 
rule and the risks are, in this case, covered by Tier 1 of this approach (assessment made 
substance by substance). 
 
                                                        
14 This value of 10 is conservative based on the publication of Boobis et al., 2010 showing that the magnitude of synergy at 
low doses did not exceed the levels predicted by additive models by more than a factor of 4. 
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Figure 5: Simplified overview of the assessment method (ECHA, 2013) 
Source: European Chemicals Agency  
 
 According to this document, similar methodology can be considered to assess combined 
exposure to multiple substances by different sources of release and/or uses, provided that 
modifications take into account the various exposure scenarios and cumulative effects.  
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Moreover, in case of multiple biocidal product types containing the same active 
substance, aggregated exposure could be assessed by combining the exposure estimates from 
uses/releases from the different product types. However this is a complicated assessment 
since the consumer may be exposed to a vast range of treated articles for which the use 
frequency as well as the ratio of first-time use versus repeated use (and thus the leaching rate) 
needs to be considered.  
Finally, further guidance still needs to be developed regarding procedural aspects on 
when combined exposure to multiple chemicals (cumulative assessment) needs to be 
performed for active substances under the BPR. 
Risk assessment for exposure to multiple contaminants by the EFSA Panel on 
Contaminants in the Food Chain (CONTAM) 
EFSA's CONTAM Panel deals with contaminants in the food chain (other than pesticide 
residues). Depending on the contaminant(s) assessed, it has applied both the whole mixture 
approach and component-based approaches mostly using dose addition as the main 
assumption for the combined effects of multiple contaminants.  
For polycyclic aromatic hydrocarbons, the CONTAM Panel concluded that the TEF 
approach could not be applied because of the inadequacy of the toxicological database and 
evidence for different MOA between PAH congeners (EFSA, 2008a). Hence, the Panel 
initially used an index chemical approach with BaP as a marker of both the carcinogenicity 
and occurrence of PAHs in a MOE approach. The approach was then refined to use the sum 
of four specific PAHs as markers of both carcinogenicity and occurrence since BaP was 
sometimes not present when other important PAHs were.  
Regarding mineral oil saturated hydrocarbons (MOSH) detected in food, since 
information on the occurrence of individual MOSH was not available, and since toxicological 
data were available only for a few MOSH complex mixtures, the whole mixture approach 
was applied (EFSA, 2012b). Although a common critical effect was identified (formation of 
hepatic microgranulomas) for most of the MOSH mixture tested, the MOA could not be 
clearly established. The NOAEL for the most potent MOSH mixture was compared to dietary 
exposure in the general population for the RA. This conservative approach was justified by 
the substantial level of uncertainty regarding the chemical composition of the MOSH mixture 
tested and the overall range of MOSH to which humans are exposed.  
A whole mixture approach was also applied to the flame retardants 
hexabromocyclododecanes (HBCDDs), predominantly consisting of three stereoisomers 
(EFSA, 2011a). A BMDL10 for neurodevelopmental toxicity was derived using toxicological 
data from a single administration of the technical mixture in mice which was then adjusted to 
body burden to take into account toxicokinetic differences between mice and humans. The 
body burden was then converted to an estimated chronic human dietary intake using half-life 
and human gastrointestinal absorption. MOEs were then derived using this estimate and 
human exposure.  
 62 
A TEF approach was applied by the CONTAM Panel to the evaluation of several groups 
of marine biotoxins, based on the rationale that the toxins have a common neurotoxic MOA 
mediated either by the disruption of the voltage-gated sodium channels or by cytotoxicity 
through perturbation of the actin cytoskeleton depending on the group of toxins (EFSA, 
2009b).  
For pyrrolizidine alkaloids (PAs), evidence that PAs with the common key chemical 
feature of double C-C bond in position 1-2 of the pyrrolizidine ring undergo a similar 
bioactivation leading to a common active metabolite responsible for the DNA-adduct 
formation led the Panel to consider the 1,2-unsaturated PAs group using the dose addition 
approach (EFSA, 2011b). Since specific data on carcinogenicity were available for two 
substances only, no TEF approach could be applied and a MOE calculation was carried out 
by dividing the BMDL10 for the most potent PA for which data were available, by the 
combined exposure to all the detected 1,2-unsaturated PAs as a conservative approach. 
Similarly, dose addition was also used in the CONTAM Panel opinion on ergot alkaloids 
(EAs) by deriving a group Acute Reference Dose (ARfD) and a group TDI considering all 
the relevant EAs to be equally potent as the most active EA tested (ergotamine) (EFSA, 
2012a). 
Opinion of the three non-food Scientific Committees of the European Commission 
The Scientific Committee on Consumer Safety (SCCS), the Scientific Committee on 
Health and Environmental Risks (SCHER) and the Scientific Committee on Emerging and 
Newly Identified Health Risks (SCENIHR) are three independent non-food Scientific 
Committees made up of external experts. They aim at providing the Commission with the 
scientific advice it needs when preparing policy and proposals relating to consumer safety, 
public health and the environment, and at drawing the Commission's attention to the new or 
emerging problems which may pose an actual or potential threat. Those committees were 
asked to advise the Commission on the issue related to chemical mixtures by addressing 
several questions. After having reviewed and analysed the available scientific literature on 
the general principles and methodologies for mixture toxicology, they reached the following 
conclusions (EC, 2011b): 
1. Under certain conditions, chemicals will act jointly in a way that the overall level of 
toxicity is affected. 
2. In a mixture, chemicals with common MOA will act jointly to produce combination 
effects that are larger than the effects of each chemical applied singly. These effects can be 
described by dose/concentration addition. 
3. For human health effects, if the intended level of protection is achieved for each 
individual substance, the level of concern for mixtures of dissimilarly acting substances 
should be assumed to be negligible. However, for ecological effects, the exposure to mixtures 
of dissimilarly acting substances at low, but potentially relevant concentrations should be 
considered as a possible concern, even if all substances are below the individual PNECs. 
Consequently there is a need to improve the current knowledge and methodologies, and to 
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develop holistic approaches for the ecological risk assessment of chemicals under realistic 
conditions. 
4. Interactions usually occur at medium or high dose levels (relative to the lowest effect 
levels). At low exposure levels, they are either unlikely to occur or toxicologically 
insignificant. 
5. In view of the almost infinite number of possible combinations of chemicals to which 
humans and environmental species are exposed, some form of initial filter to focus on 
mixtures of potential concern is necessary. Several criteria for such screening were offered, 
such as exposures at significant levels (e.g. close to the HBGVs, DNELs, or PNECs for 
several components); multi-constituent substances or commercial mixtures with 
component/substance of concern; potential serious adverse effects of one or more chemicals 
at the likely exposure levels; frequent or large scale exposure of the human population or the 
environment; persistence of the chemical in the body/the environment; known information of 
potential interaction at realistic levels of exposure; predictive information that chemicals act 
similarly (QSAR and structural alert); or presence of one or more components assumed to 
have no threshold for effect. 
6. A major knowledge gap at the present time is the lack of exposure information and the 
limited number of chemicals for which there is sufficient information on their MOA, as well 
as the absence of an agreed inventory of MOA, and of a defined set of criteria how to 
characterise or predict a MOA for data-poor chemicals. 
7. If no MOA information is available, the dose/concentration addition method should be 
preferred over the independent action approach. The likelihood of synergistic interaction at 
actually relevant exposure levels has to be assessed on a case-by-case basis from MOA 
information on the individual chemicals. 
They also proposed a decision tree for evaluating the risk of chemical mixtures, 
presented in Figure 6 . 
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Figure 6: Decision tree for the risk assessment of mixtures (EC, 2011b) 
Source: European Commission 
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International frameworks dealing with human risk assessment of combined exposure to 
multiple chemicals (EFSA, 2013b) 
Although not a guidance document, this is a scientific report reviewing the terminology, 
methodologies and frameworks developed by national and international agencies for the 
human risk assessment of combined exposure to multiple chemicals and providing 
recommendations for future activities at EFSA in this area. It refers to “risk assessment of 
combined exposure to multiple chemicals” in order to support such harmonisation in 
terminology as proposed by the International Programme on Chemical Safety (IPCS) of the 
World Health Organisation (WHO). However, the use of this terminology is not restrictive; 
for example, the term “cumulative risk assessment” is used in the pesticide field for the 
settings of Maximum Residue Levels (MRLs) under Regulation (EC) No 396/2005. 
It reviews the different steps of a risk assessment of combined exposure to multiple 
chemicals (i.e. problem formulation defining the relevant exposure, hazard and population to 
be considered; exposure assessment, hazard assessment and risk characterisation) and the 
different existing methodologies (i.e. whole mixture approach or component-based 
approaches for hazard assessment, depending on the toxicological data available). Additivity 
is the most common assumption through either dose addition with a similar MOA or response 
addition with a dissimilar MOA. Methods using the dose addition assumption include the 
Hazard Index approach with variants such as the target-organ toxicity dose, the reference 
point index/point of departure index, the relative potency factor and the toxicity equivalency 
factor approaches. For chemicals with a dissimilar MOA, the probability of observing a toxic 
response for each chemical component in the mixture is first estimated and components are 
then summed to estimate total risk from combined exposure to the multiple chemicals. Using 
the assumption of interactions (toxicokinetic and toxicodynamic), combined toxicity for the 
multiple chemicals is categorised as either less than additive (antagonism, inhibition, 
masking) or greater than additive (synergism, potentiation). Methods for deriving risk 
estimates for interactions include interaction-based Hazard Index and Hazard Index modified 
for binary interactions. For higher tier risk assessment (tier 3), full probabilistic models can 
be developed for exposure assessment and physiologically-based toxicokinetic (PB-TK) 
models and physiologically-based toxicokinetic-toxicodynamic (PB-TK-TD) models for 
hazard assessment. A typical example of the use of a PB-TK includes the derivation of 
interaction-based Hazard Index using tissue doses accounting for multiple toxicokinetic 
interactions between the multiple chemicals. The choice of the tier depends on data 
availability, the purpose of the risk assessment and the resources available. Uncertainty 
analysis included in this methodology aims at identifying the sources and magnitude of 
uncertainty in a tiered manner (qualitative, semi-quantitative or probabilistic) associated with 
exposure assessment, hazard assessment and risk characterisation, and help to identify data 
gaps, strengths and limitations of the assessment and to make recommendations on future 
research. 
This report shows that most national and international frameworks described apply 
stepwise decision trees and tiered approaches for the risk assessment of combined exposure 
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to multiple chemicals based on the original framework developed by the US EPA. Key 
differences include the separation of two different frameworks for cancer and non-cancer 
effects (ASTDR) versus the use of single tiered approach (three Non-Food Committees, 
WHO) and the use of dose addition as the default approach unless evidence demonstrates 
otherwise (WHO, three Non-Food Committees, EFSA).  
The report recommends the development of harmonised terminology and methodologies 
for human risk assessment of combined exposure to multiple chemicals, as well as a 
consistent approach to the assessment of priority mixtures across the different EU regulations 
and directives. The development of methodologies for risk assessment of exposure to 
multiple chemicals combined with other stressors (e.g. biological hazards, physical agents) is 
also proposed as a longer term objective.  
This report concludes with several recommendations regarding each step of the risk 
assessment process: for problem formulation, priority chemicals should be identified in a way 
that takes account of differences in legal frameworks (i.e. regulated substances versus 
contaminants).  
For exposure assessment, it is recommended to collect occurrence data for multiple 
priority chemicals in individual food samples, to develop case studies/training sets to 
compare deterministic versus probabilistic methods, and methodologies for aggregate 
exposure assessment for priority chemicals.  
For hazard assessment, further exploration of the scientific basis for both the whole 
mixture approach and the setting of assessment groups for component-based approaches 
should be carried out, and better information regarding MOA/MEA (Mechanism of Action) 
of multiple substances should be generated, from toxicokinetic and toxicity studies as well as 
from the use of predictive and alternative methodologies. To improve the basis for setting 
CAGs/AGs, toxicokinetic and toxicodynamic data for multiple chemicals of priority in 
humans and major test species should be collected. Finally, this report also recommends the 
development of a guidance document for uncertainty analysis regarding hazard assessment 
and risk characterisation for multiple chemicals. 
 
4.1.2   Ecotoxicological guidance and environmental mixture risk assessment 
EFSA Guidance Document on Risk Assessment for Birds and Mammals (EFSA, 2009a) 
The basic concept underlying the pesticide RA for birds and mammals is that the 
exposure of animals occurs mainly via pesticide residues in their food. Appendix B of the 
EFSA Guidance for RA to birds and mammals (EFSA, 2009a) addresses how to deal with 
exposure to mixtures of active substances (and possibly also co-formulants) in the 
environment.  
Combinations of active substances (a.s.) and also formulations are rarely experimentally 
tested in birds, whereas formulation toxicity data are more often available for mammals, 
since they are also used for classification and labelling. A four-step approach on how to deal 
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with mixtures of a.s. and formulations is described in the guidance and briefly summarised 
here. 
In a first step, the acute toxicity for mixtures (surrogate LD50) is calculated based on the 
concentration addition/toxic unit approach. If data are available, the toxicities of co-
formulants are also considered in the calculation. The toxicity per fraction is calculated to 
determine the contribution of each a.s. to the overall mixture toxicity. If one a.s. alone is 
responsible for a major part of the mixture toxicity it might be sufficient to perform a single 
substance RA for this a.s. and to avoid further steps 2-4. In the case of higher tier refinements 
in which consideration of different environmental fate parameters may result in a different 
residue composition than in the initial mixture, the equation for calculating the mixture 
toxicity has to be adjusted by using Multiple Application Factors (MAF). If synergisms are 
expected, targeted studies should be performed and the calculation approach not followed. 
In the second step, measured formulation toxicity data are considered if dose-response 
test data (step 2a) or limit test data (step 2b) are available. If measured data show higher 
toxicity than the calculated toxicity, the measured data should be used in tier 1 RA to account 
for any additional effect caused by components not considered in the calculation (e.g. co-
formulants) or synergistic effects that might also occur in the environment. The use of 
calculated toxicities in such cases should be considered only at higher tier refinements and 
based on careful justification that factors leading to the higher measured toxicity of the 
formulation would not be relevant under field conditions. If the calculated mixture toxicity is 
higher than the measured one, the calculated should be used instead. 
In the third step sublethal and reproductive effects are also considered. It is generally 
recommended not to use calculated mixture toxicities for endpoints from long-term and 
reproductive studies. Reliable results would only be expected if data are available on exactly 
the same endpoints and ideally based on ECx values with the same x avoiding variations that 
could be introduced by using NOAELs. Thus, calculation of mixture toxicities for sublethal 
and reproductive endpoints is recommended only on case-by-case basis. Then all a.s. in one 
group could be expressed after weighing against the most toxic representative of the group 
and the RA would be performed for the whole group by applying the corresponding NOEC 
for the most toxic compound. 
Step 4 describes the determination of the exposure estimates for the mixture risk 
assessment. In a first step, for single applications, the formulation component concentrations 
are simply summed up to calculate environmental residues. If several applications have to be 
considered, the default MAF of Tier 1 should be applied to the mixture. For refinements 
based on specific properties of individual a.s., the residue composition might be adjusted and 
does not need to remain as in the original mixture. If the RA is based on measured 
formulation toxicity data, the exposure refinement is not applicable.  
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EFSA PPR Panel Guidance on tiered risk assessment for plant protection products for 
aquatic organisms in edge-of-field surface waters (EFSA, 2013d)  
A guidance document on the risk assessment of plant protection products (PPPs) was 
developed by the PPR Panel of EFSA and published in July 2013. It specifies how the risk to 
aquatic organisms in edge-of-field surface waters should be assessed for active substances 
and plant protection products, i.e. formulations. 
Usually, approval of active substances at EU level is performed for single active 
substances (a.s.), but there is growing concern in several Member States that PPP exposure in 
the environment will be characterised by simultaneous and sequential exposure to multiple 
pesticides due to usual crop protection programs on one or also neighbouring fields in 
agricultural areas. Since the number of PPPs applied on one field over a growing season is 
highly variable and the potential number of PPP combinations is expected to be huge, it was 
not considered possible to perform ERA for all possible combinations. To reduce however 
the potential risk from multiple PPP exposure in the single substance RA, two options can be 
chosen, i.e. (1) the ecological threshold option (ETO), accepting negligible population effects 
only, and (2) the ecological recovery option (ERO), accepting some population-level effects 
if ecological recovery takes place within an acceptable time period. The selection of ETO for 
the RA of individual PPPs is more likely to avoid stress caused by the multiple uses of 
different PPPs. Although a RA that considers recovery of sensitive populations may be a 
reasonable option for surface waters adjacent to crops with a limited PPP input, it is more 
uncertain if ERO can be achieved when assessing risks for individual PPPs for their use in 
crop protection programmes characterised by intensive PPP use (simultaneous or repeated 
use of different PPPs). Thus, strict rules are set out on when the ERO should be avoided in 
order to be protective. 
For the approval of PPP formulations containing more than one a.s., a decision scheme 
and guidance is included on how to consider mixture effects (Chapter 10.3 of EFSA 2013b). 
The intention is to improve the mixture RA without increasing testing requirements, so that 
the use of calculated mixture toxicities should be considered whenever possible and justified.  
The toxicity calculation is based on the principle of concentration addition. When 
measured data are available for the mixture toxicity, these are compared to the calculated 
mixture toxicity in order to identify whether interactions (antagonism or synergism) occur. It 
is also important to consider whether the composition of the experimentally studied mixture 
deviates in composition from the mixture composition that is considered in exposure 
assessment (predicted environmental concentration for the mixture, PECmix). In such cases, 
the mixture toxicity should be calculated for both compositions and compared to the 
measured mixture toxicity. Depending on the deviation between the calculated and measured 
mixture toxicity, it is recommended to use one or the other in the RA.  
In the calculated mixture toxicity usually only the a.s. are included and the contribution 
of co-formulants should therefore be carefully considered in these comparisons. If toxicity 
data for individual co-formulants are available, these can be easily incorporated in the 
calculations.  
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Regarding the exposure assessment, as a conservative first step, it is usually assumed 
that all mixture components appear in the environment with the maximum concentrations at 
the same time, which are then summed up to determine the PECmix. If further exposure 
refinement is needed, predicted exposure profiles can be used and PECmix can be calculated 
for a time series of e.g. days, so that also the ratio exposuremix/toxicitymix (ETRmix) is 
calculated for each day. If refined toxicity data are used from higher tiers that would result in 
the use of different assessment factors, the RQmix approach needs to be applied, whereas 
otherwise the ETRmix approach will be followed. ETRmix or RQmix are calculated to assess 
whether the risk is acceptable. In both cases, the assessment is done separately for each 
organism group (e.g. fish, algae, plants, invertebrates). 
EFSA Guidance Document on the risk assessment of plant protection products on bees 
(Apis mellifera, Bombus spp. and solitary bees) (EFSA, 2013a) 
A guidance document for the risk assessment of plant protection products on bees was 
published by EFSA in July 2013. It was developed based on the respective Scientific Opinion 
of the PPR Panel
15
. Chapter 10 of the guidance addresses mixture toxicity and the toxicity of 
formulated products with more than one active substance. The concept of concentration 
addition is proposed for calculating mixture toxicity using a Sum of Toxic Units (TU) 
approach. If measured toxicity values for formulations with more than one active substance 
are available, these should be compared to the calculated mixture toxicity to verify the 
applicability of dose additivity. Differences might be explained e.g. by co-formulants that 
were not considered in the calculation, toxicokinetic interaction or synergism/potentiation of 
effect. If the measured toxicity of the formulation is lower than the calculated one, the 
calculated one should be used in the RA in a first tier. On the exposure side, in a first tier the 
simultaneous co-occurrence of all components at the maximum concentration is assumed as a 
conservative approach. Mixture exposure estimates can be refined taking into consideration 
the real concentration profiles predicted for the individual components, which might have 
peak concentrations at different times.  
Environmental mixture risk assessment in the context of the Biocidal Product Regulation 
In 2012, the EU council and Parliament adopted a regulation
16
 that implements an EU-
wide, harmonized system for the authorization for biocidal products. Such products are most 
of the time multi-component products (i.e. "intentional mixture") and the assessment of 
possible combination effects between the different components is a critically important step 
during the regulatory environmental risk assessment of these products. To assess the mixture 
effects of biocidal products from their ingredients, a tiered approach has been proposed by 
Bachaus et al., (2013) which accommodates different data situations, optimizes resource 
usage, limits animal testing as far as possible and should ensure adequate protection of the 
environment.  
                                                        
15 EFSA Panel on Plant Protection Products and their Residues (PPR); Scientific Opinion on the science behind the 
development of a risk assessment of Plant Protection Products on bees (Apis mellifera, Bombus spp. and solitary bees). 
EFSA Journal 2012; 10(5) 2668. [275 pp.] doi:10.2903/j.efsa.2012.2668. 
16 Regulation (EU) No 528/2012. Biocidal Product Regulation (BPR) 
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This approach is mainly based on concentration addition as a component based 
approach, as the use of non-testing methods with respect to ecotoxicity data is already 
stressed in the Biocidal Products Regulation. It also facilitates the re-use of existing data for 
individual ingredients, which is expected to increase as the BPR promotes data sharing 
between applicants. CA is either approximated by summing up PEC/PNEC ratios (Figure 7) 
or as sums of toxic units (Figure 8). It is suggested to take into account potential interactions 
(i.e synergistic effects) by initially penalizing the CA-based assessment with an additional 
assessment factor, termed "IF" ("Interaction Factor"), in particular if there is no 
ecotoxicological data for the product in question. A default value of 2 is provisionally 
proposed as sufficiently protective, unless available evidence exists showing that the IF might 
have to be set to a value greater than 2, or decreased to 1 (Figure 7); however the authors 
recognized that the use and the initial size of this IF might warrant later review and perhaps 
adjustment.  
 The minimum requested set of data for a component-based assessment consists of 
complete information on the product composition, and the PEC/PNEC ratio for the 
compound of highest concern (typically the active ingredient). As only semi-quantitative data 
are needed for this purpose, QSAR estimates, hazard classification data according to the CLP 
regulation or censored data (e.g. from limit tests) and simple exposure estimates should be 
sufficient. Then, the final risk of the product is estimated by calculating the Risk Quotient of 
the product. If RQProd <1, no further testing or data evaluation would be required; if RQProd 
>1, the PEC, PNEC and/or IF might be refined by providing additional data; the whole 
mixture might be subject to direct biotesting, or a more detailed component-based assessment 
might be carried out using quantitative risk estimates for every relevant compound instead of 
using only the highest concern one. If after having applied these various options, there is still 
reason for concern, direct product testing or the application of CA in the form of the sum of 
toxic units (STU) might be performed (Figure 8). The sum of toxic units is calculated for 
each ecotoxicological endpoint, which is species-specific, and implies that data for all 
relevant compounds are available for all endpoints. The maximum STU indicates which 
endpoint for which species is expected to be most sensitive for the biocidal product in 
question and is therefore used for the final assessment.  
Independent action was considered as not suitable for incorporation into a tiered 
approach without explicit confirmatory studies as it might lead to an underestimation of the 
actual environmental risk. Whole product testing is considered where appropriate but 
according to the authors it should be regarded as a "gold standard" for the assessment of acute 
toxicities or if synergistic interactions are suspected. 
An ECHA guidance document based on this proposal was published in 2014 (ECHA, 
2014). This guidance is regarded as “transitional” because it was initiated under the “old” 
Biocidal Products Directive and finalised before the relevant new Biocidal Products 
Regulation guidance document was fully developed. It is therefore made available as a 
Transitional Guidance document until the relevant new document is ready for publication. 
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Figure 7: Approach for environmental risk assessment of biocidal products based on 
PEC/PNEC summations (Backhaus et al., 2013). Open Access article distributed under the terms of 
the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0) 
 
PEC: Predicted Environmental Concentration, PNEC: Predicted No Effect Concentration; RQProd: Risk Quotient 
for the product, TU: Toxic Unit, IF: Interaction Factor, n= number of compounds in the mixture. 
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Figure 8: Toxic Unit based approach for environmental risk assessment of biocidal products 
(Backhaus et al., 2013) Open Access article distributed under the terms of the Creative Commons 
Attribution License (http://creativecommons.org/licenses/by/2.0) 
 
PEC: Predicted Environmental Concentration, PNEC: Predicted No Effect Concentration; RQProd: Risk Quotient 
for the product, TU: Toxic Unit, IF: Interaction Factor, IA: Independent Action,  n= number of compounds in 
the mixture, AF: Assessment Factor. 
 
This guidance addresses the ERA of mixture toxicity of biocidal products as well as 
synergistic effects as required by the BPR by applying a tiered scheme, and focuses on 
component-based approaches and whole-mixture testing, which may be the only viable 
option in certain cases (i.e when it is suspected that a component in the mixture acts as a 
synergist, and may cause an interactive type of joint action for which CA -or IA for that 
matter- is an invalid assumption, or when even higher tier effect modelling predicts 
unacceptable risk). However, testing should always be the last option, and if this approach is 
chosen, careful consideration should be taken to determine the most relevant mixture to be 
tested. As a matter of fact, testing of the product might be useful when the environment is 
directly exposed to the formulated product, but in most cases, the environment is exposed to a 
mixture that is different from the original composition of the product
17
.  
As a first step of this ERA, the concerned environmental compartments and the type of 
mixture to which it would be exposed (i.e the product itself or a modified mixture) should be 
identified, as well as the relevant substances of the mixtures (i.e. biologically active 
chemicals that are present at sufficiently high concentrations and are contributing to the 
overall toxicity of the respective mixture). In case of indication for synergistic interactions, a 
case-by-case risk assessment should be performed; if there is no indication for synergistic 
effects, it is recommended to proceed with the tiered approach.  
                                                        
17 In this guidance document the terms “mixture” and “relevant mixture ” are used for the product itself and the ecologically 
relevant mixture, respectively 
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The tiered approach developed in this guidance is a 4-stages approach which 
accommodates different data situations, optimises resource usage and limits biotesting as far 
as possible. It mainly builds on using component-based approaches (CBAs) based on the 
concept of CA for mixture toxicity prediction, which is either approximated by summing up 
PEC/PNEC ratios or implemented as sums of Toxic Units (STU). As previously, the concept 
of IA was assessed as not being suitable for incorporation into a tiered approach without 
explicit confirmatory studies, as it might otherwise lead to an underestimation of the actual 
environmental risk. In addition, IA would lead to higher data demands compared to CA. 
However, if the applicant can prove that IA adequately describes the toxicity of a given 
product by submitting appropriate data, e.g. information about the MoAs and the 
concentration-response relationships of the mixture components, these data should be taken 
into account for mixture toxicity assessment and assessed according to expert judgment.  
Each of the upper tiers involves a less conservative and more accurate assessment than 
the previous tiers but requires also more resources, including additional exposure and toxicity 
data. The tiers must not be performed step by step for a respective product, e.g. in case the 
data for Tier 3 are available in the beginning, the assessment can be started with Tier 3. 
Tier 1 implies the summation of the PEC/PNEC ratios if there are available for all 
relevant ingredients, to calculate the risk quotient of the mixture (RQProduct)
18
. If RQProduct <1, 
the risk is considered as acceptable; if it is >1, a refinement of the PEC- and/or PNEC-values 
by providing additional information on the exposure and/or hazard characterisation of the 
compounds can be performed, or the RA can continue with tier 2, 3 or 4, or effective Risk 
Mitigation Measures (RMM) should be defined. Ultimately, the only remaining option is the 
non-authorisation of the product. 
The refinement in Tier 2 and Tier 3 consists of looking separately at the combined risk 
from all relevant substances towards each separate trophic level, by calculating the Sum of 
Toxic Units (STU) for each trophic level. Two approaches are presented: First, a modified 
Toxic Unit Summation (TUS) which can take into account varying data sets for the relevant 
substances (Tier 2) and secondly, the standard TUS for cases where homogeneous data sets 
are available for all relevant substances (Tier 3). This method is a more realistic approach 
than Tier 1, as it combines effects for each trophic level (e.g. separate risk-ratios are 
calculated for all relevant substances for algae, daphnids and fish). The only difference 
between the two Tiers is that Tier 2 gives the opportunity to use different AFs for each 
relevant substance, whereas a common AF factor is being used in Tier 3, selected depending 
on the amount of available data according to the rules set up in the TGD.  
If in Tiers 2 or 3 the criterion for an acceptable risk for the environment is still not met, 
i.e. RQProduct > 1, a refinement of the PEC- and/or ECx-values by providing additional 
information on the exposure and/or hazard characterisation of the compounds, or the  
definition of effective Risk Mitigation Measures (RMM) might be an option. If this is not 
                                                        
18 It should be pointed out that this summation is fundamentally different from the concept of CA, of which one assumption 
is that all individual toxicity data refer to same biological endpoint and organism; yet the PNECs from the various 
compounds might be based on data from completely different endpoints and species. Consequently, the use of PEC/PNEC 
sums derived from a set of different species or endpoints are only recommended for first-tier CA assessment in the opinion 
on mixture toxicity assessment as put forward by the EU scientific committees.  
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possible, ultimately the RA can proceed to Tier 4 with the direct testing of the mixture of 
concern (either the biocidal product, if there is a direct release of the product into 
environment or the ecologically relevant mixture in case the composition of the product 
changes radically before release to environment). If the direct biotesting of the mixture of 
concern, i.e. the product and/or the ecologically relevant mixture is not possible and other 
options such as a further refinement of the single substance data or the definition of effective 
RMMs are not applicable, the only remaining option is the non-authorisation of the product. 
EU and Endocrine Disrupting Chemicals (EDCs) 
In 2011, a "State of the art assessment of endocrine disrupters" was published, 
commissioned by the European Commission (Kortenkamp et al., 2011). This report is not a 
guidance document, but aims at summarising advances in the state of the science since the 
WHO IPCS report of 2002 and mapping out the currents requirements regarding endocrine 
disruptors in different pieces of EU chemicals regulation (i.e. PPP regulation, REACH and 
the Biocide Regulation).  
It highlights the fact that there is good evidence that several EDCs can work together to 
produce combined effects. Especially when there is simultaneous exposure to chemicals 
affecting the same endpoint, EDCs can produce additive effects, even when combined at low 
doses that individually would not produce observable effects. According to a WHO report, 
this has the effect of “making accurate risk assessment difficult or impossible” (WHO-UNEP, 
2012). From a regulatory point of view, it is therefore of great importance to have information 
about the spectrum of EDCs that are present in relevant exposure scenarios. This information 
is currently fragmentary, and this lack of information makes it likely that the full extent of 
risks associated with EDCs might be underestimated.  
In 2013, EFSA SC also published a Scientific Opinion on the hazard assessment of 
EDCs (EFSA, 2013e). Regarding interactions and modes of action, the SC recognises that 
information may be obtained at the receptor level from in vitro studies. However, because of 
differences in the toxicokinetic properties of the substances, this is not enough to predict the 
nature of the combined effects at the organism level, even if the EDCs have a similar MOA. 
Moreover, the current tests are being developed to address single substances, and it is 
necessary to first develop the tests for single substances with adequate dose response data for 
reference substances, before addressing combined exposure to multiple substances. Thus, 
there is also a gap concerning guidance on the assessment of effects triggered by combined 
exposure to EDCs, and a need to develop mixture methodology in this context. 
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4.2    Assessment of mixture toxicity in other geographical areas 
 
4.2.1   United States of America 
 
The US Environmental Protection Agency (US EPA) is the main US authority engaged 
in industrial chemicals and mixtures management, risk assessment and regulation. The Food 
and Drug Administration (FDA) and the Agency for Toxic Substances and Disease Registry 
(ATSDR) also play a role, with the FDA establishing tolerance levels for hazardous 
substances in food and consumer items, and the ATSDR evaluating data on releases of 
hazardous substances and creating and maintaining registers of exposed people (Kortenkamp 
et al., 2009). This paragraph reviews the main guidance documents dealing with mixture 
toxicity issued from those different US authorities, and the context in which they have been 
developed. 
Environmental Protection Agency (EPA) 
Cumulative risk assessment (CRA) for contaminated sites 
The Comprehensive Environmental Response Compensation and Liability Act 
(CERCLA) which came into force as early as 1980 specifically requires mixture risk 
assessment during the evaluation of risks stemming from hazardous waste sites and chemical 
accidents. These risk assessments are termed "cumulative risk assessment" (CRA) as they 
consider the combination of risks associated with exposure to multiple chemicals and non-
chemical stressors by all routes and pathways (an exposure pathway being here how a 
chemical moves from the waste site to a human subject), and from all sources, including 
multiple time frames and multiple health outcomes. In contrast, the term “aggregate risks” is 
used to describe risks that stem from exposure to one substance by multiple pathways and 
routes (WHO, 2009); it should be thus reserved for single chemicals to avoid any confusion. 
In this context, US EPA has published five guidelines dealing with the risk assessment 
of chemicals, including one dealing with chemical mixtures, as well as the "Risk Assessment 
Guidance for Superfund (RAGS)" in 1989 (USEPA, 1987, 1989) in which extensive and 
detailed guidance on mixture assessment is given. A risk assessment for a mixture is 
composed of three steps: exposure assessment, toxicity assessment and risk characterisation.  
Exposure assessments are made on “reasonably maximally exposed” people, and 
decision making is based on the worst-case (highest exposure likely to occur). The initial list 
of chemicals to be evaluated in a typical site risk assessment is given by the EPA’s Contract 
Laboratory Program (CLP) Target Compound and Target Analyte List (TCP/TALs)
19
. The 
outcome of exposure assessments for hazardous waste sites are estimates of exposure or dose 
for each chemical for defined subpopulation disaggregated by time periods and exposure 
pathways. 
                                                        
19 http://www.epa.gov/superfund/programs/clp/target.htm. It includes 52 volatile chemicals, 30 pesticides and Aroclors, 24 
metals, cyanide, and 67 semivolatile chemicals. 
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The toxicity assessment is based on the toxicity information for each considered 
chemical, found in the IRIS database (reference values such as reference dose - RfD
20
- or 
reference concentration - RfC
21
- are used).  
The risk characterisation is then calculated from these inputs, differently for carcinogens 
and non-carcinogens. Figure 9 gives the basic principles of CRA for Superfund sites, as 
practiced by US EPA. For carcinogens, it is assumed that there is no dose threshold, and that 
the dose-response function is essentially linear. Because risk estimates are probabilities, 
cancer risks associated with different substances can be added together irrespective of 
whether the substances cause cancer by (1) similar mechanisms, or (2) completely 
independent mechanisms. Under such conditions the use of simple effect summation for the 
estimation of a cancer risk estimate produces results similar to independent action, because 
the predicted cancer probabilities are very much smaller than 0.001 (Kortenkamp et al., 
2009). 
For non-carcinogenic chemicals, a hazard quotient (HQ) is calculated for each pathway 
and each averaging period. An overall summary hazard index (HI - Application of dose 
addition) is then calculated as the sum of HQs for each pathway and each chemical. If HI ≤ 1, 
it is assumed that there is unlikely to be a risk of deleterious effects and the analysis is 
complete. If HI > 1, further analysis may be performed to determine whether application of 
dose additivity to all the chemicals simultaneously is justifiable. 
These documents do not really go further than a basic application of additivity concepts. 
In particular, there is little in the 1989 guidance about how to deal with toxicological 
interactions (Kortenkamp et al., 2009). In 2000, the US EPA published a Supplementary 
Guidance for Health Risk Assessments for Mixtures, in which some of these gaps were filled. 
Table 6 gives an overview of evolution of the US EPA's guidance documents on mixtures 
whereas brief summaries of the guidance documents are given in the Annex I.  
 
 
                                                        
20 Reference dose (RfD): An estimate (with uncertainty spanning perhaps an order of magnitude) of a daily oral exposure to 
the human population (including sensitive subgroups) that is likely to be without an appreciable risk of deleterious effects 
during a lifetime. It can be derived from a NOAEL, LOAEL, or benchmark dose, with uncertainty factors generally applied 
to reflect limitations of the data used. http://www.epa.gov/risk/glossary.htm 
21 Reference concentration (RfC): An estimate (with uncertainty spanning perhaps an order of magnitude) of a continuous 
inhalation exposure to the human population (including sensitive subgroups) that is likely to be without an appreciable risk 
of deleterious effects during a lifetime. It can be derived from a NOAEL, LOAEL, or benchmark concentration, with 
uncertainty factors generally applied to reflect limitations of the data used. http://www.epa.gov/risk/glossary.htm 
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Figure 9: Cumulative risk assessment for waste sites in US EPA Risk Assessment Guidance for 
Superfund (RAGS) 
Source: United States Environmental Protection Agency 
(http://www.epa.gov/oswer/riskassessment/ragsa) 
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Table 6: US EPA publications on mixture assessment and evolution of the EPA guidance documents  
Guidance Principles and Strengths Deficiency 
US EPA 1986-Guidelines 
for the health assessment 
of Chemical Mixtures 
-Use basic application of additivity concepts (dose addition or independent 
action) 
-Approach: use data on the mixture of concern, when available; or 
information about similar mixture; or evaluation pairwise interactions 
between mixtures constituents, or assume dose additivity for chemicals with 
the same MOA, or response additivity for chemicals with the same health 
endpoint but different MOA. 
-Consider multiple chemicals, exposure routes and effects. 
Consideration of chemicals interaction only through the use of 
interaction coefficient if toxicological data are available. 
US EPA 1989-Risk 
Assessment -Guidance for 
superfund. Vol 1. Human 
Health Evaluation Manual. 
Part A.   
- Use basic application of additivity concepts (dose addition or independent 
action) 
- Consider multiple chemicals, exposure routes and effects. 
-Implemented component-based approaches for the assessment of the 
effects of multiple chemicals 
- Make a distinction between carcinogens and non-carcinogens:  
*carcinogenic substances: component risks are added, following the 
principles of independent action.  
*non-cancer endpoint: the doses of mixture components are scaled and 
added (application of the dose addition concept, termed "the hazard index") 
- Develop the quantitative evaluation of exposures via multiple pathways by 
using the hazard quotient concept 
- Toxicological interaction: a default approach was defined, stipulating 
application of dose addition or independent action, where appropriate 
- To produce an hazard index (HI), CRA summed hazard quotients of 
individual chemicals that had similar adverse health outcomes, but not 
necessarily similar modes of action 
- Lack of detail regarding procedures for conducting multi-pathway 
analyses. 
Supplementary Guidance 
for conducting health risk 
assessment of chemical 
mixtures. US EPA, 2000 
-Default approach of HI or relative potency for "toxicologically similar" 
components, independent action for "toxicologically independent" 
components 
-Development of a process for the quantitative evaluation of toxic 
interactions (Interaction Hazard Index) 
- Lack of workable procedures for multi-chemical, multi-pathway 
exposure assessments, as well as for multiple effects produced by 
mixtures 
-Interactions are addressed only in terms of altered or joint toxicity. 
USEPA, 2002 Guidance on 
Cumulative Risk 
Assessment of pesticide 
chemicals that 
have a common 
mechanism of toxicity  
-The CRA begins with the identification of a group of chemicals, a CMG 
(Common Mechanism Group). It is assume that identification of a CMG 
implies dose addition for its member chemicals, so dose addition is the only 
possibility considered. 
- Does not focus on single pathways of exposure (e.g., from pesticide 
residues in food, water, or residential/non-occupational uses) for individual 
chemicals, but on the potential for individuals to be exposed to multiple 
pesticides by all pathways concurrently (i.e. cumulative risk assessment). 
-Considers only chemicals that produce an effect by a common MOA, 
and omits other chemicals that might also induce the same effect of 
interest, although by different mechanisms.  
-Does not consider toxic interactions, and mixture effects are by default 
assumed to be additive. 
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Table 6: US EPA publications on mixture assessment and evolution of the US EPA guidance documents (Continued) 
Guidance Principles and Strengths Deficiency 
USEPA, 2003. Framework 
for Cumulative Risk 
Assessment, Risk 
Assessment Forum, 
EPA/630/P-02/001F 
-Offers a basic structure and provides starting principles for EPA's 
cumulative risk assessments, and the basic principles around which to 
organize a more definitive set of cumulative risk assessment guidance. 
-Define Cumulative risk as the combined risk from aggregate exposures to 
multiples agents or stressors 
-Define Aggregate exposure as the combined exposure of an individual (or 
define population) to a specific agent or stressor via relevant routes, 
pathways, and sources). 
Give no explicit default approach, only refers to previous documents 
(particularly EPA 2000) 
USEPA, 2006- 
Considerations for 
developing alternative 
health risk assessment 
approaches for addressing 
multiples chemicals, 
exposures and effects 
 
-The approaches extend those ideas to include kinetic modelling to integrate 
exposures occurring through multiple routes, interactions affecting fate and 
transport and interactions affecting multi-route joint toxicity 
-Emphasize the links between the exposed population and the multiple 
factors being addressed 
- CRA is defined explicitly as considering the health risks that stem from 
multiple chemicals, via multiple routes and exposure pathways, within 
multiple time frames. Multiple health effects are taken into account. 
-Currently much information is lacking regarding compound toxicity and 
kinetics to use in kinetic modelling 
-Relies on known concentrations for many chemicals which is frequently 
unknown 
-Give no explicit default approach, only refers to previous documents 
(particularly EPA 2000) 
USEPA 2007 – Concepts, 
methods and data source 
for cumulative health risk 
assessment of multiples 
chemicals, exposures and 
effects: a resource 
document. EPA/600/R-
06/013F, National Center 
for Environmental 
Assessment, Cincinnatti, 
OH. 
-Resource document for identifying specific element and approaches for 
implementing cumulative risk assessments (presentation of concepts, 
methods and data sources). 
-Define cumulative risk assessment as the analysis, characterisation and 
possible quantification of the combined risks to health or the environment 
from multiple agents or stressors. 
Give no explicit default approach, only refers to previous documents 
(particularly EPA 2000) 
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CRA and pesticides 
The passage of the Food Quality Protection Act (FQPA) in 1996, requiring the 
estimation of health risks from combinations of pesticides with a common mode of action, 
also played a role in the evolution of CRA by triggering the development of procedures for 
pesticide mixture assessment. In order to fulfil this requirement, the US EPA first developed 
guidelines to determine which pesticides should qualify for inclusion in common mechanism 
groups (USEPA, 1999), and then published a guidance document concerning the application 
of the hazard index principle to pesticides, with an aggregate risk formula equivalent to the 
total hazard quotient in the Superfund guidance (USEPA, 2002a). The 10 steps of the risk 
assessment for pesticide mixtures are described in Figure 10. The US EPA’s pesticide CRA 
follows the broad principles developed for Superfund sites, although with some 
modifications: the selection process of chemicals which should be considered was modified 
and the procedure was extended to deal with simultaneous exposures from food, drinking 
water and residential (non-occupational) use of pesticides for the general population 
(Kortenkamp et al., 2009). This risk assessment procedure was used to extensively assess the 
risk linked to mixtures of organophosphates, carbamates, triazines and chloroacetanilides 
(USEPA, 2002b, 2006c, b, 2007b).  
Figure 10: Cumulative risk assessment of pesticide chemicals that have a common mechanism of 
toxicity (USEPA, 2002a) 
Source: United States Environmental Protection Agency 
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The first step reflects the need to identify a group of chemicals that are considered to 
induce a common toxic effect by a common mechanism, a so-called common mechanism 
group (CMG), and to evaluate the registered and proposed uses for each chemical in the 
CMG, to further identify potential exposure pathways and exposure routes.  
Then, the various endpoints associated with this common mechanism of toxicity are also 
identified. An important aspect of this assessment step is to determine if the common effect is 
expressed across all exposure routes for each chemical in the CMG. To avoid useless testing 
and quantitative dose-response analysis, pesticides that contribute to exposures by minor 
pathways are excluded from the CMG, forming a subset, termed cumulative assessment 
group (CAG). For each CAG member, dose response analyses are performed to determine its 
toxic potency for the common effect. The concept of dose addition is normally used to 
estimate the combined risks in the CAG, although deviation from this basic principle is 
permitted if appropriate. Then, one chemical from the CAG is selected to serve as an index 
chemical, and the relative potencies of the CAG members to this index chemical are defined 
for the standardization of their common toxicity in terms of relative potency factors (RPF). 
The index chemical should be well evaluated for its toxicity, because such data are then used 
to characterise risks as margins of exposure. RPF are used to convert exposures of all 
chemicals in the CAG into exposure equivalents of the index chemical, rather like the 
procedure used with TEFs for dioxin-like chemicals. 
Then, a detailed exposure assessment is made by developing detailed exposure scenarios 
for all CAG members, including determination of potential human exposures by all relevant 
pathways, durations and routes where simultaneous exposure may occur, as well as sequential 
exposures. The output of this analysis is an aggregation of exposures via all routes and 
pathways, for each chemical, which is then expressed in terms of an equivalent exposure of 
the index chemical, by using RPFs. 
Finally, in the risk characterisation phase, the exposure assessment yields a dose measure 
for the mixture that is expressed as equivalent exposure to the index chemical. The results 
and conclusions of the cumulative risk analysis must be described and the risk contributions 
from each pathway and route should be evaluated both individually and in combination, in 
order to identify risk contributors. The risk characterisation step also includes descriptions of 
variability and major areas of uncertainty and the need for uncertainty and safety factors is 
determined. 
Other applications of CRA by US EPA 
 
The 1996 amendments to the Safe Drinking Water Act also required consideration of 
chemical mixtures. In this context US EPA was charged with developing new approaches for 
the assessment of complex mixtures, with particular focusing on disinfection by-products. 
Again, default assumptions about joint additive effects were adopted, and considerations of 
synergistic or antagonistic effects remained minimal (Kortenkamp et al., 2009). 
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Finally, cumulative risk assessment has also been applied to estimate the health effects 
of air pollutants, in the context of the National-Scale Air Toxics Assessment (NATA)
22
, US 
EPA's comprehensive evaluation of air toxics in the U.S. In this work, the US EPA 
considered 177 air pollutants, and used dispersion models to estimate their concentrations in 
ambient air. These were used as input values for the estimation of both cancer and non-cancer 
risks.  
NATA estimated simultaneous exposures to the selected chemicals at the census tract, 
country or state level at a point in time. The cumulative methods applied were dose addition 
and independent action. For carcinogens, lifetime cancer risk estimates for inhalation 
exposures were added (independent action). For non-carcinogens, the common health effect 
of concern was respiratory irritation and single-chemical hazard quotients for respiratory 
irritants were added to yield a “respiratory hazard index” (dose addition) (USEPA, 2007 ). 
However, the CRA summed hazard quotients of individual chemicals that had similar 
adverse health outcomes, but not necessarily similar modes of action. Like the previous 
applications of CRA, synergistic or antagonistic effects were not considered, nor were non-
chemical stressors taken into account (Kortenkamp et al., 2009). 
Framework for CRA 
In 2003, the US EPA published a Framework for Cumulative Risk Assessment 
(USEPA, 2003), which provides starting principles for EPA's cumulative risk assessment, for 
the future development of a comprehensive and detailed guidance on methods for evaluating 
cumulative risk. This report emphasizes chemical risks to human health including the effects 
from a variety of stressors, including non-chemical stressors. This was further developed in a 
the 2006 publication on the "Considerations for developing alternative health risk assessment 
approaches for addressing multiple chemicals, exposures and effects" (USEPA, 2006a). This 
document is not a guidance document, but presents concepts that could assist the 
development of detailed guidance in the future, and provides explicit approaches for 
addressing some of the complicating “multiples” in cumulative risk assessment. These 
approaches include new methods and the extension of existing methods to address health risk 
from multiple chemicals and multiple exposure pathways and times.  
Agency for Toxic Substances and Disease Registry (ATSDR) 
The ATSDR is the principal federal public health agency involved with hazardous waste 
issues. The agency is responsible for preventing or reducing the harmful effects of exposure 
to hazardous substances on human health, and for implementing the health-related parts of 
the Superfund law and of other laws that protect the public from hazardous wastes and 
environmental spills of hazardous substances. ATSDR also advises the EPA, as well as other 
federal and state agencies, community members, and other interested parties, on the health 
impacts of Superfund sites.  
                                                        
22
 http://www.epa.gov/nata/ 
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Under the CERCLA, the ATSDR assesses whether adequate information on health 
effects is available for the priority hazardous substances; if not, the ATSDR initiates, in 
cooperation with the National Toxicology Program, a program of research to determine these 
health effects. The Act also requires that ATSDR develops methods to determine the health 
effects of substances in combination with other substances with which they are commonly 
found, where feasible. Similarly, the FQPA requires that factors be considered in 
establishing, modifying or revoking tolerances for pesticide chemical residues in food, and 
that these should include available information on the cumulative effects of substances with a 
common mode of action (Kortenkamp et al., 2009). 
To address these requests, ATSDR’s Division of Toxicology has developed a research 
program for chemical mixtures, which includes a trend analysis to identify mixtures most 
often found in environmental media, in vivo and in vitro toxicological testing of mixtures, 
quantitative modelling of joint action, and methodological development. The agency has also 
devised a guidance manual that outlines the latest methods for mixture assessment (ATSDR, 
2004).  
ATSDR Guidance document for the assessment of joint toxic action of chemical 
mixtures 
This guidance manual aims both at assisting the agency in determining whether exposure 
to chemical mixtures at hazardous waste sites may impact public health and at serving as a 
basis for the development of interaction profiles (see below). 
The approach developed in the mixtures guidance manual is consistent with the US EPA 
guidance articulated since 1986. This approach is a semi-quantitative screening process. A 
step-by-step procedure is outlined in a flow chart, before being discussed and illustrated by 
examples, for the assessment of both non-carcinogenic and carcinogenic effects. These flow 
charts are presented in Figure 11 and Figure 12. 
The strategies for non-cancer and cancer effects are similar. Exposure data and 
toxicological information on the mixture of concern (or a similar mixture) are the preferred 
basis for an assessment. If no data are available, no whole mixture studies and no Minimal 
Risk Levels (MRLs) or comparable health guideline values for the mixture or guidance 
regarding a health assessment approach, a components-based approach is undertaken.  
Component-based mixture assessments make use of the hazard index and are fully 
compatible with US EPA approaches. The components-based approach focuses on mixture 
components that are present at toxicologically significant exposure levels. Linked 
physiologically-based pharmacokinetic/pharmacodynamic (PBPK/PD) models for two or 
more components may be used to predict the potential for interactions, or possibly for 
noncancer or cancer health effects from the mixture. The hazard index method is used to 
screen for non-cancer health hazards from potential additivity of the components. Cancer 
risks for the components are summed to screen for health hazards from potential additivity of 
carcinogenic effects. A weight-of-evidence method is used to evaluate the potential impact of 
interactions on non-cancer and cancer health effects.  
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Figure 11: Strategy for exposure-based assessment of joint toxic action of chemical mixtures: 
non-carcinogenic effects (ATSDR, 2004) 
Source: Agency for Toxic Substances and Disease Registry (http://www.atsdr.cdc.gov) 
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Figure 12: Strategy for exposure-based assessment of joint toxic action of chemical mixtures: 
carcinogenic effects (ATSDR, 2004) 
Source: Agency for Toxic Substances and Disease Registry (http://www.atsdr.cdc.gov) 
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In deriving hazard quotients, the US EPA recommends the use of RfD also for effects 
that occur at higher doses, not only the critical effects, which may lead to overestimations of 
risks. To deal with this potential complication, the target organ toxicity dose (TTD) 
modification of the hazard index was developed for chemicals that affect an endpoint at a 
dose higher than for the critical effect (Kortenkamp et al., 2009).  
Moreover, the hazard index concept assumes dose additivity, and does not take into 
account potential toxic interactions. In order to fill this gap, another modification of the 
hazard index approach is also developed in this document, by using additional uncertainty 
factors to accommodate the possibility of deviations from expected additivity. It evaluates 
binary mixtures and introduces a classification that indicates the expected direction of 
interaction (synergistic or antagonistic) by using an alphanumerical scoring system. The 
scores are then combined with the hazard index. 
Other documents from the ATSDR  
In addition, a series of documents called interaction profiles
23
 were developed for certain 
mixtures of concern found in environmental media, in food, or in site-specific exposure 
settings. The purpose of these documents is to evaluate data on the toxicity of the 'whole' 
priority mixture (if available) and on the joint toxic action of the chemicals in the mixture in 
order to recommend approaches for the exposure-based assessment of the potential hazard to 
public health.  
Food and Drug Administration (FDA) 
The FDA is the US agency responsible for protecting public health by assuring the 
safety, efficacy and security of human and veterinary drugs, biological products, medical 
devices, the nation's food supply, cosmetics, and products that emit radiation. 
The FDA has issued a guidance document for industry on drug-drug interaction studies 
(FDA, 2006). The focus of this guidance is to advise on studies aimed at establishing whether 
one drug influences the absorption, distribution, metabolism, excretion, or the effects of 
another drug, and the promoted strategy is based on in-vitro study, in-vivo study and PBPK 
modelling. The idea is not to determine additive combination effects between drugs, and 
consequently no component-based approaches are suggested. Guidance relevant to pesticide 
residues or additives in food could not be located (Kortenkamp et al., 2009). 
National Research Council (NRC) 
The National Research Council (NRC) is the operating arm of the United States National 
Academies, which produces reports that shape policies, inform public opinion, and advance 
the pursuit of science, engineering, and medicine. In 1989, the Safe Drinking Water 
Committee of the National Research Council (NRC) discussed possible modifications to the 
approaches for estimating the toxicity of mixtures in drinking water, suggesting to group 
                                                        
23
 Available at: http://www.atsdr.cdc.gov/interactionprofiles/index.asp 
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mixture components according to toxicity endpoints, such as specific organ toxicity or 
carcinogenicity, with the aim of assessing their combined hazards and risks (NRC, 1989). 
In 1994, while reviewing the methods used for the determination of carcinogenic risks 
associated with exposure to hazardous air pollutants, the NRC pointed out that people at risk 
are exposed to a mixture of chemicals, each of which is possibly associated with an increased 
probability of one or more health effects (NRC, 1994), and that emitted substances might be 
carried to and deposited on other media, such as water and soil, and cause people to be 
exposed via routes other than inhalation (e.g. dermal absorption or ingestion). In such cases, 
data are often available on only one of the adverse effects (e.g. cancer) associated with each 
chemical: the issue is how best to characterise and estimate the potential aggregate risk posed 
by exposure to a mixture of toxic chemicals. 
The method used by the US EPA of adding the risks related to each chemical in a 
mixture for developing a risk estimate was considered appropriate when the only risk 
characterisation needed is a point estimate for use in screening. When a more comprehensive 
uncertainty characterisation is desired, the NRC recommended that the US EPA uses 
appropriate statistical (e.g., Monte Carlo) procedures to aggregate cancer risks from exposure 
to multiple compounds. They further recommended that in the analysis of animal bioassay 
data on the occurrence of multiple tumour types, the cancer potencies should be estimated for 
each relevant tumour type that is related to exposure, and the individual potencies should be 
summed for those tumours. 
More recently, the NRC was asked by the US EPA to look into the necessity of 
conducting a cumulative risk assessment for phthalates, because phthalates make up a 
chemical class that produce similar effects and have similar chemical structures, and, if 
necessary, to suggest an approach for such an assessment. In their report (NRC, 2008) the 
committee strongly advised that risk assessment should group chemicals that cause common 
adverse outcomes; thus it should consider not only certain phthalates, but also other 
chemicals that could potentially cause the same health effects, instead of focusing exclusively 
on chemicals that are structurally or mechanistically similar, which is US EPA's current 
practice. Accordingly, phthalates and other agents that affect male reproductive development 
in animals, including antiandrogens, should be considered in a cumulative risk assessment. A 
focus solely on phthalates to the exclusion of other antiandrogens would be artificial and 
could seriously underestimate cumulative risk. This is different from current US EPA current 
practice, which often considers only chemicals that are structurally related, on the assumption 
that they exert their effects by similar mechanisms leading to a final health outcome. The 
NRC committee pointed out that this practice ignores how exposures to different chemicals 
may result in the same health effects.  
To the question of whether dose addition, independent action, or some other method 
should be used for estimating risk associated with phthalates and other antiandrogens, the 
committee concluded that the answer should be based on empirical data that directly test any 
proposed method. Results of the conducted mixture studies in laboratory animals with 
phthalates and/or other antiandrogens indicate that the mixture effects in each case are 
predicted well with dose addition methods, although a variety of mechanisms are involved. 
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Moreover, when the model predictions differed significantly, no case could be found in 
which independent action predicted mixture effects better than dose addition. Thus, the 
evidence supports the use of dose addition as an approximation in estimating cumulative risk 
posed by phthalates and other antiandrogens. 
There are several approaches for conducting cumulative risk assessment with the dose-
addition approach. This report outlines a few options, each having some advantages and 
disadvantages; it was left to the EPA to evaluate each option and determine which is most 
appropriate. 
The committee also recommended that the conceptual approach taken for phthalates - to 
consider chemicals that cause similar health effects - should also be applied when completing 
any cumulative risk assessment. For instance, the US EPA could evaluate the risk of 
combined exposures to lead, methylmercury, and polychlorinated biphenyls because all 
contribute to cognitive deficits consistent with IQ reduction in children, albeit by very 
different mechanisms. 
 
Other US administrations  
Other administrations dealing with the assessment of mixture toxicity general use 
additivity approaches similar to the hazard index. This is the case of The American 
Conference of Governmental Industrial Hygienists (ACGIH), of The Occupational Safety and 
Health Administration (OSHA) and of The National Institute of Occupational Safety and 
Health (NIOSH) for the evaluation of occupationally relevant combined exposures. The 
National Academy of Sciences also recommends a hazard index approach, where the sum of 
the ratios of the measured concentrations to the acceptable concentrations for the individual 
components has to be kept at levels equal to, or lower than, unity, to investigate multiple 
chemical exposures in freshwater aquatic systems (Kortenkamp et al., 2009).  
Another example of the use of concentration addition in an environmental context is the 
development of a Pesticide Toxicity Index (PTI) by the US Geological Survey, in charge of 
providing scientific information to help facilitate effective management of natural resources. 
This index combines measures of pesticide exposures of aquatic biota with acute toxicity data 
derived from laboratory assays to produce a single index for a sample or a site (USGS, 2006). 
The development of the PTI was limited to pesticide compounds routinely measured and to 
toxicity data readily available from existing databases. The PTI for a particular sample is the 
sum of toxicity quotients (measured concentration divided by the median toxicity 
concentration from bioassays) for each detected pesticide. Thus, the PTI is in effect an 
indicator of combined effects from pesticides that are to be expected under the assumption of 
concentration addition, and this approach is very similar to the sum of Hazard Quotients used 
by US EPA. 
The PTI can be calculated for specific groups of pesticides and for specific taxonomic 
groups, and although it does not determine whether water in a sample is toxic, its values can 
be used to rank or compare the toxicity of samples or sites on a relative basis for use in 
further analysis or additional assessments. The index is also useful for assessing the relative 
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contribution of specific pesticides to an overall assumed effect, but as the median toxicity 
values are based on short-term laboratory assays with high effect levels (50%), it may limit 
the usefulness of PTI for estimations of long-term effects. Moreover, the PTI makes 
allowance only for additive effects and does not take possible synergisms or antagonisms into 
account. Nevertheless, despite these limitations, the PTI’s make best use of available data and 
are a valuable tool for comparative assessments of water quality. 
Conclusion 
The US EPA approach to cumulative risk assessment has evolved over the years. 
However, approaches that can deal with more than additive combination effects are still 
lacking. Moreover, taking account of multiple chemicals via multiple routes is not always 
possible, which is both due to a lack of knowledge in key areas, and to an absence of 
appropriate data. For the estimation of risks from chemical mixtures, the EPA, ATSDR and 
other relevant bodies employ a variety of approaches, ranging from whole mixture 
approaches to component-based approaches, depending on the risk assessment context. Dose 
addition and independent action are both applied, and guidance advises when to use either 
concept. For specific groups of chemicals, including dioxins, organophosphates and 
polycyclic aromatic hydrocarbons, toxic equivalency factors are employed. 
4.2.2   Canada 
 
In 1994, the Canadian Federal Environmental Assessment Review Office published a 
reference guide describing an approach for addressing cumulative environmental effects 
under the Canadian Environmental Assessment Act (FEARO, 1994). Specifically, this 
reference guide reviews the concept of cumulative environmental effects, discusses the 
relevant requirements of the Act and proposes a framework for addressing cumulative 
environment effects under the Act.  
This reference guide was supplemented in 1999 with the The Practitioners Guide, 
providing further information on cumulative effects (CEAA, 1999). Cumulative effects are 
defined as "the effect on the environment which results from effects of a project when 
combined with those of other past, existing and imminent projects and activities", which 
"may occur over a certain period of time and distance". It considers the combined effects of 
human activities on ecosystems, including chemical pollution, global warming and loss of 
biodiversity. Thus, this assessment is not restricted to chemical effects. Moreover, it does not 
necessarily cover chemical mixture assessment issues. In 2007, the Canadian Environmental 
Assessment Agency released an updated policy statement (CEAA, 2007). 
In 2003, Health Canada issued a science policy notice on aggregate exposure and risk 
assessments (PMRA, 2003). Aggregate exposure and risk assessments involve the analysis of 
exposure to a single chemical by multiple pathways and routes of exposure. The pathways of 
exposure considered include the potential for pesticide residues in food and drinking water, as 
well as residues from pesticide use in residential, non-occupational environments. All 
potential, relevant routes of exposure (oral, dermal, inhalation) and pathways (through food, 
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drinking water and residential use) are analysed within an aggregate exposure assessment; 
however this document does not consider concurrent exposure to several chemicals. 
4.2.3   Guidance from major international bodies  
World Health Organisation (WHO) and the International Programme on Chemical Safety 
(IPCS)  
Through the International Programme on Chemical Safety (IPCS), the WHO works to 
establish the scientific basis for the sound management of chemicals, and to strengthen 
national capabilities and capacities for chemical safety.  
During the last 20 years, the IPCS has established and regularly re-evaluated toxic 
equivalency factors (TEFs) for dioxins and related compounds, for humans, mammals, birds 
and fish. These TEFs have been used for the risk management in UN Member States and 
adopted formally by a number of countries and supranational bodies. TEF values are re-
evaluated on a regular basis (preferably at five-year intervals); but the last re-evaluation of 
human and mammalian TEFs was carried out in 2005. As a result, a number of TEF values 
have been changed, notably for PCBs, octachlorinated congeners and pentachlorinated 
furans
24
, and the project has also served to update the database summarizing all studies 
published on the relative potency of dioxins, furans, and dioxin-like PCBs.  
Together with the FAO, the WHO also worked on the project to update the principles 
and methods for the assessment of chemicals in food, through the Joint FAO/WHO Expert 
Committee on Food Additives (JECFA), and the Joint FAO/WHO Meeting on Pesticide 
Residues (JMPR). In response to their need for general guidance for risk assessments, the 
IPCS sponsored the preparation of two Environmental Health Criteria (EHC) monographs, 
EHC 70 (Principles for the safety assessment of food additives and contaminants in food) and 
EHC 104 (Principles for the toxicological assessment of pesticide residues in food). FAO and 
WHO have also initiated a joint Project to update and consolidate principles and methods for 
the risk assessment of chemicals in food. A website has been set up to provide reports and 
other information on the project as they become available
25
, but the information available on 
this website does not indicate that combination effects of pesticides and/or food additives will 
be taken into account (Kortenkamp et al., 2009). Reports have also been published in 2008, 
2010 and 2012 to assess the risk from melamine, bisphenol A and histamine exposure 
through food intake. 
In 2001, the IPCS also developed a coherent framework for integrated risk assessment. 
IPCS define the term integrated risk assessment as a science-based approach that combines 
the processes of risk estimation for humans, biota, and natural resources into one assessment. 
The report details this general framework and contains four case studies intended to illustrate 
the benefits of integrated risk assessment: persistent organic pollutants; UV radiation effects 
on amphibians, coral, humans and oceanic primary productivity; tributyltin and triphenyltin 
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compounds; and organophosphorous pesticides in the environment
26
. Considerations of the 
effects of sequential and simultaneous exposure to several chemicals are an integral part of 
the framework, but the specifics of mixture hazard characterisation are not described 
(Kortenkamp et al., 2009). 
In March 2007, the IPCS convened an international workshop on current issues in 
aggregate/cumulative risk assessment (i.e. the combined risk from exposure to one or more 
agents via all relevant routes and pathways), in order to discuss and review available methods 
for assessing combined risks from exposures to multiple chemicals, to develop working 
definitions for the different types of exposures, effects and risks of chemicals, and to initiate 
the development of a framework for assessment of risks to multiple chemicals.  
The workshop agreed on the following working definitions for key terms and concepts: 
• Exposure to the same chemical by multiple pathways and routes should be described as 
“Single Chemical, All Routes” (sometimes also referred to as “aggregate exposure”). 
• Exposure to “Multiple Chemicals by a Single Route” should be distinguished from 
“Multiple Chemicals by Multiple Routes”, and both these possibilities are the topic of the 
framework development. 
• Chemicals that act by the same mode of action and/or at the same target cell or tissue 
display “Dose Additive” combination effects. 
• Where chemicals act by diverse modes of action or at different target cells or tissues, 
the combined effects are “Effects Additive” or “Response Additive”. 
• Synergy and antagonism are defined as departures from dose additivity, not response 
additivity. 
• “Mode of Action” is a biologically plausible sequence of key events that lead to an 
observed effect. 
• “Mechanism of Action”, in contrast, involves a sufficient understanding of the 
molecular basis for an effect so that causation can be established. 
The workshop also proposed a preliminary framework for consideration of risk from 
exposure to multiple chemicals, which is intended as an iterative process involving step-wise 
consideration of exposures and hazards in several tiers, depending on the data available to 
support the analysis (WHO, 2009). 
The analysis begins with a consideration of the potential for cumulative exposure, before 
any assessments of hazards take place. In its first tier, the workshop report recommends 
adopting dose addition, if there is no evidence for synergisms or antagonisms. Chemicals to 
be subjected to this procedure should be grouped according to their chemical structure, 
similarity of target tissue and/or similarity in the manifestation of toxicity. Should the 
combined risks turn out to be not acceptable, the assessment should be refined further by 
additional consideration of temporal aspects of the common toxic effect, the presence of a 
common metabolite, analysis of key biological targets and consideration of information about 
environmentally relevant mixture ratios and exposure levels (Kortenkamp et al., 2009). 
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The IPCS Framework and several case studies (on carbamates, commercial hexane, food 
additives, application of TTC in the assessment of chemical mixtures found in surface water, 
and pharmaceuticals in surface waters) were further developed during 2010 and subsequently 
published (Meek et al., 2011; OECD, 2011b), and needs for further work on combined 
exposures were identified (OECD, 2011b). 
The WHO also published in 2012, as part of collaboration with the United Nation 
Environment Programme (UNEP), a "State of the Science of Endocrine Disrupting 
Chemicals (WHO-UNEP, 2012). This document is not strictly a guidance document but it is 
an update of the scientific knowledge, including main conclusions and key concerns, on 
endocrine disruptors. The authors express the view that EDCs are a concern to public and 
wildlife health and that EDCs represent a challenge, as their effects depend on both the level 
and timing of exposure, being especially critical when exposure occurs during development. 
Moreover, this document highlights the reality of simultaneous exposure to many EDCs; 
thus, it is argued that the measurement of the linkage between exposure to mixtures of EDCs 
and disease or dysfunction is more physiologically relevant than a focus on linking one EDC 
to one disease, which it is claimed may severely underestimate the disease risk from such 
mixtures. EDCs might act at low levels of exposure, and might exhibit dose-response curves 
that are non-linear and potentially non-monotonic (WHO-UNEP, 2012). According to 
EFSA's Scientific Committee (EFSA, 2013e) (EFSA, 2013) the debate is evolving in the 
scientific community as to the existence and/or relevance of low-dose effects and NMDRs in 
(eco)toxicology in relation to endocrine disruption or other endpoints/modes of action, but 
still lacks consensus. More work needs to be conducted to agree the definitions of the 
respective terms, and in practical terms to consider whether or how it could impact upon risk 
assessment (i.e. assessment of dose response relationships for adverse effects) and testing 
strategies. 
In this context, the WHO report concludes that new approaches are needed to examine 
the effects of mixtures of EDCs on disease susceptibility and etiology. Moreover, since only a 
narrow spectrum of chemicals and a few classes of EDCs have been assessed, a more 
comprehensive assessment of human and wildlife exposures to diverse mixtures of EDCs are 
needed. 
Organisation for Economic Co-operation and Development (OECD) 
Over the last 40 years, the OECD Chemicals Programme has been helping its member 
governments to develop and implement high-quality chemicals management policies and 
instruments. OECD countries now have science-based, rigorous and comprehensive systems 
for assessing and managing the risk of chemicals.   
A key mission of the OECD is to work for mutual acceptance of data on the hazardous 
effects of chemicals. In this context, many of the activities focus on the development of 
guidelines for chemicals testing. However, the OCDE also established a Cooperative 
Chemicals Assessment Programme (CoCAP), based on the previous High Production 
Volume (HPV) Chemicals Programme, to better respond to the needs of member countries. 
The programme specifically addresses a number challenges, such as assessing more 
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chemicals in a shorter period of time, addressing all chemicals on the market, or avoiding 
duplication of on-going work in other countries. In this context, the programme put in place a 
forum to exchange experience among member countries to avoid duplication of effort and 
identify issues for collaborative work, amongst which the effects from exposure to multiple 
chemicals
27
. 
OECD has produced guidance on limiting the number of toxicological tests to be carried 
out by grouping chemicals into closely related categories (OECD, 2007), a category being "a 
group of chemicals whose physico-chemical and human health and/or environmental 
toxicological properties and/or environmental fate properties are likely to be similar or follow 
a regular pattern as a result of structural similarity". The similarities may be based on 
common functional group(s), common constituents or chemical classes, similar carbon range 
numbers (which is frequent with complex substances known as “substances of Unknown or 
Variable composition, Complex reaction products or Biological material” or UVCB 
substances); an incremental and constant change across the category; or the likelihood of 
common precursors and/or breakdown products, via physical or biological processes, which 
result in structurally similar chemicals (e.g. the “metabolic pathway approach” of examining 
related chemicals such as acid/ester/salt). An updated version of this guidance should be 
published this year. 
In this so-called category approach, data for chemicals and toxicological endpoints that 
have been tested are used to estimate the corresponding properties of untested chemicals, to 
avoid supplementary testing. In principle, this approach can also be used to define groups of 
chemicals to be subjected to mixtures risk assessment. An example is the TEQ approach, 
used for polychlorinated dioxins and furans (PCDD/F), which was originally designed to 
estimate the toxicity of untested congeners but which has matured into a framework for 
assessing mixtures of PCDD/F. In 2011, OECD published a new Series on Testing and 
Assessment on forming chemical categories based on mechanistic information and on the 
Adverse Outcome Pathway (AOP) (OECD, 2011a). This document reviews the knowledge 
on mechanism or MOA in the context of key events or processes that lead to specific adverse 
outcomes that are used in RA; proposes how to organise scientific data on mechanism or 
MOA as key events; and examines a series of case studies using adverse outcome pathways. 
This document also recognized that AOPs provide a means of supporting assessment of 
combined exposure to multiple chemicals within and across AOPs. 
European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC) 
Established in 1978, ECETOC is a European industry association that develops and 
promotes science in human and environmental risk assessment of chemicals. 
In its report “Aquatic Toxicity of Mixtures” (ECETOC, 2001), ECETOC emphasized the 
need for practical methods to deal with the possibility that mixtures of chemicals present in 
aquatic systems express additive effects, even when individual substances are present at 
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concentrations not expected to lead to chronic toxicity on their own. Five approaches were 
listed and are presented in Table 7 along with their advantages and disadvantages. 
More recently, ECETOC published a new guidance document on the same issue 
(ECETOC, 2011a). Acknowledging the fact that the use of modelling to predict the toxicity 
of mixtures allows implementation of prospective risk assessment schemes, applicable when 
environmental mixtures can be reliably predicted (i.e. in product assessment, where the 
product is a mixture, or where joint emissions can be adequately predicted and quantified), it 
was recognized that, once released into the environment, relative concentrations of the 
constituents and the associated risk will change. In this case predicting the chemicals to 
which an environment is exposed is difficult and often impossible. In this context, this 
document presents a framework which retrospectively allows the evaluation of the potential 
impact of chemicals or chemical mixtures in the environment. The suggested approach is 
shown in Figure 13. 
The starting point for assessing the potential ecological impact of a chemical or chemical 
mixture is having an understanding of the reference condition, and to identify an impact when 
the "ecological status" of a site is compared to the ecological reference. Then, well 
established methods such as Whole Effluent Testing (WET) and Direct Toxicity Assessment 
(DTA) can be successfully employed to confirm or not, that chemicals are responsible. This 
can then be followed by Toxicity Identification Evaluation (TIE), Effect Directed Analysis 
(EDA) or Bioassay Directed Fractionation (BDF) to identify the toxic components within 
effluents or environmental samples allowing effective management.  
If an environmental impact has no obvious cause, then causal analysis approaches should 
be employed to investigate and determine which stressors are the most probable cause of the 
impact (i.e. habitat, conventional pollutants, natural perturbation such as invasive species, or 
anthropogenic stressors such as toxic chemicals). 
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Table 7: Approaches to assess aquatic toxicity of mixtures 
Toxic unit summation using 
actual environmental 
concentrations 
PEC/PNEC summation 
 
Use of a correction factor to 
modify individual chemical 
assessments 
Environmental 
monitoring 
 
Biological field 
monitoring 
Principles:  
-Individual substances are 
identified and their concentrations 
are measured.  
-For each chemical, QSAR-based 
toxicity values (NOECs, LC50…) 
are derived to establish TU.  
-TU are summed up, if ∑TU > 1, 
further evaluations are considered. 
 
Advantage: -Only substances 
actually present in the environment 
are included 
-Used of measured value. 
 
 
Weakness: -Approach  only viable 
if the number of chemicals is low, 
as the identification and 
quantification of chemicals is time 
consuming, analytical methods 
may be lacking, and special 
problems may arise when the limit 
of detection is larger than the 
biologically effective 
concentrations of chemicals (as is 
the case with some hormonally 
active chemicals). 
Principles: Use of predicted 
values (PEC; PNEC) which 
are relatively easily available 
for a large number of 
chemicals. 
 
 
 
 
Advantages: -Straightforward 
approach, uses of available 
data  
- Does not require (initially) 
environmental measurements.  
 
Weakness: Predicted values 
may not always be reliable 
and may over-estimate risks 
where individual PEC/PNEC 
ratios are overly conservative. 
 
 
Principles: This approach aims to 
adapt and modify existing RA 
procedures for individual chemicals 
by applying a “mixtures correction 
factor” to each individual substance. 
It is based on conventional RA for 
deriving PEC/PNEC ratios, but 
determines ratios of PEC to PNEC 
times X, where X is the number of 
chemicals also present in a mixture. 
 
Advantage: Ease of use, especially on 
a case-by-case basis 
 
 
Weakness: X, the number of 
chemicals occurring together with the 
one to be assessed, is largely 
unknown, and may fluctuate. 
Assumption that substances are 
present at concentrations proportional 
to their PEC/PNEC ratios: more 
prevalent substances would be 
weighted in the same way as all 
others, leading to a skewed analysis 
of the situation. 
 
Principles: Chemical 
and/or biological 
monitoring techniques, e.g. 
biomimetic approaches 
using membrane devices, 
can provide valuable 
surrogate measures of 
bioavailable substances. 
 
 
Advantages: Relatively 
easy to use  
 
 
 
Weakness: Poorly  
validated methods 
 
Principles: Well established 
approach to assess whether 
effects have actually 
occurred in ecosystems.  
 
 
 
 
 
 
Advantages: Provides an 
integrated biological picture; 
chemical measurements are 
unnecessary if effects are not 
observed.  
 
Weakness: In case of 
noticeable effects, causes are 
difficult to establish, 
monitoring techniques are 
not protective because they 
can establish effects only 
after they have occurred. 
 
 
TU: Toxic Unit, ratio of concentration to toxicity value; PEC: predicted environmental concentrations; PNEC: predicted no-effect concentration
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Figure 13: Suggested approach to assessment of ecologic risk of mixtures of chemicals in the 
aquatic environment (ECETOC, 2011a) 
TSS: Total Suspended Solids, BOD: Biological Oxygen Demand; SPEAR: Species at risk, CADDIS: Causal 
Analysis/Diagnosis Decision Information System; WET: Whole Effluent Testing, DTA: Direct Toxicity 
Assessment, TIE: Toxicity Identification Evaluation, EDA: Effects Directed Analysis; WoE: Weight of 
Evidence; WLR: Weighed Logistic Regression  
Source: European Centre for Ecotoxicology and Toxicology of Chemicals ( http://www.ecetoc.org) 
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ECETOC also held a Workshop on combined exposure to chemicals in 2011(ECETOC, 
2011b). The resulting report focuses on the state of the science and on technical aspects of 
co-exposure, and discusses reliable and pragmatic approaches to risk assessment of combined 
exposure to chemicals. 
It was recognized that according to available evidence, the toxicity of mixtures is often 
dominated by a few of their components, which should be identified at an early stage. In this 
context, the Maximum Cumulative Ratio (MCR) approach was suggested as a useful tool for 
both human health and environmental risk assessments. It was also suggested to develop a 
tiered approach beginning with limited data and a high degree of conservatism, moving if 
necessary to a requirement of more realistic data and a reduction in conservatism and 
increased expert input. TTC or an equivalent approach would be a potentially important 
element of the lower tier assessment.  
Further research needs were also identified, such as better understanding of mode of 
action, improved methodologies of exposure assessment including assimilation of better 
databases and data processing methods. The TTC approach and non-testing methods would 
also needs further development for use in this context; and the development of transparent, 
scientifically-valid criteria for prioritising combinations that need to be assessed, and 
considering interactions where exposure to biological or physical stressors is currently near 
the threshold of effects, was suggested as a next step. 
European Chemical Industry Council (CEFIC)  
CEFIC also proposed a two-step approach (Price et al., 2012) for the evaluation of 
human and ecological effects from exposures to multiples chemicals from a single or multiple 
sources. The first step consists of a screening tool which aims at identifying those cases 
where effects from combinations of chemicals might be of potential concern and need further 
risk management measures. If yes, the second step consists of the use of a decision tree 
proposing a "Tiered risk assessment" and building on existing Europe Scientific Committee's 
decision tree and the WHO framework for mixtures, and incorporating the recently developed 
MCR tool (cf. Table 1). This decision tree, shown in Figure 14, allows four different groups 
of combined exposures to be identified, each of which requires different strategies for 
managing the effects: 
Group I: combined exposures of concern because one or more individual chemicals are a 
concern; thus there is a need to address the chemical specific concerns for the exposures and 
efforts to refine the assessment need to focus on the chemicals of concern. 
Group II: combined exposures of low concern for both individual chemicals and for their 
combined effects; this group can be set aside as a low concern when evaluating combined 
exposures. 
Group III: combined exposures of low concern for individual chemicals but of concern for 
the combined effects. This is the critical group for further assessments since the concern for 
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these exposures cannot be identified using a chemical-by-chemical approach. This group is 
further divided into two subgroups:  
- Group IIIA, where one chemical provides the majority of toxicity of the combined 
exposure; this chemical should be the focus of either refining the risk assessment or reducing 
exposure. 
- Group IIIB, where no chemical dominates the toxicity of the exposure. Group IIIB 
exposures need to be the focus for refining the assessment by developing data on the modes 
of action (MoAs) for the chemicals that drive the toxicity of exposures.  
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Figure 14: CEFIC decision tree  
Red: European Scientific Committees' decision tree; green: WHO framework for mixtures.  
Source: The European Chemical Industry Council (http://www.cefic.org/) 
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Convention for the protection of the marine environment of the North-East Atlantic 
(OSPAR)  
OSPAR is the mechanism by which fifteen governments of the western coasts and 
catchments of Europe, together with the European Union, cooperate to protect the marine 
environment of the North-East Atlantic. To answer the requirements set out in §3 of OSPAR 
2012/5 Recommendation for a Risk-based Approach (RBA) to the Management of Produced 
Water Discharges from Offshore Installations (OSPAR, 2012b), OSPAR published 
guidelines providing general guidance when undertaking ERA for all produced water 
discharges offshore (OSPAR, 2012a). 
The RBA follows principles of environmental risk assessment already in use in the EU 
(ECHA -TGD) and US (US-EPA Guidance on risk assessment). The RBA approach has as 
far as possible been aligned with ECHA guidelines on risk assessment for single chemicals, 
and the assessment of mixtures was developed according to the best scientific practice. 
The first step in the RBA process is data collation, in which information on the discharge 
is collected. The risk is determined using combined information from Hazard Assessment 
(Step 2) and Exposure Assessment (Step 3).  
In the hazard assessment step, the inherent capacity of the discharge to cause adverse 
effects is evaluated, either on the basis of properties of the effluent (with a PNEC based on 
whole effluent testing and the use of an assessment factor) or of the individual substances. 
This last case requires derivation of PNECs from single species laboratory toxicity tests 
(preferably NOEC), and the grouping of substances based on a combination of the chemical 
structure, toxic mode of action and toxicity of the substance. The toxicity of the group will 
then be represented by the PNEC of representative chemicals in the group.  
In step 3, an exposure assessment is carried out to derive the PECs for the receiving 
environment around an offshore installation. The assessment can also be based on the 
effluent as a whole or on the combination of individual substances. The output will be then 
respectively the concentration of produced water effluent (PEC) in the receiving 
environment, expressed as a percentage of the original effluent or the concentration of 
substances discharged with the produced water in the receiving environment (PEC). The PEC 
can be determined by modelling the concentrations in the receiving environment, by use of a 
1-, 2- or 3-dimensional dilution/dispersion model. It should be demonstrated that dilution is 
not overestimated by the model by use of (peer reviewed) field validation study(s). If 
available, a model that takes account of different fate processes should be used, in order to 
provide a more accurate PEC. 
In step 4, a risk characterisation is carried out by comparing the predicted environmental 
concentration of the substance and/or the effluent (PEC) and the hazard (PNEC) at a given 
distance as a minimum. The risk can be further characterised by identification of the 
contribution of the individual substances (both naturally occurring and man-added 
substances) or groups of substances (e.g. through TIE/EDA) to the overall risk. If risk 
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estimates are calculated on a substance based approach, the PEC/PNEC ratios for the 
individual identified substances should be combined to calculate the overall risk estimate for 
the produced water. As ECHA does not provide guidance for mixtures, this guideline 
recommends a combined approach based on species sensitivity distributions (Appendix 7). If 
needed, the risk characterisation can be refined by reducing uncertainties (as uncertainties 
lead to high assessment factors in the derivation of the PNEC), by collecting additional data 
and/or undertaking additional toxicity testing to obtain more reliable PNECs, or by obtaining 
more advanced dilution/fate modelling for instance.  
Then, in step 5 (risk management) and 6 (monitoring), contracting parties should review 
management options, evaluate measures and develop and implement site-specific actions to 
reduce those risks which are not adequately controlled. Monitoring is used in order to verify 
the effectiveness of any risk management measures. It may also be used to detect changes in 
the discharge and in the receiving environment. 
Conclusions 
 
Although overarching analytical frameworks offer general guidance on ways to 
evaluate cumulative risk, we often lack adequate scientific knowledge and understanding 
about exposures, health or environmental effects, and the link between exposure and effects 
to implement them fully. The reality is that quantitative analyses are impractical in the 
context of many real-world problems because data on interactions among environmental 
stressors are scarce, information on place- and population-specific exposures is lacking, and 
verified mechanistic models relating exposure to effect are unavailable. 
The situation is complex and different with regard to prospective or retrospective risk 
assessment. With regard to prospective risk assessment the definition of environmentally 
relevant mixtures (i.e. mixture composition: number, identity and concentrations of 
individual substances) is generally considered easier than for retrospective risk assessment, 
but still not without problems.  
Dose addition (or concentration addition) has found widespread acceptance as an 
assessment concept for chemical mixtures if there is no evidence for synergistic or 
antagonistic behaviour and is extensively used by US authorities, regulatory and International 
bodies. 
Less clarity exists in deciding on criteria for choosing the chemicals that are to be 
subjected to CRA by using dose (concentration) addition. Suggestions include the grouping 
of substances according to their chemical structure, similarity in toxicological mechanism or 
mode of action, target tissue and/or similarity in the manifestation of toxicity. However, 
narrowing similarity criteria might lead to the exclusion of chemicals that also contribute to 
joint effects, whereas inclusion of too many chemicals might render procedures of cumulative 
risk assessment unwieldy. 
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To conclude, the development of harmonised terminology and methodologies for 
human and environmental risk assessment of combined exposure to multiple chemicals is 
needed, as well as a consistent approach to the assessment of priority mixtures across the 
different EU regulations and directives. The development of methodologies for risk 
assessment of exposure to multiple chemicals combined with other stressors (e.g. biological 
hazards, physical agents) might also be proposed as a longer term objective. 
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List of abbreviations 
 a.s. Active substance 
ADI Acceptable Daily Intake 
AF Assessment/Adjustment Factor 
AOP Adverse Outcome Pathway 
ATE 
ATSDR 
Acute Toxicity Estimate 
Agency for Toxic Substances and Disease Registry 
BAT Best Available Techniques 
BDF Bioassay Directed Fractionation 
CAG Cumulative Assessment Group 
CEAA 
CEFIC 
CERCLA 
 
CLP 
CMG 
CMR 
CRA 
CSA 
DA 
DE 
DNEL 
DTA 
EC 
ECETOC 
ECHA 
ED 
EDA 
EDC 
EFSA 
EIA  
ELV 
EMA 
EQS 
EU 
FQPA 
ERA 
FAO 
FDA 
FEARO 
FOCUS 
Canadian Environmental Assessment Act 
European Chemical Industry Council 
Comprehensive Environmental Response Compensation and Liability 
Act 
Classification, Labelling and Packaging 
Common Mechanism Group 
Carcinogenic, Mutagenic and Reprotoxic 
Cumulative Risk assessment 
Chemical Safety Assessment 
Dose addition 
Daily exposure 
Derived No-effect-Levels 
Direct Toxicity Assessment 
European Commission 
European Centre for Ecotoxicology and Toxicology of Chemicals 
European CHemicals Agency 
Effective Dose 
Effect Directed Analysis 
Endocrine Disrupting Compound 
European Food Safety Authority 
Environmental Impact Assessment 
Emission Limit Value 
European Medicines Agency 
Environmental Quality Standard 
European Union 
Food Quality Protection Act 
Environmental Risk Assessment 
Food and Agriculture Organization of the United Nation 
Food and Drugs Administration 
Canadian Federal Environmental Assessment Review Office 
FOrum for Co-ordination of pesticide fate models and their Use 
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FQPA 
GHS 
 
GM 
GMO 
HEG 
HI 
HQ 
IA 
IPCS 
IPPC 
LC50 
LOAEL 
MEA 
MCR 
MCS 
MRL 
MOA 
MOE 
MS 
NATA 
NOAEL 
NRC 
OECD 
OSPAR 
 
PBPK/PD 
PBT 
PCB 
PCDD/F   
PEC 
PEF 
PNEC 
PPP 
PTI 
RA 
RBA 
RAGS 
RfC 
RfD 
RfPI 
RPF 
Food Quality Protection Act 
Globally Harmonised System of Classification and Labelling of 
Chemicals 
Genetically Modified 
Genetically Modified Organism 
Homogeneous Exposure Group 
Hazard Index 
Hazard Coefficient 
Independent Action 
International Programme on Chemical Safety 
Integrated Pollution Prevention and Control 
Lethal Concentration 50 
Low Observed effect Concentration 
Mechanism of Action 
Maximum Cumulative Ratio 
Multi-Constituent Substances 
Maximum Residue Level 
Mode Of Action 
Margin Of Exposure 
Member States 
National-Scale Air Toxics Assessment 
No Observed Adverse Effect Level 
National Research Council 
Organisation for Economic Co-operation and Development 
Convention for the protection of the marine environment of the 
North-East Atlantic 
Physiologically-Based PharmacoKinetic/PharmacoDynamic 
Persistence, Bioaccumulation and Toxicity 
PolyChlorinated Biphenyl 
Polychlorinated dioxin and furan 
Predicted Environmental Concentration 
Potency Equivalency Factor 
Predicted No Effects Concentrations 
Plant Protection Products 
Pesticide Toxicity Index 
Risk Assessment 
Risk-Based Approach 
Risk Assessment Guidance for Superfund 
Reference Concentration 
Reference Dose 
Reference Point Index 
Relative Potency Factor 
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SE 
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TU 
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US EPA 
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WHO 
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Reference value 
Scientific Committee for Consumer Safety 
Scientific Committee on Emerging and Newly Identified Health 
Risks 
Scientific Committee on Health and Environmental Risks 
Short-term Exposure 
Soil Framework Directive 
Toxic Equivalency factor 
Toxicity Identification Evaluation 
Threshold of Toxicological Concern 
Target organ Toxicity Dose 
Toxic Unit 
Uncertainty Factor 
United States Environmental Protection Agency 
Substances of Unknown or Variable composition, Complex reaction 
products or Biological materials 
very Persistent, very Bioaccumulative 
Whole Effluent Testing 
Water Framework Directive 
World Health Organization 
Weight-Of-Evidence 
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Glossary 
Acute toxicity: Adverse effects of finite duration occurring within a short time (up to 14 d) after 
administration of a single dose (or exposure to a given concentration) of a test substance or after 
multiple doses (exposures), usually within 24 h of a starting point (which may be exposure to the 
toxicant, or loss of reserve capacity, or developmental change, etc.).  
 
Additive effect: Effect observed after exposure to two or more chemical agents which act jointly but 
do not interact. The total effect is the simple sum of the effects of separate exposure to the agents 
under the same conditions.  
 
Adverse effect: Change in the morphology, physiology, growth, reproduction, development or 
lifespan of an organism which results in impairment of functional capacity to compensate for 
additional stress or increased susceptibility to the harmful effects of other environmental influences  
 
Aggregate risk: Risk associated with all pathways and routes of exposure to a single chemical.  
 
ARfD (Acute reference dose): Estimate of the amount of substance in food and/or drinking water, 
expressed on a body weight basis, that can be ingested over a short period of time, usually during one 
day, without appreciable risk to the consumer on the basis of the data produced by appropriate studies 
and taking into account sensitive groups within the population (e.g. children and the unborn).  
 
Chronic effect: Consequence that develops slowly and/or has a long lasting course: may be applied 
to an effect that develops rapidly and is long-lasting.  
 
Coincidental mixtures: mixtures that are composed of unrelated chemicals from different sources, 
but having the potential to reach the same "receptor population", e.g. by their presence in or migration 
into the same medium (e.g. groundwater), or through multiple pathways. 
 
Combined exposure: exposure of the same person to the same substance in the same setting via 
different routes of entry into the body or from different products containing the same substance. It 
might be considered to be synonymous with "aggregate exposure".  
 
Combined toxicity: Response of a biological system to several chemicals, either after simultaneous 
or sequential exposure. It can take three possible forms: dose-addition, response-addition or 
interaction.  
 
Common mechanism group: Group of chemicals determined to cause a common toxic effect by a 
common mechanism of toxicity  
 
Common mechanism of toxicity: Pertains to two or more substances that cause a common toxic 
effect to experimental animals or to human health by the same, or essentially the same, sequence of 
major biochemical events. Hence, the underlying basis of the toxicity is the same, or essentially the 
same, for each chemical.  
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Common toxic effect: Two or more substances that are known to cause the same toxic effect in or at 
the same anatomical or physiological site or location (e.g. same organ or tissue). Thus, a toxic effect 
observed in studies involving animals exposed to a pesticide is considered common with a toxic effect 
caused by another chemical if there is concordance with both site and nature of the effect.  
 
Cumulative assessment group (CAG): Group of active substances that could plausibly act by a 
common mode of action, not all of which will necessarily do so. The first and most conservative level 
of grouping is based on the organ or organ system level being the target of the pesticide toxicity 
(CAG 1). Further refinement to form a second level of grouping (CAG 2) is based on the 
identification and characterisation of specific effects in the organ or organ system.  
 
Cumulative risk: Several definitions of this term are given depending on the context. In Europe, it is 
intended to be the risk deriving from the exposure to compounds that share the same mode of action 
(dose addition) or that have similar effects but do not act at the same molecular target (response 
addition) and is contrasted to synergistic risk (EFSA 2008b). Regarding pesticides, it has been defined 
as the risk resulting from exposure to more than one active substance via the diet (EFSA 2013c). The 
US EPA defines cumulative risk as the combined risk from aggregate exposure to multiple agents or 
stressors which may include chemical, as well as biological or physical agents (USEPA 2003). 
 
Dissimilar mode of action: Occurs where the mode of action and possibly, but not necessarily, the 
nature and sites of toxic effects differ between the chemicals in a mixture, and one chemical does not 
influence the toxicity of another. The effects of exposure to such a mixture are the combination of the 
effects of each component compound (also referred to as response-addition).  
 
Dose addition: see similar mode of action.  
 
Generated mixtures: mixtures that contain additional compounds that are by-products of processes 
involved (e.g. smelting, drinking water disinfection, fuel combustion); they are usually originating 
from a single source.  
 
Hazard: Inherent property of an agent (e.g. pesticide) or situation having the potential to cause 
adverse effects when an organism, system, or (sub-) population is exposed to that agent or situation.  
 
Hazard assessment: Process that includes hazard identification and characterisation and focuses on 
the hazard in contrast to risk assessment where exposure assessment is a distinct additional step.  
 
Hazard characterisation: Qualitative and, wherever possible, quantitative description of the inherent 
property of an agent or situation having the potential to cause adverse effects. This is the second stage 
in the process of hazard assessment.  
 
Hazard identification: Identification of the type and nature of adverse effects that an agent has an 
inherent capacity to cause in an organism, system, or (sub) population. This is the first stage in the 
process of hazard assessment.  
 
Hazard index (HI): Sum of Hazard Quotients, i.e. ratios between exposure and the reference value 
for the common toxic effect of each component in a mixture or a CAG.  
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Index Compound (IC): The chemical used as the point of reference for standardizing the common 
toxicity of the chemical members of the CAG. The index compound should have a clearly defined 
dose-response, be well defined for the common mechanism of toxicity, and have a 
toxicological/biological profile for the common toxicity that is representative of the CAG. 
 
Intentional mixtures: mixtures that are intentionally manufactured as such (i.e. regulated and 
manufactured products such as pesticide formulations or laundry detergent). 
 
Interaction: Umbrella term for synergies (mixture effects greater than expected) and antagonisms 
(mixture effects smaller than expected). Interactions can be judged in relation to additivity 
expectations derived from dose addition or independent action 
 
Mechanism of action: Detailed explanation of the individual biochemical and physiological events 
leading to a toxic effect  
 
Mechanism of toxicity: Mechanism of toxicity is defined as the steps leading to a toxic effect 
following interaction of a pesticide with biological targets. All steps leading to an effect do not need 
to be specifically understood. Rather, it is the identification of the crucial events following chemical 
interaction that are required to describe a mechanism of toxicity. In the context of this document, 
mechanism of toxicity refers to the mechanism by which a pesticide is toxic to humans or 
experimental animals and plants, and not the mechanism by which it is toxic to target or intended 
species (i.e. its mechanism of pesticidal action). With some pesticides, however, the mechanism 
responsible for causing toxicity to humans or experimental animals and plants is similar to the 
mechanism of pesticidal action. 
 
Mode of action (MoA): Biologically plausible sequence of key events leading to an observed effect 
supported by robust experimental observations and mechanistic data. It refers to the major steps 
leading to an adverse health effect following interaction of the compound with biological targets, it 
does not imply full understanding of mechanism of action at the molecular level.  
 
Pathway of exposure: The physical course a chemical takes from the source to the organism exposed 
(e.g., through food/feed, drinking water, emissions etc.). 
 
Response addition: see dissimilar mode of action  
 
Risk assessment: Process intended to calculate or estimate the risk to a given target organism, 
system, or (sub-) population, including the identification of attendant uncertainties, following 
exposure to a pesticide or agent of concern as well as the characteristics of the specific target system. 
It is the first component in a risk analysis process. 
 
Route of exposure: Means by which a chemical enters an organism after contact (e.g., ingestion, 
inhalation, or dermal absorption). 
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Similar mixtures: mixtures having the same chemicals but in slightly different proportions or having 
most but not all chemicals in common and in highly similar proportions. Similar mixtures are thus 
expected to have similar fates, transports, and health effects. 
 
Similar mode of action: Describes the mode of action when all chemicals in the mixture act by the 
same mechanism/mode of action, and differ only in their potencies. The effects of exposure to a 
mixture of these compounds are assumed to be the sum of the potency-corrected effects of each 
component (also referred to as dose-addition). 
 
Substances: Chemical elements and compounds, as they occur naturally or by manufacture, including 
any impurity inevitably resulting from the manufacturing process.  
 
Synergism: Pharmacological or toxicological interaction in which the combined biological effect of 
two or more substances is greater than expected on the basis of the simple summation of the toxicity 
of each of the individual substances.  
 
Toxic effect: Effect known (or reasonably expected) to occur in experimental animals/plants and 
presumably in humans that results from exposure to a chemical substance and that will or can 
reasonably be expected to endanger or adversely affect the human or environmental health. 
 
Toxic equivalency factor (TEF): Ratio of the toxicity of a chemical to that of another structurally 
related chemical (or index compound) chosen as a reference. 
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Annex 
Guidance Documents 
US EPA 
Guidelines for the health assessment of Chemical Mixtures. US EPA, 1986 
   This document aims to generate a consistent approach for evaluating data on the chronic 
and subchronic effects of chemical mixtures and to set forth principles and procedures to 
guide EPA scientists in the conduct of risk assessments, acknowledging that most instances 
of environmental contamination involve concurrent or sequential exposures to a mixture of 
compounds that may induce similar or dissimilar effects over exposure periods ranging from 
short-term to lifetime. In these Guidelines, mixtures are defined as any combination of two or 
more chemical substances regardless of source or of spatial or temporal proximity; a complex 
mixtures might be made of related compounds produced as commercial products and 
eventually released to the environment, or consisting of scores of compounds that are 
generated simultaneously as byproducts from a single source or process. I might also consists 
of compounds, often unrelated chemically or commercially, which are placed in the same 
area for disposal or storage, eventually come into contact with each other, and are released as 
a mixture to the environment. 
   This report emphasizes broad underlying principles of the various science disciplines 
(toxicology, pharmacology, statistics…) necessary for assessing health risk from chemical 
mixture exposure, and that risk assessments will be conducted on a case-by-case basis, giving 
full consideration to all relevant scientific information. Agency scientists will identify the 
strengths and weaknesses of each assessment by describing uncertainties, assumptions, and 
limitations, as well as the scientific basis and rationale for each assessment. The Agency may 
also be required to take action because of the number of individuals at potential risk or 
because of the known toxicologic effects of these compounds that have been identified in the 
mixture The prediction of how specific mixtures of toxicants will interact must be based on 
an understanding of the mechanisms of such interactions. No single approach to risk 
assessments for multiple chemical exposures is recommended in these Guidelines, but 
guidance is given for the use of several approaches depending on the type of mixture, the 
known toxic effects of the components, and the nature and quality of the available data. 
Given the complexity of this issue and the relative paucity of empirical data from which 
sound generalizations can be constructed, emphasis must be placed on flexibility, judgment, 
and a clear articulation of the assumptions and limitations in any risk assessment that is 
developed. 
   The basic assumption in the recommended approach is that it is preferable to base the risk 
assessment on data from the mixtures of  concern or similar mixture. If data are available on 
the mixture of concern, the preferred approach for predicting the effects of subchronic or 
chronic exposure will be to use subchronic or chronic health effects data and adopt 
procedures similar to those used for single compounds, either systemic toxicants or 
carcinogens, although keeping in mind that dose-response models used for single compounds 
are often based on biological mechanisms of the toxicity of single compounds, and may not 
be as well justified when applied to the mixture as a whole. Factors such as the persistence of 
the mixture in the environment, the variability of the mixture composition over time and the 
possible different rates of degradation in the environment should also be taken into account.  
   If data are available on several mixtures of the same components that have different 
component ratios which encompass the temporal or spatial differences in composition of the 
mixture of concern, an attempt should be made to determine if significant differences exist 
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among the chemical mixtures, and ranges of risk can be estimated based on the toxicologic 
data of the various mixtures. If no significant differences are noted, then a single risk 
assessment may be adequate.  
   If data on the mixture are not available, the risk assessment might be based on data 
available on similar mixtures: (i.e., a mixture having the same components but in slightly 
different ratios, or having several common components but lacking one or more components, 
or having one or more additional components), a decision must be made whether the mixture 
on which health effects data are available is or is not “sufficiently similar” to the mixture of 
concern to permit a risk assessment. In determining reasonable similarity, consideration 
should be given to any information on the components that differ between the mixture on 
which health effects data are available and the mixture of concern. Particularly on any 
toxicologic or pharmacokinetic data on the components or the mixtures which would be 
useful in assessing the significance of any chemical difference between the similar mixture 
and the mixtures of concern. 
   In the case of a mixture containing carcinogens and toxicants, an approach based on the 
mixture data alone may not be sufficiently protective, as in a chronic study on a two-
components mixture of one carcinogen and one toxicant, the presence of the toxicant could 
mask the activity of the carcinogen (i.e at doses sufficient to induce a carcinogenic effect, the 
toxicant could induce mortality so that no carcinogenic effect could be observed). 
Consequently, the mixture approach should be modified to allow the risk assessor to evaluate 
the potential for masking, of one effect by another, on a case-by-case basis. 
   If the only data available are on mixture components, the risk assessment may be based on 
the toxic or carcinogenic properties of the components in the mixture. When little or no 
quantitative information is available on the potential interaction among the components, 
additive models are recommended for systemic toxicants. Nonetheless, dose additive models 
are not the most biologically plausible approach if the compounds do not have the same mode 
of toxicologic action. Consequently, depending on the nature of the risk assessment and the 
available information on modes of action and patterns of joint action, the Federal Register 
most reasonable additive model should be used. 
   For systemic toxicants, the risk assessment methodology used for single compounds most 
often results in the derivation of an exposure level which is not anticipated to cause 
significant adverse effects. Depending on the route of exposure, media of concern, and the 
risk assessments type, these exposure levels may be expressed in a variety of ways such as 
acceptable daily intakes (ADIs) or reference doses (RfDs), levels associated with various 
margins of safety (MOS), or acceptable concentrations in various media. For such estimates, 
the “hazard index” (HI) of a mixture based on the assumption of dose addition may be 
defined as: 
 
 HI = E1/AL1 + E2/AL2 +. . . + Ei/ALi (2-1) 
 
 where: Ei = exposure level to the i
th
 toxicant* and ALi = maximum acceptable level 
 for the i
th 
toxicant. 
 
   Since the assumption of dose addition is most properly applied to compounds that induce 
the same effect by similar modes of action, a separate hazard index should be generated for 
each end point of concern. Dose addition for dissimilar effects does not have strong scientific 
support, and, if done, should be justified on a case-by-case basis in terms of biological 
plausibility. The assumption of dose addition is justified when the mechanisms of action of 
the compounds under consideration are known to be the same. In any event, if a hazard index 
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is generated the quality of the experimental evidence supporting the assumption of dose 
addition must be clearly articulated. 
   The hazard index is only a numerical indication of the nearness to acceptable limits of 
exposure or the degree to which acceptable exposure levels are exceeded. As this index 
approaches unity, concern for the potential hazard of the mixture increases, if it exceeds 
unity, the concern is the same as if an individual chemical exposure exceeded its acceptable 
level by the same proportion.  
If dose-response curves are estimated for systemic toxicants, however, dose-additive or 
response additive assumptions can be used, with preference given to the most biologically 
plausible assumption. 
- For carcinogens, whenever linearity of the individual dose-response curves has been 
assumed (usually restricted to low doses), the increase in risk P, caused by exposure 
d, is related to carcinogenic potency B, as: 
P = d B  
For multiple compounds, this equation may be generalized to: 
P = ∑di Bi  
   This equation assumes independence of action by the several carcinogens and is equivalent 
tothe assumption of dose addition as well as to response addition with completely negative 
correlation of tolerance, as long as P < 1. An index for n carcinogens can be developed by 
dividing exposure levels (E) by doses (DR) associated with a set level of risk: 
HI = E1/DR1 + E2/DR2 +. . .+ En/DRn  
   The less linear the dose-response curve is, the less appropriate are those equations, perhaps 
even at low doses, and because of the uncertainties in estimating dose-response relationships 
for single compounds, and the additional uncertainties in combining the individual estimate 
to assess response from exposure to mixtures, response rates and hazard indices may have 
merit in comparing risks but should not be regarded as measures of absolute risk. 
   None of the above equations incorporates any form of interaction; if data are available that 
suggest that two or more components in the mixture may interact, such information must be 
assessed in terms of both its relevance to subchronic or chronic hazard and its suitability for 
quantitatively altering the risk assessment. If chronic or subchronic toxicity or 
carcinogenicity studies have been conducted that permit a quantitative estimation of 
interaction for two chemicals, then it may be necessary to use an interaction ratio (observed 
response divided by predicted response) to treat the two compounds as a single toxicant with 
greater or lesser potency than would be predicted from additivity. Other components of the 
mixture, on which no such interaction data are available, could then be separately treated in 
an additive manner. However, the use of an interaction ratio is useful only in assessing the 
magnitude of the toxicant interaction for the specific proportions of the mixture which was 
used to generate the interaction ratio. 
   The likelihood that other compounds in the mixture may interfere with the interaction of the 
two toxicants must also be taken into account. If this is likely, then a quantitative alteration of 
the risk assessment may not be justified, as in such cases, the risk assessment may only 
indicate the likely nature of interactions, either synergistic or antagonistic, and not quantify 
their magnitudes.  
For each risk assessment, the uncertainties regarding the composition of the mixtures, health 
effects, or exposures, should be clearly discussed and the overall quality of the risk 
assessment should be characterised 
   Assumptions and limitations are discussed in part 3 of the guidelines, regarding information 
interaction data, additivity models, and exposure. For example, the use of interaction data 
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from acute toxicity studies to assess the potential interactions on chronic exposure is highly 
questionable unless the mechanisms of the interaction on acute exposure were known to 
apply to low-dose chronic exposure. The use of information from two-component mixtures to 
assess the interactions in a mixture containing more than two compounds also is questionable 
from a mechanistic perspective, as the addition of a third compound which either chemically 
alters or affects the absorption of one of the first two compounds could substantially alter the 
degree of the toxicologic interaction. There is also some concerns with the use of interaction 
data on experimental mammals to assess interactions in humans. If systematic differences in 
toxic sensitivity to single chemicals exist among species, then it seems reasonable that the 
magnitude of toxicant interactions among species also may vary in a systematic manner. 
Thus, even if excellent chronic data are available on the magnitude of toxicant interactions in 
experimental mammal, there is uncertainty that the magnitude of the interaction will be the 
same in humans. 
   Finally, the guidelines are formulated in part to bridge gaps in risk assessment methodology 
and data. By identifying these gaps and the importance of the missing information to the risk 
assessment process, EPA wishes to encourage research and analysis that will lead to new risk 
assessment methods and data. 
 
Technical Support document on risk assessment of chemical mixtures (1988) United 
states environmental Protection Agency. Office of research and development. 
Washington, DC 20460. EPA/600/8-90/064 
  This document was recommended by the U.S. EPA's Science Advisory Board as a means of 
providing the broad technical background for the principles and procedures described in the 
"Guidelines for Health Risk Assessment of Chemical Mixtures". 
  Chapter 2 discusses the nature of the available information on three general categories of 
mixtures: complex mixtures, mixtures composed of a single class of chemicals and simple 
mixtures. This section intends to illustrate the difference between the types of information 
that are available on the various categories of mixtures. Emphasis is placed on the description 
of the tests used to assess the toxicity of the mixtures as well as the available methods and 
feasibility of these methods for quantitatively measuring interactions of the components in 
the mixtures. To conclude, this chapter discus on additional topics: interactions of 
carcinogens with other compounds, some results from the Agency's data base on mixtures 
and quantitative measures of interactions. 
  An overview of mechanisms of interaction is presented in chapter 3, which discuss the ways 
in which compounds may interact: direct chemical-chemical reactions that result in the 
formation of a different chemical species as well as the biological bases of toxicants 
interactions such as effects on absorption, distributions, metabolism, excretion and receptor 
site affinity.  
  Chapter 4 reviews the mathematical models and statistical procedures used to assess toxic 
interactions, including dose addition, response addition, generalized linear models, and 
response surface models. This chapter concludes with a critical review of statistical methods 
used in research article that are covered in the Agency's mixtures data base. 
  Chapter 5 reviews and reevaluates the guidelines on mixtures based on the agency's 
experience in applying these guidelines as well as considerations of new information that has 
been obtained and new approaches that have been proposed since the guidelines where 
developed. It separately discusses complex mixtures, similar mixtures and simple mixtures. 
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For complex mixtures, emphasis remains on in vivo bioassays, the applicability of which can 
be extended by the concept of sufficient similarity. Recognizing the highly variable nature of 
some complex mixtures as well as the difficulty and expense of obtaining good in vivo 
bioassays, the relative potency method, the "toxic equivalency factor" method and analogous 
methods based on in vitro assays, are more strongly endorsed than in the original guidelines. 
A limitation of dose addition is also discusses, primarily related to limitations of risk 
assessment of single compounds. 
  The report concludes (Chapter 6) with a brief outline of research needed to improve or 
validate the risk assessment procedures for mixtures. Because the reassessment of the 
guidelines relies heavily on the use of in vitro tests, emphasis is placed on the validation of 
such tests using whole animal assays.  
  The two most significant conclusions in the document are that the available literature is 
extremely poor for use in quantifying the extent of synergism expected from environmental 
exposures, and that validation of in vitro and short-term in vivo studies seems to be the most 
promising approach for assessment of complex mixtures. 
Risk Assessment Guidance for Superfund. Vol 1. Human Health Evaluation Manual. 
Part A. US EPA, 1989 
  The Comprehensive Environmental Response, Compensation, and Liability Act of 1980 
(CERCLA, or “Superfund), establishes a national program for responding to releases of 
hazardous substances into the environment. The National Oil and Hazardous Substances 
Pollution Contingency Plan (NCP) is the regulation that implements CERCLA. NCP 
establishes, among other things, the overall approach for determining appropriate remedial 
actions at Superfund sites. To help meet this Superfund mandate, EPA has developed a 
human health evaluation process as part of its remedial response program. The goal of this 
process is to provide a basic framework for developing health risk information at Superfund 
sites necessary to assist decision-making at remedial sites, and also gives specific guidance 
on appropriate methods and data to use.  
   Chapter 1 summarizes the human health evaluation process conducted during the remedial 
investigation and feasibility study (RI/FS). This methodology has been established for 
characterizing the nature and extent of risks posed by uncontrolled hazardous waste sites and 
for developing and evaluating remedial options. The three main parts of this process - 
baseline risk assessment, refinement of preliminary remediation goals, and remedial 
alternatives risk evaluation - are described in details in part A, B and C of the guidance 
document respectively. 
   The human health assessment process is involves in the baseline risk assessment and 
implies the following step: the project scoping, the site characterisation, and the feasibility 
study. 
   The purpose of the project scoping is to define the appropriate type and extent of 
investigation and analysis that should be undertaken for a given site. The main objectives of 
scoping are to identify the types of decisions that need to be made, to determine the types 
(including quantity and quality) of data needed, and to design efficient studies to collect these 
data. Potential site-specific modelling activities should be discussed to ensure that modelling 
results will supplement the sampling data and effectively support risk assessment activities. 
Project scoping implies the establishment of a conceptual model of the site to assist in 
evaluating the possible impacts of releases from the site on human health and the 
environment, considering in a qualitative manner the sources of contamination, potential 
pathways of exposure, and potential receptors. This is also the starting point for the risk 
assessment, as exposure pathways are identified for further investigation and quantification. 
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   During site characterisation, the sampling and analysis plan developed during project 
scoping is implemented and field data are collected and analysed to determine the nature and 
extent of threats to human health and the environment posed by the site, and to develop a 
baseline risk assessment. Part of the human health evaluation, this baseline risk assessment is 
an analysis of the potential adverse health effects (current or future) caused by hazardous 
substance releases from a site in the absence of any actions to control or mitigate these 
releases, which results are used to help determine whether additional response action is 
necessary at the site; modify preliminary remediation goals help support selection of the "no-
action" remedial alternative, where appropriate; and document the magnitude of risk at a site, 
and the primary causes of that risk. 
   After an initial planning stage, there are four steps in the baseline risk assessment process: 
data collection and analysis; exposure assessment; toxicity assessment; and risk 
characterisation.  
- Data collection and evaluation involves gathering and analysing the data relevant to 
the human health and identifying the substances present at the site that are the focus 
of the risk assessment process.  
- An exposure assessment is conducted to estimate the magnitude of actual and/or 
potential human exposures, the frequency and duration of these exposures, and the 
pathways by which humans are potentially exposed. In the exposure assessment, 
reasonable maximum estimates of exposure are developed for both current and future 
land-use assumptions. Current exposure estimates are used to determine whether a 
threat exists based on existing exposure conditions at the site. Future exposure 
estimates are used to provide decision-makers with an understanding of potential 
future exposures and threats and include a qualitative estimate of the likelihood of 
such exposures occurring. Conducting an exposure assessment involves analyzing 
contaminant releases; identifying exposed populations; identifying all potential 
pathways of exposure; estimating exposure point concentrations for specific 
pathways, based both on environmental monitoring data and predictive chemical 
modelling results; and estimating contaminant intakes for specific pathways. The 
results of this assessment are pathway-specific intakes for current and future 
exposures to individual substances.  
- The toxicity assessment considers: (1) the types of adverse health effects associated 
with chemical exposures; (2) the relationship between magnitude of exposure and 
adverse effects; and (3) related uncertainties such as the weight of evidence of a 
particular chemical’s carcinogenicity in humans, and typically relied heavily on 
existing toxicity information. This toxicity assessment is generally accomplished in 
two steps: hazard identification and dose-response assessment. Hazard identification 
aims at determining whether exposure to an agent can cause an increase in the 
incidence of an adverse health effect; it involves characterizing the nature and 
strength of the evidence of causation. Dose-response evaluation aims at quantitatively 
evaluating the toxicity information and characterizing the relationship between the 
dose of the contaminant administered or received and the incidence of adverse health 
effects in the exposed population. From this quantitative dose response relationship, 
toxicity values are derived that can be used to estimate the incidence of adverse 
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effects occurring in humans at different exposure levels.  
- The risk characterisation summarizes and combines outputs of the exposure and 
toxicity assessments to characterise baseline risk. During risk characterisation, 
chemical-specific toxicity information is compared against both measured 
contaminant exposure levels and those levels predicted through fate and transport 
modelling to determine whether current or future levels at or near the site are of 
potential concern.  
In situations where the results of the baseline risk assessment indicate that the site poses little 
or no threat to human health or the environment and that no further (or limited) action will be 
necessary, the FS should be scaled-down as appropriate. 
   The purpose of the feasibility study is to provide the decision-maker with an assessment of 
remedial alternatives, including their relative strengths and weaknesses, and the trade-offs in 
selecting one alternative over another. The FS process involves developing a reasonable 
range of alternatives and analyzing these alternatives in detail using nine evaluation criteria. 
Because the RI and FS are conducted concurrently, this development and analysis of 
alternatives is an interactive process in which potential alternatives and remediation goals are 
continually refined as additional information from the RI becomes available. 
   The next two chapters present additional background material for the human health 
evaluation process. Chapter 2 discusses statutes, regulations, guidance, and studies relevant to 
the Superfund human health evaluation, and chapter 3 discusses issues related to planning for 
the human health evaluation. The remainder of the manual is organized by the three parts of 
the human health evaluation process: the baseline risk assessment is covered in Part A of the 
manual (Chapters 4 through 10); refinement of preliminary remediation goals is covered in 
Part B of the manual; and the risk evaluation of remedial alternatives is covered in Part C of 
the manual. 
Chapters 4 through 8 provide detailed technical guidance for conducting the steps of a 
baseline risk assessment, and Chapter 9 provides documentation and review guidelines. 
Chapter 10 contains additional guidance specific to baseline risk assessment for sites 
contaminated with radionuclides. 
Supplementary Guidance for conducting health risk assessment of chemical mixtures. 
US EPA, 2000 
   This document has been published as a supplement to the EPA Guidelines for the Health 
Risk Assessment of Chemical Mixtures of 1986, in which the emphasis is on dose-response 
and risk characterisation. The principles and concepts put forth in the Guidelines remain in 
effect, but this document intends to provide more details on these principles and their 
applications.  
   The primary purpose of this document is to generate a consistent Agency approach for 
assessing health risks from exposures to multiple chemicals, denoted by the general term 
“mixtures.” The resulting mixtures risk assessments are intended to assist decision makers by 
characterizing health risks for the particular exposure conditions of interest. Because 
exposure scenarios and the available supporting data are highly diverse, this document has 
been developed as a procedural guide that emphasizes broad underlying principles of the 
various science disciplines (environmental chemistry, toxicology, pharmacology, statistics) 
necessary for providing information on the relationship between multichemical exposure and 
potential health effects. This document addresses only risks to human health from 
multichemical exposures (ecological effects are beyond its scope),  and focuses on 
procedures for dose-response assessment and risk characterisation 
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   After an overview of the background and scope, the document puts forth the risk 
assessment paradigm for mixtures, considering problem formulation, hazard identification, 
dose-response assessment, exposure, and risk characterisation. It suggests that a chemical 
mixture risk assessment should begin with an assessment of available data quality, which 
would then leads to the selection of a risk assessment method. The major concerns are 
whether the available data are on components or whole mixtures, whether the data are 
composed of either similar components or similar mixtures that can be thought of as acting 
by similar toxicologic processes, and whether the data may be grouped by emissions source, 
chemical structure, or biologic activity. 
   It describes detailed procedures for chemical mixture assessment using data on the mixture 
of concern, data on a toxicologically similar mixture, and data on the mixture component 
chemicals. The state of the science varies dramatically for these three approaches. The whole-
mixture procedures are most advanced for assessing carcinogenic risk, mainly because of the 
long use of in vitro mutagenicity tests to indicate carcinogenic potency. In vitro test 
procedures for noncancer endpoints are still in the pioneering stage. In contrast, the 
component-based procedures, particularly those that incorporate information on toxicologic 
interactions, are most advanced for noncarcinogenic toxicity.  
   New guidance is provided that gives more specific details on the nature of the desired 
information and the procedures to use in analysing the data. Among these are methods for 
using whole-mixture data on a toxicologically similar mixture, such as the comparative 
potency methods; methods for incorporating information on toxicological interactions to 
modify a Hazard Index (HI) into an interaction-based hazard index; and generalized 
procedures for mixtures involving classes of similar chemicals.  
   The comparative potency method is based on the use of a set of mixtures of highly similar 
composition to estimate a scaling factor that relates toxic potency between two different 
assays of the same toxic endpoint. The mixture of concern can then be tested in one of the 
assays, and the resulting potency is then adjusted by the scaling factor to estimate the human 
cancer potency. The comparative potency method involves extrapolation across mixtures and 
across assays. It is restricted to a set of different assays that monitor the same, single type of 
health effect, and to different mixtures that are considered toxicologically similar. The basic 
assumption is that the curves of dose response for the assays are the same shape and that the 
relationship between any two mixtures will be the same, whichever assay is used. The 
guidance give an example of this methodology applied to the estimation of human cancer unit 
risk from exposure to polycyclic organic matter (POM). 
   The interaction-based hazard index is based on the key assumptions that interactions in a 
mixture can be adequately represented as departures from dose addition, and that influence of 
all the toxicologic interactions in the mixture can be adequately approximated by some 
function of the pairwise interactions. Toxicologic interactions have been mostly studied with 
binary mixtures. The assumption is made that higher order interactions are relatively minor 
compared to binary interactions; one way to include interactions in a mixture assessment is 
then to modify the noninteractive assessment by knowledge of these binary interactions. 
Thus, this interaction-based HI evaluates binary mixtures and introduces a classification that 
indicates the expected direction of interaction (synergistic or antagonistic) by using an 
alphanumerical scoring system. The scores are then combined with the hazard index. Thus, 
each term is modified according to the influence (interaction) of the other components, and 
then these modified terms are summed. The full formula for the interaction-based HIINT  is 
the following: 
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where: 
HIINT = HI modified by binary interactions data, 
HQi = hazard quotient for chemical i (unitless, e.g., daily intake/RfD), 
fij = toxic hazard of the j
th
 chemical relative to the total hazard from all chemicals potentially interacting with 
chemical i (thus j cannot equal i), 
Mij = interaction magnitude, the influence of chemical j on the toxicity of chemical i, 
Bij = score for the strength of evidence that chemical j will influence the toxicity of chemical i, and 
Ɵij = degree to which chemicals i and j are present in equitoxic amounts. 
 
  In this report, there are also expanded discussions of the concerns when using only whole-
mixture data as well as when using only data on the individual chemical components; 
moreover no single approach is recommended, but guidance is given for the use of several 
approaches depending on the nature and quality of the data.  
   The appendices contain definitions, a discussion on toxicologic interactions and 
pharmacokinetic models. Method-specific user fact sheets for quantitative risk assessment, 
which are intended to provide a concise overview of each currently available method, are 
given. These fact sheets provide the following information relative to the risk assessment 
approach: 
- Type of Assessment 
- Data Requirements 
- Section(s) 
- References 
- Strategy of Method 
- Ease of Use 
- Assumptions 
- Limitations 
- Uncertainties 
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